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Abstract
Homeostasis is established through bidirectional communication between the periphery and the central
nervous system. To maintain homeostasis, some biological drives can become prioritized over others.
This changing balance between biological drives encourages peak performance and survival. However,
when homeostasis is disturbed, chronic inflammatory diseases such as obesity, chronic pain, and arthritis
can arise. We became interested in understanding if competing biological drives could be leveraged for
therapeutic purposes. Food restriction inhibits inflammation; therefore, we explored how hunger and
feeding neural circuits affect responses to noxious agents. Our first study investigated the role of hunger
to alleviate pain behavior. We found that hunger significantly reduces time spent licking during the
inflammatory phase of a formalin pain assay but leaves intact pain responses to acute threats. We next
evaluated if hypothalamic hunger neurons are involved in this behavioral change. Stimulation of agoutirelated protein expressing (AgRP) neurons significantly reduced formalin pain behavior. To determine the
central nodes that mediate this effect, we systematically screened AgRP neuron projections for their
ability to suppress pain. Only AgRP neurons projecting to the hindbrain parabrachial nucleus was able to
reduce inflammatory pain behavior. Our second study investigated the role of hunger to influence
inflammatory responses of an injury site. Using two models of localized inflammation, we found that food
deprivation robustly reduces inflammation, pro-inflammatory cytokine levels, and associated temperature
increases induced by injection of noxious stimuli [complete Freund’s adjuvant (CFA) or formalin].
Activation of AgRP neurons recapitulated the effect of food deprivation on inflammation. We then
evaluated the role of each AgRP axonal target structure to reduce inflammation. Interestingly, stimulation
of AgRP neurons that project to the paraventricular nucleus of the hypothalamus or the parabrachial
nucleus were sufficient to reduce CFA-induced inflammation. Finally, we identified the vagus nerve as a
key pathway for the anti-inflammatory effect of hunger. We propose that hunger, through AgRP neurons,
inhibits pro-inflammatory responses from the central nervous system and changes the output of efferent
vagal fibers. This body of work reveals a central node for the reduction of pain and inflammation,
highlighting a novel role for hypothalamic circuits to influence injury responses.
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ABSTRACT
CENTRAL CONTROL OF PAIN AND INFLAMMATION THROUGH A HUNGER CIRCUIT
Michelle L. Klima
J. Nicholas Betley

Homeostasis is established through bidirectional communication between the periphery
and the central nervous system. To maintain homeostasis, some biological drives can become
prioritized over others. This changing balance between biological drives encourages peak
performance and survival. However, when homeostasis is disturbed, chronic inflammatory
diseases such as obesity, chronic pain, and arthritis can arise. We became interested in
understanding if competing biological drives could be leveraged for therapeutic purposes. Food
restriction inhibits inflammation; therefore, we explored how hunger and feeding neural circuits
affect responses to noxious agents. Our first study investigated the role of hunger to alleviate pain
behavior. We found that hunger significantly reduces time spent licking during the inflammatory
phase of a formalin pain assay but leaves intact pain responses to acute threats. We next evaluated
if hypothalamic hunger neurons are involved in this behavioral change. Stimulation of agouti-related
protein expressing (AgRP) neurons significantly reduced formalin pain behavior. To determine the
central nodes that mediate this effect, we systematically screened AgRP neuron projections for
their ability to suppress pain. Only AgRP neurons projecting to the hindbrain parabrachial nucleus
was able to reduce inflammatory pain behavior. Our second study investigated the role of hunger
to influence inflammatory responses of an injury site. Using two models of localized inflammation,
we found that food deprivation robustly reduces inflammation, pro-inflammatory cytokine levels,
and associated temperature increases induced by injection of noxious stimuli [complete Freund’s
adjuvant (CFA) or formalin]. Activation of AgRP neurons recapitulated the effect of food deprivation
on inflammation. We then evaluated the role of each AgRP axonal target structure to reduce
inflammation. Interestingly, stimulation of AgRP neurons that project to the paraventricular nucleus
of the hypothalamus or the parabrachial nucleus were sufficient to reduce CFA-induced
iii

inflammation. Finally, we identified the vagus nerve as a key pathway for the anti-inflammatory
effect of hunger. We propose that hunger, through AgRP neurons, inhibits pro-inflammatory
responses from the central nervous system and changes the output of efferent vagal fibers. This
body of work reveals a central node for the reduction of pain and inflammation, highlighting a novel
role for hypothalamic circuits to influence injury responses.
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CHAPTER 1:

INTRODUCTION

Chronic inflammatory diseases pose a huge global health threat according to the World
Health Organization. Over 40% of Americans are living with a chronic inflammatory condition and
that number is expected to rise over the next 30 years (Pahwa et al., 2020). Chronic inflammatory
diseases include a range of etiologies such as cardiovascular disease, allergies, arthritis and joint
diseases, and pain diseases. Each type of disease poses its own economic and personal burden
for the patient. Current treatments for chronic inflammatory diseases typically involve diet and
activity changes as well as medication therapy. However, prognosis for many chronic inflammatory
diseases is poor, leaving patients to suffer.
This dissertation focuses on two aspects of chronic inflammatory diseases: pain and
inflammation. Pain and inflammation are natural responses to injury and immune threats that are
critical for survival. However, both can become maladaptive and lead to chronic inflammatory
disease (Pahwa et al., 2020). In 2010, it was estimated that 100 million Americans suffer from
chronic pain and spend at least $560 million dollars in healthcare each year (Gaskin and Pain,
2012). Chronic and maladaptive pain are a public health concern that can be tackled with proper
medications; however, the current treatment options are causing other obstacles for their users.
The most commonly used drug class for pain management are opioids, which have a very high
abuse potential and pose their own threat to public health. In fact, one in four chronic pain patients
using opioid treatments is also receiving medical attention for opioid abuse disorder (ASAM, 2016).
Prescription opioids are fueling the opioid epidemic in the United States. In 2019, more than 50,000
Americans died from opioid-related use. The high incidence of opioid addiction makes it necessary
to reduce the number of opioid prescriptions by finding alternate pain and inflammation
management strategies that do not have an abuse potential.
The central nervous system plays a role in all physiological functions rendering it an
effective therapeutic target for diseases that affect the whole body. The main goal of the central
nervous system is to maintain homeostasis between all biological drives and physiological needs
1

to ensure survival. Under certain conditions it becomes necessary for one biological drive to be
prioritized over another and adjust behavior and physiology accordingly. Using this theory of
competing biological drives, we have shown that hunger can outcompete pain and inflammatory
responses to an injury. This mechanism may be leveraged as a therapeutic target to manage
conditions of chronic pain and inflammation that have been historically difficult to treat.

The central nervous system contributes to the maintenance of physiological needs
including hunger.
All physiological functions of the body require coordination and communication between
organs to create homeostasis for a proper balance between biological drives. The autonomic
nervous system is a major homeostatic regulator as it innervates nearly all organs in the body to
facilitate the management of many different functions. Typically, autonomic neurons sense
biological factors from their target organs and send that signal to the central nervous system for
integration; together these two processes are called the central autonomic network. The central
nervous system then sends the signal to various brain regions which ultimately transmit a response
through motor neurons back to the periphery to maintain whole-body homeostasis (Gibbons, 2019).
Brain regions throughout the brainstem, midbrain and cortex contribute to the network including the
nucleus tractus solitarius (NTS), the parabrachial nucleus (PBN), the periaqueductal gray (PAG),
the hypothalamus, and the insular cortex (Figure 1.1, adapted from Benarroch, 1993). The central
autonomic network contributes to pairing physiological needs with emotions, maintaining
homeostasis among neuroendocrine and autonomic function, initiating stress responses, and
facilitating viscerosensory behaviors such as breathing, circulation and vomiting (Benarroch, 1993).
Disorders of these brain regions can cause disturbances in autonomic function. For instance,
hypothalamic disorders can cause disruptions of healthy feeding behavior and energy metabolism
leading to obesity or anorexic phenotypes (Carmel, 1980). The autonomic control of food intake is
of particular relevance for the work outlined in this dissertation.
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Food intake and energy expenditure are highly regulated processes to maintain
homeostasis between nutrient requirements and energy stores. Despite uncontrollable factors
such as food availability, emotions and social environments that influence individual meal sizes,
overall energy homeostasis is preserved for each individual (Schwartz et al., 2000). The basic
mechanism to maintain energy homeostasis is to balance anabolic and catabolic metabolism. This
balance is key to creating appropriate body adiposity through suitable food intake and energy
expenditure. Signals from body fat stores and gut hormones integrate in the central nervous system
to activate the appropriate metabolic pathway and inhibit competing pathways. Leptin and insulin
are adiposity signals released by body fat that directly activate the hypothalamus. When these
adiposity signals are at low concentrations in the blood stream, they cause the anabolic pathway
to be inhibited yet the catabolic pathway is activated. This creates a body state conducive to
restoring fat reserves by reducing energy expenditure and increasing food consumption. Upon the
ingestion of food, the digestive tract releases satiation signals that act in the NTS to rebalance the
metabolic pathways and determine the appropriate amount of food to consume (Schwartz et al.,
2000). Energy homeostasis pits different cell types, hypothalamic nuclei, and brainstem regions
against one another to create a dynamic balance dependent on physiological, social, and
environmental cues.

Interoceptive cues can change behavior and physiology based on environmental and
physical needs of the animal.
Interoception is the ability of the body to sense its internal state and adjust physiology or
behavior to maintain homeostasis across different biological needs (Quadt et al., 2018, Sherrington,
1906). Interoception requires bidirectional communication between the body and brain with
hormones and neuropeptides. There are three main aspects of interoception: afferent signaling,
central processing, and efferent signaling. Various receptor types ranging from chemoreceptors to
mechanoreceptors detect changes in the periphery (Berntson and Khalsa, 2021). This information
is sent to the central nervous system through humoral and neural pathways, especially through the
3

vagus nerve. These signals are then processed in the brainstem and transduced throughout
homeostatic, emotional, and physiological processing centers (Berntson and Khalsa, 2021; Quadt
et al., 2018). Ultimately, these signals converge in the cortex to integrate the components and
determine appropriate changes in mood, physiology, and behavior to maintain peak performance.
The signals for adjustments are then sent back to the body through efferent pathways, including
the vagus nerve (Quadt et al., 2018).
The immune system works effectively through interoceptive cues to induce sickness
behavior and physiological changes to create a healing environment. The immune system
communicates threats to the central nervous system through the vagus nerve. Immune cells and
vagal neurons have similar humoral and neuropeptide channels allowing for efficient and immediate
communication (Goehler et al., 2000; Quadt et al., 2018). The immune interoceptive cues cause
changes to behavior including fatigue and social isolation to reduce bodily harm and infection.
Interestingly, immune signals also cause a reduction in consumption behaviors presumably to
direct resources to the immune response instead of digestion (Quadt et al., 2018). This is a prime
example of an interoceptive cue deprioritizing other biological drives. Immune challenges can
minimize the necessity of food and water in order for the body to attend to the most salient need –
the infection or injury. Understanding how biological drives out compete each other could be a
powerful tool leveraged for management of chronic inflammatory diseases to return the body to
homeostasis.

Feeding behavior is maintained within the arcuate nucleus of the hypothalamus through a
balance of AgRP and POMC activity.
The brain integrates signals from the periphery and external environment to carry out
behaviors to ensure survival. Of particular interest during my graduate work is feeding behavior.
Feeding is a sophisticated behavior informed by energetic, nutritional, and environmental needs.
The arcuate nucleus of the hypothalamus (ARC) has evolved to be especially poised for feeding
through two primary cell populations: the anorexigenic pro-opiomelanocortin (POMC) neurons and
4

the orexigenic agouti related protein expressing (AgRP) neurons. AgRP and POMC neurons
receive satiety and hunger signals from the periphery via neural, humoral, and endocrine signaling
to influence feeding, energy expenditure and body weight. The two cell populations share inhibitory
connections to keep orexigenic and anorexigenic signals in balance with each other. POMC
neurons are activated by satiety signals and release alpha-melanocyte-stimulating hormone to
activate melanocortin-4 receptors (Mc4r) to reduce food intake and increase energy expenditure.
AgRP neurons, conversely, are activated by hunger signals and release AgRP, neuropeptide-Y
(NPY), and gamma-Aminobutyric acid (GABA) to increase food intake (Hahn et al., 1998; Horvath
et al., 1992, 1997). Both populations project to targets throughout the brain to initiate associated
behavioral and physiological changes required to carry out the desired feeding phenotype.
AgRP and POMC neurons are necessary to maintain proper feeding behavior. In fact,
ablation of AgRP neurons in adult animals will cause animals to experience irreversible starvation
(Gropp et al., 2005; Luquet et al., 2005). Interestingly, this phenotype is not seen when AgRP is
ablated during development suggesting there are compensatory mechanism at play during
development to ensure feeding and survival (Luquet et al., 2005). Alternatively, ablation of POMC
neurons in adult animals causes an increase in food intake and leads to obesity (Gropp et al.,
2005). While there is a constant interplay between POMC and AgRP neurons, my thesis work
specifically interrogates AgRP neurons.

AgRP neuron activation, naturally by deprivation or experimentally, induces feeding
behavior.
It has been well established that AgRP neuron activity can be causally linked to food
deprivation. AgRP mRNA is significantly higher in the ARC of mice food deprived compared to ad
libitum fed controls. Further, co-expression of AgRP mRNA with NPY mRNA increases significantly
when animals are food deprived (Hahn et al., 1998). Additionally, deprivation leads AgRP neurons
to have more spontaneous neurotransmitter release than in the fed conditions. This increased
plasticity suggests that AgRP neurons are more active during deprived states (Yang et al., 2011).
5

Consistent with the increased plasticity, AgRP neurons also produce more dendritic spines, have
increased synaptic transmission, and thus increased excitability during food deprivation (Liu et al.,
2011). Taken together these data show that food deprivation activates AgRP neurons.
AgRP neurons are sufficient to reproduce aspects of hunger in the absence of peripheral
cues. Activation of AgRP neurons through chemogenetics (Krashes et al., 2011) or optogenetics
(Aponte et al., 2011) causes an animal to voraciously eat under ad libitum conditions (Figure 1.2).
Krashes et al. (2011) showed that animals expressing the excitatory designer receptors activated
by designer drugs (DREADD, HM3D), will eat more chow than controls for at least 4 h after an
activation of the synthetic receptors with an injection of clozapine-n-oxide (CNO) (Figure 1.2a).
Aponte et al. (2011) also showed that AgRP activation leads to immediate food intake by using
photostimulation on AgRP neurons expressing the light sensitive channel channelrhodopsin-2
(ChR2). They further showed that feeding is dependent on acute AgRP activation since there were
no long-term feeding changes once the stimulation had ended (Figure 1.2c). Manipulating food
intake through AgRP neuron activation is reliable and repeatable as we were able to produce
similar food intake measurements with chemogenetic and optogenetic activation (Figure 1.2b,
1.2d). This rapid, reversible, and specific activation provides a model of feeding behavior without
the off-target, chronic effects of hunger. Although hunger is a robust, complex body condition that
involves multiple systems, we can manipulate a specific pathway to isolate aspects of feeding
influenced solely by AgRP neurons.
AgRP neurons ramify to seven areas throughout the brain: bed nucleus of the stria
terminalis (BNST), paraventricular hypothalamus (PVH), lateral hypothalamus (LH), paraventricular
thalamus (PVT), central amygdala (CeA), PAG, and PBN (Figure 1.3a). Strikingly, AgRP
projections have a one-to-one connection meaning there are no collateral axon projections to other
targets; each AgRP axon communicates with one single brain region (Betley et al., 2013). This
architecture allows for individual projection target activation of AgRP axons to understand functional
differences between AgRP projection sites. Optogenetics is a robust tool to test each projection
6

region’s role in a particular behavior. In this approach, optic fibers are placed over each target
region in mice expressing ChR2 (Figure 1.3b). Betley et al. (2013) spearheaded this method and
evaluated each projection target’s role in food intake. They found that only four AgRP target regions
induced immediate feeding, while the other three had no effect on feeding (Figure 1.3c). Stimulation
of AgRP axon terminals in the BNST, PVH, LH and PVT significantly increased food intake,
however the amounts of food consumed was different between each target. Stimulation of AgRP
axon terminals in the PAG, PBN, and CeA had no effect on food intake (Betley et al., 2013). This
difference in consumption suggests that each target structure plays a different role in encouraging
feeding behavior.

AgRP neurons can initiate feeding through the deprioritization of other behaviors and
biological drives.
It has been hypothesized that AgRP neurons can influence feeding through behavioral
mechanisms other than just consumption. Interestingly, AgRP axons interact with structures that
compose the central autonomic network (see Figure 1.1 and Figure 1.3a). This intimate connection
with autonomic control centers suggests that AgRP neurons are able to influence more than just
food intake. In fact, AgRP neurons have been shown to prioritize feeding by deprioritizing other
competing need states. Animals have several homeostatic needs that are regulated by behavior to
adapt for the current physiological and environmental condition. Some of these behaviors include
sleep, hydration, feeding, reproduction, and predator evasion. In certain scenarios, one need state
can become more dire than others. For instance, under extreme starvation it can become more
important for an animal to risk predation to forage for food. In fact, AgRP neurons have been shown
to influence adaptive behavior to reduce anxiety in response to high-risk situations to acquire food
(Burnett et al., 2016; Jikomes et al., 2016). AgRP neurons can also deprioritize social interactions,
water-seeking behavior, fertility, pain, and sleep (Alhadeff et al., 2018; Burnett et al., 2016;
Goldstein et al., 2018; Padilla et al., 2017). Taken together, these data show that AgRP neurons
can temper other need states to prioritize feeding.
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Frequent food restriction can improve health and longevity in many different species.
Food is essential for survival, however, evolutionarily food was less available than in
modern society. Because of this, the body developed in a way to survive when food became scarce.
Organs such as the liver and adipose tissue conserve energy from previous meals to enable
survival in times with less energy consumption. Further, in fasted states, metabolic, endocrine, and
nervous system functions adapt to allow for peak performance ultimately to acquire more food
(Mattson et al., 2017). Today, high-caloric foods are readily available, and rates of obesity are
rapidly increasing (Rakhra et al., 2020). The typical Western diet is composed of artificial foods
high in fat, sugar, and sodium and minimal amounts of fruits and vegetables (Institute of Medicine,
2010). Many chronic inflammatory diseases are believed to be directly related to the excess caloric
ingestion, including diabetes, cardiovascular disease, and some cancers (Rakhra et al., 2020). With
this disordered eating in mind, changing feeding behavior to match our evolutionary physiology
may be a cure for obesity-related diseases.
Food restriction has been recently hailed as a “miracle cure” for improved health and longer
lifespan by improving cardiac function and maintaining a healthy body weight. Ultimately this leads
to lower incidences of neurological, cardiac, and respiratory diseases, and cancer (Golbidi et al.,
2017; Mattson et al., 2017). Recommended fasting diets range from multiple days with no food
consumption, to daily caloric restrictions, to restricted feeding in specific hours of the day. Each
method of restriction is being tested and validated using clinical and pre-clinical studies, however,
rarely are two methods compared in the same study making it impossible to compare the
effectiveness of each approach in a controlled manner (Mattson et al., 2017). However, restriction
has been shown to increase lifespan in various model organisms. Bacteria, yeast, and worms
survived significantly longer when raised in environments with no available nutrients (Figure 1.4a1.4c, adapted from Longo and Mattson, 2014). Mice also lived significantly longer than ad libitum
fed controls when maintained on a fasting schedule from a young age (Figure 1.4d, adapted from
Longo and Mattson, 2014). There have been mixed results in preclinical work on the effectiveness
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of restrictive diets on health. Factors such as age, genetic background, feeding method, and time
course of the restriction can influence the success of each treatment approach (Mattson et al.,
2017). Overall, caloric restriction seems to be a key factor in a healthy life, highlighting a need to
better understand the mechanisms responsible for the beneficial effects of food restrictions.

Food restriction reduces inflammation likely contributing to the benefits of caloric deficit on
longevity.
Food restriction inhibits inflammation. Fasting inhibits the activation of inflammasomes
(Traba and Sack, 2017; Traba et al., 2015; Vandanmagsar et al., 2011), preventing the production
and release of pro-inflammatory cytokines and reducing serum levels of tumor necrosis factor alpha
(TNFα), interleukin-1B, interleukin-18, brain-derived neurotrophic factor, and ceramides
(Brandhorst et al., 2015; Johnson et al., 2007; Meydani et al., 2016; Youm et al., 2015). Food
restriction also reduces oxidative stress, particularly in mononuclear cells and leukocytes (Dandona
et al., 2001; Heilbronn and Ravussin, 2003; Johnson et al., 2007), alleviating inflammation. Beyond
inflammatory pathways, food restriction can improve other indications of inflammation such as bone
density (Brandhorst et al., 2015; Youm et al., 2013), cognitive impairment (Youm et al., 2013),
respiration (Johnson et al., 2007), muscle (Mercken et al., 2013) and cardiac (Fontana et al., 2004)
function, metabolism (Brandhorst et al., 2015), and neuroendocrine function (Heilbronn and
Ravussin, 2003), sympathetic nerve output (Heilbronn and Ravussin, 2003), and cancer incidence
(Brandhorst et al., 2015). These anti-inflammatory effects may contribute to the beneficial effects
of food restriction on longevity, given the role of inflammation in the development of age-associated
diseases (Franceschi and Campisi, 2014; Youm et al., 2013). Thus, a better understanding of how
fasting reduces inflammation will be key to the prevention and treatment of inflammatory diseases.
Food deprivation leads to a series of complex physiological changes in both the central
nervous system and the periphery. However, it is unclear if the mechanisms by which hunger
affects inflammation are nucleated in the brain or in the periphery. For example, food deprivation
influences peripheral hormone levels, gene expression, physiology, and metabolic factors that may
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influence the immune system (Al-Hasani and Joost, 2005; Culbert et al., 2016; Wang et al., 2006).
Alternately, it has also been shown that central manipulation of the Sirtuin 1 gene in AgRP neurons
can influence adaptive immune responses (Matarese et al., 2013). These hunger-activated AgRP
neurons are known to drive feeding behavior (Hahn et al., 1998; Horvath et al., 1992, 1997;
Sternson and Eiselt, 2015). Importantly, AgRP neuron activity also alleviates pain caused by an
inflammatory chemical injury (Alhadeff et al., 2018). These data raise the possibility that AgRP
neurons may contribute to the anti-inflammatory effects of hunger. The work in this dissertation
investigates how hunger, through AgRP neurons, can influence pain and inflammation as a
potential therapeutic mechanism for chronic inflammatory diseases.
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Figure 1.1 | The central autonomic network is composed of brain regions throughout the
brainstem, midbrain, and cortex (adapted from Benarroch, 1993).
Diagram of a human brain with key central autonomic network regions labeled.
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Figure 1.2 | Chemogenetic and optogenetic activation of AgRP neurons induces rapid,
reversible, and reliable food intake.
(a) Krashes et al (2011) used chemogenetic activation of AgRP to initiate food intake. (a1)
Schematic: Expression of the hM3D in AgRP neurons in the ARC. (a2) Food intake was
significantly higher in HM3D mice treated CNO than control mice. (b) Our laboratory is able to
recapitulate food intake using chemogenetic activation on AgRP neurons. Mice expressing HM3D
had significantly higher food intake after CNO administration than saline. (c) Aponte et al (2011)
used optogenetic stimulation of AgRP neurons to initiate food intake. (c1) Experimental design:
An optical fiber was implanted above the ARC to allow for stimulation of AgRP neurons. Food
intake was measured at 1 h increments before, during and after stimulation. (c2) Mice without
ChR2 expression (control) had no significant difference in food intake across time points. Mice
expressing ChR2 in AgRP neurons consumed significantly more food during stimulation than
before or after. (d) Our lab is able to recapitulate food intake using optogenetics on AgRP
12

neurons. Mice expressing ChR2 in AgRP neurons consumed significantly more food with
stimulation. Data expressed as mean ± standard error of the mean (SEM): n.s.=not significant,
*=p<0.05, ***=p<0.001.
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Figure 1.3 | AgRP neuron architecture allows for interrogation of individual axon targets
for any given behavior (adapted from Betley et al., 2013).
(a) AgRP neurons in the ARC ramify to 7 brain regions. (b) Fibers can be placed over each target
region to activate axon terminals from AgRP neurons expressing ChR2. (c) Stimulation of ARC à
aBNST, PVH, LH, and PVT causes a significant increase in food intake. Stimulation of ARC à
CeA and PAG had no effect on food intake. Data expressed as mean ± SEM: n.s.=not significant,
**=p<0.01, ***=p<0.001.
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Figure 1.4 | Food restriction can increase longevity in simple organisms and complex
animals (adapted from Longo and Mattson, 2014).
(a) Percent survival of Escherichia coli grown in either nutrient-rich Lyosgeny Broth (LB) or
nutrient-free sodium chloride (NaCL) mediums (Gonidakis et al., 2010). (b) Percent survival of
Saccharomyces cerevisiae grown in either nutrient-rich (DBY746, SDC) solution or nutrient-free
water (Wei et al., 2008). (c) Percent survival of Caenorhabditis elegans living in a standard
nutrient-rich environment (control fed), a 10% caloric nutrient environment (10% control), or in a
nutrient-free environment (no bacteria) (Kaeberlein et al., 2006). (d) Percent survival of male
C57BL/CJ mice maintained on an ad libitum or alternating day fasting diet (Goodrick et al., 1990)
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CHAPTER 2:

HUNGER REDUCES THE AFFECTIVE AND BEHAVIORAL COMPONENTS
OF INFLAMMATORY PAIN.

I worked in collaboration with Dr. Amber Alhadeff while she was a post-doctoral researcher in the
Betley laboratory to complete the publication Alhadeff et al., 2018. As a listed author on the
manuscript, I helped complete experiments, analyze data, and interpret the results. More
specifically, I conducted formalin pain assays for: ad libitum fed v food deprived mice, AgRP axon
mice, AgRP peptides in the PBN; performed the conditioned place aversion assay; and
addressed reviewer concerns about the affective properties of PBN stimulation: open field assay
[tail suspension test, hedonic feeding assay, conditioned place preference, conditioned place
aversion (data not published)].
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Summary
Hunger and pain are two competing signals that individuals must resolve to ensure survival.
However, the neural processes that prioritize conflicting survival needs are poorly understood.
We discovered that hunger attenuates behavioral responses and affective properties of
inflammatory pain without altering acute nociceptive responses. This effect is centrally controlled,
as activity in hunger-sensitive Agouti-Related Protein (AgRP)-expressing neurons abrogates
inflammatory pain. Systematic analysis of AgRP projection subpopulations revealed that the
neural processing of hunger and inflammatory pain converge in the hindbrain parabrachial
nucleus (PBN). Strikingly, activity in AgRPàPBN neurons blocked the behavioral response to
inflammatory pain as effectively as hunger or analgesics. The anti-nociceptive effect of hunger is
mediated by Neuropeptide Y (NPY) signaling in the PBN. By investigating the intersection
between hunger and pain, we have identified a neural circuit that mediates competing survival
needs and uncovered NPY Y1 receptor signaling in the PBN as a target for pain suppression.
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Introduction
Survival depends on fulfilling salient needs in a changing environment. Formative
behavioral observations highlighted the remarkable ability of individuals across species to
adaptively respond to dynamic physiological and environmental challenges (Pavlov and Folʹbort,
1926; Tinbergen, 1951). Given these insights, it is surprising that the neural and molecular
mechanisms governing the prioritization of adaptive behaviors remain elusive. While great strides
have been made in understanding how individual need states such as hunger, thirst, fear and pain
are signaled in the brain, relatively little is known about how the brain prioritizes such needs.
Pain is a natural response to injury, but long-term inflammation and associated pain can be
maladaptive. While acute pain is reflexive in that it is triggered by activation of primary sensory
neurons (i.e. nociceptors) in the periphery, inflammatory pain is mediated at least in part by central
mechanisms (Coderre et al., 1990). From this perspective, targeting central nociceptive pathways
may be an effective way to selectively reduce inflammatory pain while leaving intact adaptive
responses to acute pain. Because persistent pain remains a major public health burden that is not
well-controlled by current analgesics (Loeser, 2012), identifying endogenous mechanisms that
specifically reduce the inflammatory response to injury may provide strategies for the design of
effective pain therapies.
As a unique approach to identify neural circuits that regulate pain, we sought to explore
competing need states that affect nociception. The response to pain is typically an adaptive
mechanism that protects organisms against dangerous stimuli. However, as other physiological
needs such as hunger increase, behavior must shift from avoiding bodily injury to fulfilling other
immediate needs. Interactions between competing needs states have been reported; for example,
acute stressors such as inescapable footshock, cold-water swims, or caloric deprivation can
produce short-term analgesia (Bodnar et al., 1977; Bodnar et al., 1978b; Hamm and Lyeth, 1984;
Hargraves and Hentall, 2005; LaGraize et al., 2004). Additionally, hunger has been shown to
influence adaptive behavioral responses to fear and anxiety (Burnett et al., 2016; Jikomes et al.,
2016; Padilla et al., 2016). We reasoned that individuals must prioritize the most acute threat to
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survival and behave accordingly. To explore the behavioral, neural, and molecular mechanisms
that rank survival needs, we examined the bidirectional interaction between hunger and different
modalities of pain.
Here, we found that hunger selectively inhibits both the behavioral response and affective
properties of inflammatory pain. Since neurons responsive to hunger are well-characterized
(Sternson and Eiselt, 2017), they provide an entry point to examine the neural circuit intersection
of hunger and pain. We discovered that hypothalamic agouti-related protein-(AgRP) expressing
neurons that project to the hindbrain parabrachial nucleus (PBN) selectively inhibit responses to
inflammatory pain. The analgesic effect of hunger on inflammatory pain is mediated by
neuropeptide Y (NPY) signaling on NPY Y1 receptors in the PBN. We further show that acute
thermal, but not inflammatory, pain inhibits the activity of AgRP neurons, demonstrating that central
mechanisms prioritize the most salient threat. Taken together, our data demonstrate that AgRP
neurons mediate the interaction between hunger and pain and have uncovered PBN NPY Y1
receptor signaling as a target for analgesia.

Results
Hunger Selectively Attenuates Responses to Inflammatory Pain.
To understand how competing survival signals are prioritized, we first explored how 24 h
food deprivation influences the behavioral response to pain induced by either chemical (formalin),
thermal (52°C hotplate) or mechanical (Von Frey filament) insults (Figure 2.1A, 2.1H, and 2.1J)
(Bodnar, 1978; Hamm and Lyeth, 1984; Hargraves and Hentall, 2005; LaGraize et al., 2004).
Formalin paw injection is a reliable and widely used model of nociception with high face validity
when tested with analgesic drugs (Hunskaar and Hole, 1987). Formalin induces distinct acute (0-5
min) and long-term inflammatory (15-45 min) phases of pain (Dubuisson and Dennis, 1977), while
responses to a hotplate or Von Frey filaments are acute and transient. We discovered that 24 h
food deprivation attenuated the duration (Figure 2.1B-2.1D) and frequency (Figure 2.1E) of
inflammatory phase paw licking after injection of a noxious chemical stimulus, similar to the effect
of an anti-inflammatory painkiller (Hunskaar and Hole, 1987) (Figure 2.S1A-2.S1E). Conversely,
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food deprivation had no effect on the acute phase response to formalin injection (Figure 2.1F and
2.1G) or the response to acute thermal (Figure 2.1H and 2.1I) or mechanical (Figure 2.1J and 2.1K)
pain, unlike an opioid painkiller (Figure 2.S1F-2.S1H). These data demonstrate that hunger
selectively blocks inflammatory phase pain responses.
To determine whether hunger influences inflammation-induced sensitization to different
modalities of pain, we next induced a persistent inflammatory response in the paw via injection of
Complete Freud’s Adjuvant (CFA) (Marchand et al., 2005). After paw injection of CFA, mice exhibit
sensitization to both mechanical (Figure 2.2A, 2.2B, and 2.2E) and thermal (Figure 2.2G and 2.2H)
stimuli. The sensitization to both of these stimuli is abolished in food restricted mice (Figure 2.2C,
2.2D, 2.2F and 2.2I), suggesting that hunger reduces inflammation-induced sensitization to thermal
and mechanical pain. Taken together, these data suggest that hunger is a powerful suppressant of
inflammatory pain response.
Pain results in both behavioral responses as well as negative affect, the latter of which has
been modeled in rodents using classic conditioning paradigms (Deyama et al., 2007; Johansen
and Fields, 2004). We first investigated how hunger influences the affective properties of pain by
examining whether hunger attenuates a condition placed avoidance normally associated with
inflammatory pain (Figure 2.3A). We found that ad libitum fed mice exhibited a conditioned place
avoidance of cues previously paired with formalin-induced inflammatory pain (Figure 2.3B-2.3D).
This post-conditioning avoidance was abolished in animals that were food restricted during
conditioning (Figure 2.3B-2.3D), a result that was independent of changes in locomotor activity
(Figure 2.3E and 2.3F). This result is not likely due to a hunger-induced deficit in associative
learning, given that food restricted mice learn to avoid contexts associated with other aversive
stimuli as effectively as ad libitum fed mice (Figure 2.3G). Similar to the attenuation of a formalin
conditioned place avoidance, we found that hunger also attenuated formalin-induced immobility
(Figure 2.3H). Together, these data suggest that hunger attenuates measures of pain-induced
negative affect, in addition to behavioral responses to inflammatory pain.
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AgRP Neurons Specifically Inhibit Inflammatory Pain
Formalin paw injection leads to paw inflammation in food deprived mice (Figure 2.S1I and
2.S1J), suggesting central mechanisms may mediate the interaction between hunger and
inflammatory pain. Neural circuits activated by hunger are well-characterized (Sternson and Eiselt,
2017). In particular, neurons that co-express agouti-related protein (AgRP), gamma-aminobutyric
acid (GABA), and Neuropeptide Y (NPY) (referred to as AgRP neurons) are critical regulators of
food intake (Luquet et al., 2005). AgRP neuron inhibition in hungry mice reduces food intake
(Krashes et al., 2011), while activation of AgRP neurons in sated mice robustly increases food
intake (Aponte et al., 2011; Krashes et al., 2011). Photostimulation of mice expressing
channelrhodopsin-2 (ChR2) in AgRP neurons (AgRPChR2) dramatically reduced both formalininduced inflammatory phase pain responses (Figure 2.4A-2.4D; Figure 2.S2A-2.S2C) and CFAinduced nociceptive sensitization (Figure 2.4E and 2.4F; Figure 2.S2F-2.S2H) relative to responses
of GFP-expressing control mice (AgRPGFP). This effect was specific to inflammatory pain as
activating AgRP neurons did not influence acute phase chemical or thermal pain responses (Figure
2.S2D, 2.S2E, 2.S2I, and 2.S2J) nor responses to control saline paw injections (Figure 2.S2K2.S2M). Initiating AgRP neuron stimulation during an ongoing pain response inhibited paw licking
within minutes (Figure 2.4G and 2.4H). This indicates that AgRP neuron activity rapidly mediates
a behavioral switch and does not rely on long-term activity of AgRP neurons that may entrain a
single behavioral state. To test whether AgRP neuron activity is sufficient to suppress inflammatory
pain, we chemogenetically inhibited AgRP neurons during hunger. Food deprived mice expressing
inhibitory Designer Receptors Exclusively Activated by Designer Drugs (DREADDs, hM4D) in
AgRP neurons (AgRPhM4D+) significantly reduce food intake relative to littermate controls
(AgRPhM4D-) following injection of the designer ligand clozapine-N-oxide (CNO, Figure 2.4I), as
previously described (Krashes et al., 2011). Inhibition of AgRP neurons significantly reduced the
protective effect of hunger on inflammatory pain (Figure 2.4J-2.4L). Thus, AgRP neuron activity
during hunger is both necessary and sufficient to suppress inflammatory pain responses without
affecting acute pain responses, recapitulating the behavioral interaction observed in hunger and
identifying a neural mechanism for the suppression of inflammatory pain.
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AgRPàPBN Neurons Specifically Inhibit Inflammatory Pain.
Given that hunger suppresses longer-term inflammatory pain responses, we next sought
to identify brain regions where hunger and nociceptive information converge. Several brain regions
innervated by AgRP neurons are also activated by formalin paw injection and implicated in
nociception (Baulmann et al., 2000). To explore potential brain regions targeted by AgRP neurons
that mediate inflammatory pain, we performed a formalin paw injection in ad libitum fed mice and
quantified neurons directly under AgRP axons that expressed the immediate early gene Fos. The
number of neurons expressing Fos protein was increased in the terminal projection fields of several
AgRP neuron target regions following formalin paw injection compared to mice who received saline
or no injection (Figure 2.5A and 2.5B; Figure 2.S3A).
Because the anatomical data suggested that multiple AgRP target regions may be involved
in the transmission of inflammatory pain, we performed a systematic analysis of the function of
each AgRP neuron projection subpopulation. Taking advantage of the one-to-one architecture of
AgRP neuron projections (Figure 2.S3C) (Betley et al., 2013), we activated individual AgRP
projection subpopulations in ad libitum fed mice and assessed behavioral responses to acute and
inflammatory formalin-induced pain (Figure 2.5C; Figure 2.S3B). Although AgRP subpopulations
that project to the bed nuclei of the stria terminals (BNST), paraventricular thalamic nucleus (PVT),
paraventricular hypothalamic nucleus (PVH), and the lateral hypothalamus (LH) are sufficient to
evoke food intake (Figure 2.S3D) (Betley et al., 2013), we found that optogenetic activation of each
of these discrete subpopulations does not reduce the behavioral response to acute or inflammatory
formalin-induced pain (Figure 2.5D-2.5F; Figure 2.S3E). Other AgRP projection subpopulations,
such as those that project to the periaqueductal grey (PAG), central nucleus of the amygdala (CeA),
and parabrachial nucleus (PBN) are not sufficient to drive food intake when stimulated (Figure
2.S3D) (Betley et al., 2013), raising the hypothesis that these populations are involved in more
nuanced aspects of feeding, such as the ability to suppress pain to facilitate food-seeking behavior.
We found that activation of AgRP projections to the PBN virtually eliminates inflammatory phase
pain responses (Figure 2.5D and 5E; Figure 2.S3E) without affecting responses to acute chemical
(Figure 5F) or thermal (Figure 2.5G) pain. The suppression of inflammatory pain by AgRPàPBN
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stimulation is not likely due to off target effects since prolonged stimulation does not reduce the
acute response to formalin-induced pain (Figure 2.S3F) or locomotor activity (Figure 2.S3G and
2.S3H). Activating AgRP neurons that project to the CeA or the PAG had no effect on acute or
inflammatory phase pain (Figure 2.5D-2.5F) nor did the delivery of light to AgRPGFPàPBN mice
(Figure 2.S3I-2.S3K). This striking specificity of AgRPàPBN neuron function demonstrates that
the PBN is a neural substrate for the interaction between hunger and inflammatory pain.
NPY Signaling in the lateral PBN Inhibits Inflammatory Pain.
To explore how AgRPàPBN signaling intersects with the neural representation of
inflammatory pain, we first examined the anatomical overlap of AgRP projections and neurons
activated by inflammatory pain. We find a dense AgRP axonal projection in the lateral PBN (lPBN)
and a more medial projection to the locus coeruleus area (Figure 2.6A). AgRP axons projecting to
the lPBN overlap with neurons activated by formalin paw injection (Figure 2.S4A), suggesting the
activity in AgRP neurons projecting to the lPBN mediates inflammatory pain.
Because AgRP neuron activity is both necessary and sufficient to provide a protective
effect against inflammatory pain during hunger (Figure 2.4), we next sought to determine the
molecular signals in the PBN that mediate the suppression of pain during hunger. We first explored
protein expression of the 3 main neurotransmitters of AgRP neurons: NPY, GABA, and AgRP.
Expression of both NPY and the GABA synthetic enzyme GAD65 were increased in axon terminals
of AgRPàlPBN neurons during hunger (Figure 2.6B and 2.6C), suggesting these molecules may
mediate the interaction between hunger and pain in the lPBN. To test the functional relevance of
these neurotransmitters, we performed microinjections of each neurotransmitter into the lPBN
immediately before formalin paw injection. NPY signaling in the lPBN robustly and selectively
attenuated inflammatory phase pain responses, without affecting acute pain responses or food
intake (Figure 2.6D-2.6G, Figure 2.S4B). Conversely, neither GABA nor AgRP signaling in the lPBN
(Figure 2.6E), nor NPY in the locus coeruleus area (Figure 2.S4C-2.S4F), had any effect on
formalin-induced pain responses. Consistent with the kinetics of NPY signaling on behavior
(Stanley and Leibowitz, 1985), the onset (Figure 2.S4G and 2.S4I) and offset (Figure 2.S4H and
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2.S4I) of AgRPàPBN neuron activity during an ongoing inflammatory phase pain response
triggered changes in nocifensive behavior within minutes.
To determine if NPY signaling in the lPBN functions in a physiologically relevant manner,
we next assessed the role of endogenous NPY signaling during hunger. Strikingly, blocking NPY
Y1 receptors (Atasoy et al., 2012) in the lPBN of food deprived mice reversed the analgesic effects
of hunger (Figure 2.6H-2.6I) while antagonism of GABA receptors did not affect inflammatory pain
(Figure 2.6H). Furthermore, blockade of Y1 receptors in the lPBN attenuated the suppression of
inflammatory pain by AgRPàPBN neuron stimulation (Figure 2.6J and 2.6K), suggesting that
AgRP neurons are the source of the analgesic NPY. This reduction in pain is likely mediated by
glutamatergic neurons in the lPBN as inhibiting VGlut2-expressing, but not Gad2-expressing,
neurons in the lPBN during the formalin assay reduced inflammatory pain (Figure 2.S5). Taken
together, these data demonstrate that lPBN NPY signaling is both necessary and sufficient for the
suppression of inflammatory pain.
Acute Pain Reduces Food Seeking and Neural Activity in Hunger Circuits.
Survival requires ranking and responding to the most critical need at a given time. Because
hunger does not suppress the response to acute pain, we reasoned that neural mechanisms may
exist to deprioritize hunger during threats to survival such as acute pain. Exposure to a 52°C
hotplate increased the latency to feed in 24 h food deprived mice (Figure 2.7A). However, no
change in food intake in hungry mice during inflammatory pain was observed (Figure 2.7B). To
gain insight into the mechanisms through which acute pain inhibits feeding behavior, we next
measured in vivo calcium dynamics in AgRP neurons as a proxy for neural activity (Figure 2.7C)
(Gunaydin et al., 2014). Chow presentation significantly reduced the activity of AgRP neurons in
hungry mice (Figure 2.S7A and 2.S7B), as previously reported (Betley et al., 2015; Chen et al.,
2015; Mandelblat-Cerf et al., 2015). Consistent with the effects of pain on food intake, acute thermal
pain, but not formalin injection, reduced the activity of AgRP neurons (Figure 2.7D-2.7G, Figure
2.S7C and 2.S7D). This suppression of AgRP neuron activity by acute thermal pain reached a
magnitude comparable to ~50% of the suppression observed upon refeeding hungry mice (Figure
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2.S7E). Together, these data suggest that acute thermal pain can influence behavior by
suppressing activity in AgRP neuron circuits.

Discussion
Here, we discovered a bidirectional interaction between hunger and pain and revealed a
neural mechanism that processes competing survival signals. We demonstrated that hunger
selectively attenuates the behavioral and affective responses to inflammatory pain. This effect is
centrally mediated by a small subset of AgRP neurons that project to the PBN. The suppression of
inflammatory pain by hunger requires NPY signaling through Y1 receptors. Conversely, acute but
not inflammatory pain inhibited feeding behavior and reduced the endogenous activity of AgRP
neurons during hunger. These findings demonstrate the utility of examining intersecting survival
needs to reveal neural circuits that influence behavior, as we have identified a mechanism for the
inhibition of inflammatory pain.
Bidirectional Behavioral Interaction Between Hunger and Pain
It has been demonstrated that hunger can both increase and decrease responses to pain
(Bodnar, 1978; Hamm and Lyeth, 1984; Hargraves and Hentall, 2005; LaGraize et al., 2004;
Pollatos et al., 2012), suggesting that these two broadly tuned survival signals may interact in a
hierarchical manner. We found that 24 h food deprivation consistently and dramatically attenuates
responses to inflammatory pain, but has no effect on thermal pain, mechanical pain or the acute
response to formalin paw injection. In comparison to previous studies, we observed two striking
results. First, hunger had no effect on acute pain resulting from thermal, mechanical or chemical
insult. While previous reports demonstrate that hunger modestly reduces (10-20%) acute pain
(Bodnar et al., 1978a; Hamm and Lyeth, 1984; Hargraves and Hentall, 2005), the majority of the
acute pain responses are left intact – an important ethological consideration to enhance survival.
Second, we found that hunger selectively and almost completely abolished inflammatory pain
responses, mimicking the effects of anti-inflammatory painkillers. This profound suppression, even
without the distractor of food, suggests an analgesic effect of hunger and provides a behavioral
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mechanism to facilitate food seeking following an injury. Taken together, our observations
demonstrate that hunger has the ability to selectively inhibit long-term pain responses while leaving
intact the adaptive ability to respond to acutely painful stimuli.
The robust suppression of inflammatory pain response by food deprivation prompted us to
explore how hunger affects other dimensions of pain. Pain induces negative emotional responses,
and it is thought that distinct neural systems regulate the sensory and affective components of pain
(Johansen and Fields, 2004). Given that hunger is a complex motivational state that involves
coordination of many distinct neural circuits (Andermann and Lowell, 2017; Grill, 2006), it is not
surprising that hunger can interface with both the sensory and affective components of pain.
Indeed, the affective components of pain were diminished by hunger, as hunger attenuated a place
avoidance of cues previously associated with inflammatory pain. The ability of hunger to inhibit both
the unpleasant aspects of pain in addition to behavioral responses to pain suggests an analgesic
effect of hunger. These findings have implications not only for the treatment of pain disorders, but
also for the treatment of affective disorders such as depression that are highly comorbid with
conditions of chronic pain (Miller and Cano, 2009; Price, 2000).
Hunger attenuated inflammatory but not acute pain, but only acute pain was capable of
inhibiting feeding behavior. Furthermore, acute thermal pain directly inhibited the activity of hungersensitive AgRP neurons, suggesting that pain is not simply a distractor from hunger. The transient
reduction in AgRP neuron activity is consistent with our observation of short- but not long-term
reductions in feeding behavior following painful stimuli. While other studies have reported robust
reductions in endogenous AgRP neuron activity by food (Betley et al., 2015; Chen et al., 2015;
Mandelblat-Cerf et al., 2015), our findings unexpectedly provide a feeding-independent mechanism
that inhibits this neural population.
Together, our data show that acute pain inhibits hunger, and that hunger inhibits
inflammatory pain. This hierarchical interaction between hunger and different modalities of pain
suggests a prioritization of survival needs, whereby behavior addresses the most urgent
environmental or physiological stimulus. Together, these observations are ethologically sound for
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survival, as they describe a system that reliably responds to acute threat but allows for the
suppression of longer-term pain when food seeking behavior is paramount for survival.
Neural and Molecular Mechanisms for the Inhibition of Pain
Activation of AgRP neurons suppressed inflammatory pain, revealing a common neural
substrate for circuits that mediate hunger and pain. It is well established that AgRP neuron signaling
influences complex behaviors that promote food seeking (Burnett et al., 2016; Dietrich et al., 2015;
Krashes et al., 2011; Padilla et al., 2016). The ability of AgRP neuron activity to robustly inhibit
inflammatory pain was surprising because analgesia is not an obvious priority for food seeking.
However, facilitating feeding behavior following injury likely requires hard-wired neural circuitry to
overcome obstacles such as pain. Interestingly, the AgRP neural network, which is composed of
parallel projections that do not all drive food intake (Betley et al., 2013), provides an anatomical
arrangement that allows distinct projections to inhibit neural processing of environmental signals
that impede feeding.
To unravel the AgRP circuitry that inhibits inflammatory pain, we performed a systematic
functional assessment of AgRP neuron subpopulations that revealed the striking specificity by
which a tiny population of neurons can initiate behavioral switching. Indeed, activity in only ~300
AgRP neurons that project to the PBN (Betley et al., 2013) specifically eliminated inflammatory
pain. The magnitude of suppression of inflammatory pain was comparable to morphine and was
more robust than most anti-inflammatory or steroid analgesics (Hunskaar and Hole, 1987). Given
that activity in AgRPàPBN neurons is insufficient to drive food intake, the suppression of pain is
not simply a consequence of being distracted by an ongoing hunger state. Rather, these neurons
facilitate food seeking by reducing responses to competing aversive drives or stimuli that are
processed in the PBN (Carter et al., 2013). Furthermore, this function of a feeding insufficient
subpopulation highlights the importance of the distributed AgRP neuron circuitry – as this
population of hunger-sensitive neurons has distinct subpopulations that interact with many systems
in the brain to regulate other survival behaviors.
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Manipulating AgRPàPBN neurons during an ongoing pain response causes changes in
nocifensive behavior within minutes. This result suggests that peptidergic neurotransmission
mediates the interaction between hunger and pain. Indeed, NPY signaling inhibited the behavioral
response to inflammatory pain. We corroborated these data by showing that Y1R antagonism in
the PBN selectively blocked the ability of hunger or AgRPàPBN stimulation to attenuate
inflammatory pain. This occlusion of the dominant NPY receptor in the PBN (Alhadeff et al., 2015)
demonstrates the necessity and sufficiency of NPY Y1 receptor signaling for the inhibition of
inflammatory pain. Genetic (Naveilhan et al., 2001) and pharmacological (Solway et al., 2011)
evidence demonstrate a role of NPY Y1 receptor in the dorsal horn of the spinal cord in mediating
pain. Within the brain, it has been demonstrated that NPY signaling in the PAG and trigeminal
nucleus also inhibits pain (Martins-Oliveira et al., 2016; Wang et al., 2001). Here, our findings
uncover the PBN as an additional site of action for the analgesic effects of NPY, and are unique in
that they selectively inhibit inflammatory pain.
GABA and AgRP signaling in the PBN have documented roles in energy balance control
(Higgs and Cooper, 1996; Skibicka and Grill, 2009). Furthermore, GABA signaling from AgRP
neurons projecting to the PBN is permissive for feeding (Wu et al., 2009), as it suppresses the
visceral malaise associated with consumption of a large meal or toxic substance (Alhadeff et al.,
2017; Campos et al., 2016; Carter et al., 2013; Essner et al., 2017). However, GABA and AgRP
agonists microinjected into the PBN did not affect acute or inflammatory pain, highlighting NPY as
the molecular meditator of pain in the PBN. While co-release of neurotransmitters is welldocumented (Hnasko et al., 2010; Jonas et al., 1998), our findings dissociate distinct behavioral
functions for co-transmitters released by a single neuron type.
Both hunger and pain are negative signals that individuals try to avoid (Betley et al., 2015;
Johansen and Fields, 2004; Keys, 1946). The finding that hunger inhibits inflammatory pain raises
the question of how one negative drive can inhibit another. Our neural circuit analysis provides
insight into this paradox. Since AgRPàPBN neuron activity does not evoke food intake (Atasoy et
al., 2012), it is unlikely that these neurons mediate the negative valence of hunger (Betley et al.,
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2015). Our findings conclusively implicate AgRPàPBN signaling in mediating the response to pain.
However, the distinct AgRP circuits that mediate the negative valence of hunger, and inhibit the
negative valence of pain, remain compelling topics for future investigation.
Conclusion
Our findings uncover a hierarchy of survival behaviors that prioritizes needs in a changing
environment. Our behavioral observations provided a unique entry point to study circuits that inhibit
pain. This unexpected ability to influence pain through activity in a distinct hypothalamicàhindbrain
hunger circuit reveals an endogenous and ethologically relevant neural circuit mechanism for
analgesia. Importantly, this neural circuit can be manipulated to inhibit potentially maladaptive
inflammatory pain without compromising adaptive responses to painful stimuli that may acutely
threaten survival. Through developing a mechanistic understanding of the influence of hunger on
nociception, these experiments provide novel targets for the development of pain management
therapies, of utmost importance in the search for non-addictive analgesics.
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Figure 2.1 | Hunger Attenuates Response to Inflammatory Pain.
(A) Experimental design (formalin test): paw injection of 2% formalin was administered at 0 min;
time spent licking paw was measured for 60 min and quantified during the acute phase (0-5 min)
and the inflammatory phase (15-45 min). (B) Time spent licking paw following formalin injection
displayed in 5 min time bins in ad libitum fed (n=6) and 24 h food deprived (n=6) mice (two-way
repeated measures ANOVA, p<0.001). (C) % time spent paw licking during acute and inflammatory
phases of formalin test (two-way repeated measures ANOVA, p<0.05). (D) Time spent paw licking
during the inflammatory phase of formalin test in ad libitum fed and 24 h food deprived mice
(unpaired t-test, p<0.001). (E) Lick bouts during the inflammatory phase of formalin test in ad libitum
fed and 24 h food deprived mice (unpaired t-test, p<0.01). (F) Time spent paw licking during the
acute phase of formalin test in ad libitum fed and 24 h food deprived mice (unpaired t-test, p=ns).
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(G) Lick bouts during the acute phase of formalin test in ad libitum fed and 24 h food deprived mice
(unpaired t-test, p=ns). (H) Experimental design (hotplate test): Latency to withdraw paw from 52°C
hotplate was measured. (I) Latency to withdraw paw in ad libitum fed (n=12) versus 24 h food
deprived (n=14) mice during hotplate test (unpaired t-test, p=ns). (J) Experimental design (Von
Frey): Paw withdrawal from Von Frey filaments was measured. (K) Withdrawal threshold (Von Frey
filament at which mouse responded to >50% of trials) in ad libitum fed (n=11) versus 24 h food
deprived (n=7) mice (unpaired t-test, p=ns). Data are expressed as mean ± SEM, ns p>0.05, t-tests
and post-hoc comparisons: *p<0.05, **p<0.01, ***p<0.001; ANOVA interaction: ¥p<0.05,
¥¥¥p<0.001; ANOVA main effect of group: ☼☼p<0.01.
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Figure 2.2 | Hunger Attenuates Inflammation-Induced Sensitization to Mechanical and
Thermal Pain.
(A) Experimental design [Complete Freund’s Adjuvant (CFA) and Von Frey Test]: CFA was injected
in the plantar surface of the hindpaw after a baseline Von Frey test. Mice were subjected again to
a Von Frey test 3 h, 24 h, and 48 h post-CFA injection. (B) Withdrawal threshold (Von Frey filament
at which mouse responded to >50% of trials) in ad libitum fed mice (n=11) before and 24 h post33

CFA injection (paired t-test, p<0.01). (C) Withdrawal threshold in food restricted mice (n=7) before
and 24 h post-CFA injection (paired t-test, p=ns). (D) Withdrawal threshold in ad libitum fed (n=11)
and food restricted mice (n=7) before and 24 h post-CFA injection (two-way repeated measures
ANOVA, p<0.05). (E) Percentage withdrawal from Von Frey filaments before and 3 h, 24 h, and 48
h post-CFA injection in ad libitum fed mice (n=11, two-way repeated measures ANOVA, p<0.001).
(F) Percentage withdrawal from Von Frey filaments before and 3 h, 24 h, and 48 h post-CFA
injection in food restricted mice (n=7, two-way repeated measures ANOVA, p=ns). (G)
Experimental design (CFA and hotplate test): mice were injected with CFA after a baseline hotplate
test. Mice were subjected again to a hotplate test 3 h, 24 h, and 48 h post-CFA injection. (H) Latency
to paw withdrawal from hotplate in ad libitum fed mice (n=5) before and 48 h post-CFA injection
(paired t-test, p<0.05). (I) Latency to paw withdrawal from hotplate in food restricted mice (n=10)
before and 48 h post-CFA injection (paired t-test, p=ns). Data are expressed as mean ± SEM, ns
p>0.05, t-tests and post-hoc comparisons: *p<0.05, **p<0.01, ***p<0.001; ANOVA interaction:
¥p<0.05, ¥¥¥p<0.001; ANOVA main effect of drug: ☼☼p<0.01, ☼☼☼p<0.001.
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Figure 2.3 | Hunger Attenuates Negative Affective Components of Pain.
(A) Experimental design [conditioned place avoidance (CPA)]: one side of a two-sided chamber
was paired with the inflammatory phase following formalin paw injection in either ad libitum fed or
food restricted mice for 4 days and the post-conditioning preference was measured in replete
animals. (B) Representative traces of locations of mice following formalin CPA. (C) Preference for
formalin-paired side before and after conditioning in ad libitum fed (n=9) and food restricted (n=7)
mice (two-way repeated measures ANOVA, p<0.05). (D) Shift in preference for formalin-paired side
in ad libitum fed and food restricted mice (unpaired t-test, p<0.05). (E, F) Mice in ad libitum fed
(n=9) and food restricted (n=7) groups exhibit similar locomotor activity both before (E) and after
(F) CPA to inflammatory phase pain (unpaired t-tests, ps=ns). (G) Shift in preference for lithium
chloride-paired side in ad libitum fed and food restricted mice (unpaired t-test, p=ns). (H) Time
spent immobile in ad libitum fed and 24 h food deprived mice during inflammatory phase following
formalin injection (n=7-10/group, two-way ANOVA, p<0.05). Data are expressed as mean ± SEM,
ns p>0.05, t-tests and post-hoc comparisons: *p<0.05, **p<0.01; ANOVA interaction: ¥p<0.05.
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Figure 2.4 | AgRP Neurons Mediate Suppression of Inflammatory Pain.
(A) Schematic and representative image of ChR2 in AgRP-IRES-Cre mice implanted with an optical
fiber (white dashed line indicates fiber track) above the ARC. Scale bar, 1 mm. (B) Top,
experimental design: 450 nm light pulse delivery began 10 min before formalin administration and
continued for the duration of the formalin test. Bottom, graph: Time spent paw licking in AgRPGFP
(n=12) and AgRPChR2 (n=12) mice following formalin administration (two-way repeated measures
ANOVA, p<0.001) (C) Inflammatory phase formalin-induced paw licking (time) in AgRPGFP and
AgRPChR2 mice (unpaired t-test, p<0.01) (D) Time spent licking paw during inflammatory phase
following saline or formalin injection in AgRPGFP and AgRPChR2 mice (two-way repeated measures
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ANOVA, p<0.001). (E) Withdrawal threshold (Von Frey filament at which mouse responded to
>50% of trials) in AgRPGFP mice (n=6) before and 24 h post-CFA injection (paired t-test, p<0.05)
(F) Withdrawal threshold in AgRPChR2 mice (n=9) before and 24 h post-CFA injection (paired t-test,
p=ns) (G) Top, experimental design: 450 nm light pulses were delivered beginning 25 min postformalin injection and lasting through the duration of the session. Bottom, graph: time spent paw
licking in AgRPGFP (n=6) and AgRPChR2 (n=6) mice [two-way repeated measures ANOVA, main
effect of stimulation (AgRPGFP vs. AgRPChR2), p<0.05]. (H) Inflammatory phase formalin-induced
paw licking (time) during laser stimulation (25-45 min) in AgRPGFP and AgRPChR2 mice (unpaired ttest, p<0.05). (I) Food intake in food deprived AgRPhM4D- (n=9) and AgRPhM4D+ (n=4) mice 4 h
following CNO injection (unpaired t-test, p<0.01). (J) Time spent paw licking in AgRPhM4D- (n=20)
and AgRPhM4D+ (n=8) mice following formalin injection (two-way repeated measures ANOVA,
p<0.05). (K) Inflammatory phase formalin-induced paw licking (time) in AgRPhM4D- and AgRPhM4D+
mice (unpaired t-test, p<0.01). (L) Acute phase formalin-induced paw licking (time) in AgRPhM4Dand AgRPhM4D+ mice (unpaired t-test, p=ns). Data are expressed as mean ± SEM, ns p>0.05, ttests and post-hoc comparisons: *p<0.05, **p<0.01, ***p<0.001; ANOVA interaction: ¥p<0.05,
¥¥¥p<0.001; ANOVA main effect of group: ☼p<0.05, ☼☼p<0.01.
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Figure 2.5 | AgRPàPBN Neuron Activity Suppresses Inflammatory Pain.
(A) Immediate early gene protein expression analysis was performed to detect changes in neural
activity in AgRP neuron target regions following formalin paw injection. Fos+ neurons in each target
region (PVH depicted here) were quantified per unilateral brain section under the area of dense
AgRP axonal projections (red, outlined by white dashed line). Scale bar, 150 µm. Graph depicts
quantification of Fos+ neurons in the PVH under AgRP axons following no treatment (n), saline
paw injection (s), or formalin paw injection (f). (B) Representative images and graphs depicting
quantification of Fos+ neurons under AgRP axons following no treatment (n), saline paw injection
(s), or formalin paw injection (f) (n=9, 2-4 images per mouse per target region, one-way ANOVA
within brain region, p<0.05 for BNST, CeA, PAG, PBN). Scale bar, 150 µm. (C) Diagram of the
major AgRP neuron projection subpopulations analyzed. Delivery of light to individual axon target
fields of AgRP neurons (BNST shown here) allows for selective activation of discrete AgRP neuron
projection subpopulations. (D) Time spent paw licking following formalin injection during
optogenetic stimulation of AgRP neuron projection subpopulations (n=9-12/target region, two-way
repeated measures ANOVA, p<0.01). (E) Inflammatory phase formalin-induced paw licking (time)
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with (+, colored boxes) and without (-, grey boxes) AgRP neuron stimulation of discrete projection
subpopulations (paired t-tests with Bonferroni correction, all ps=ns except for PBN, p<0.001). (F)
Acute phase formalin-induced paw licking (time) with (colored boxes) and without (grey boxes)
AgRP neuron stimulation of discrete projection subpopulations (paired t-tests with Bonferroni
correction, all ps=ns). (G) Latency to paw withdrawal from 52°C hotplate in AgRPàPBNChR2 mice
(n=12, one-way ANOVA, p=ns). Data are expressed as mean ± SEM, ns p>0.05, t-tests and posthoc comparisons: *p<0.05, **p<0.01, ***p<0.001; ANOVA interaction: ¥¥p<0.01; ANOVA main
effect of group: ☼☼☼p<0.001.
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Figure 2.6 | Lateral PBN NPY Signaling Suppresses Inflammatory Pain.
(A) Representative image of AgRP fibers terminating in the lateral PBN (lPBN) and locus coeruleus
area. LC, locus coeruleus; lPBN, lateral PBN; scp, superior cerebellar peduncle. Scale bar, 500
µm.

(B)

Representative

images

of

NPY

(red),

GAD65

(green)

and

AgRP

(blue)

immunofluorescence in AgRPàlPBN neuron boutons of ad libitum fed and 24 h food deprived
mice. Scale bar, 5 µm. (C) Average intensity of NPY, GAD65, and AgRP immunofluorescence in
24 h food deprived mice (n=3 mice, 256 boutons) relative to ad libitum fed controls (n=2 mice, 366
boutons) (unpaired t-tests, ps<0.001). (D) Experimental design: lPBN microinjections were
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performed immediately before formalin paw injection. (E) Formalin-induced paw licking (time) in
lPBN vehicle-, NPY-, GABA agonists-, and AgRP analogue-microinjected mice (n=6-8/group, twoway ANOVA, main effect of drug p<0.01). Post-hoc comparisons: *p<0.05 vehicle vs. NPY;
Φp<0.05 NPY vs. AgRP analogue. (F) Inflammatory phase formalin-induced paw licking (time) in
lPBN vehicle- and NPY-microinjected mice (unpaired t-test, p<0.01). (G) Acute phase formalininduced paw licking (time) in lPBN vehicle- and NPY-microinjected mice (unpaired t-test, p=ns). (H)
Formalin-induced paw licking (time) in lPBN vehicle-, Y1 receptor (Y1R) antagonist-, and GABA
receptor antagonist-microinjected mice (n=6-7/group, two-way repeated measures ANOVA,
p<0.001). (I) Inflammatory phase formalin-induced paw licking (time) in lPBN vehicle- and Y1R
antagonist-microinjected mice (unpaired t-test, p<0.05). (J) Formalin-induced paw licking (time) in
lPBN vehicle- and Y1 receptor (Y1R) antagonist-microinjected mice with AgRPàPBN neuron
stimulation (n=6, two-way repeated measures ANOVA, p<0.01). (K) Inflammatory phase formalininduced paw licking (time) in lPBN vehicle- and Y1R antagonist-microinjected mice with
AgRPàPBN neuron stimulation (unpaired t-test, p<0.05). Data are expressed as mean ± SEM, ns
p>0.05, t-tests and post-hoc comparisons: *p<0.05, **p<0.01, ***p<0.001; ANOVA interaction:
¥¥p<0.01, ¥¥¥p<0.001; ANOVA main effect of drug: ☼p<0.05, ☼☼p<0.01, ☼☼☼p<0.001.
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Figure 2.7 | Acute Pain Inhibits Feeding Behavior and Activity in AgRP Neurons.
(A) Left, experimental design: latency to feed (first bite) was measured following 60 s exposure to
a 52°C hotplate. Right, graph: latency to feed after 60 s exposure to either a 25°C or 52°C plate
(n=8, paired t-test, p<0.01). (B) Left, experimental design: 1 h food intake was measured after
formalin paw injection. Right, graph: 1 h food intake in food deprived mice after paw injection of
saline or formalin (n=21, paired t-test, p=ns). (C) Left, schematic and representative image of
expression of the calcium indicator GCaMP6s in AgRP neurons. Scale bar, 500 µm. Right,
configuration for monitoring calcium dynamics in vivo using GCaMP6s expressed in AgRP neurons.
The 490 nm excitation activates the calcium-dependent GCaMP6s signal and the 405 nm excitation
activates the calcium-independent (isosbestic) GCaMP6s fluorescence. (D) Calcium-dependent
(mean, dark green; SEM, green shading) and calcium-independent (mean, dark purple; SEM,
purple shading) change in fluorescence (ΔF/F) in AgRP neurons following exposure to 25°C or
52°C plate (n=10). Grey shaded region indicates time exposed to hotplate. (E) Quantification of
change in fluorescence (30 s time bins) in mice following exposure to 25°C or 52°C plate (n=10,
two-way repeated measures ANOVA, p<0.01). (F) Calcium-dependent (mean, dark green; SEM,
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green shading) and calcium-independent (mean, dark purple; SEM, purple shading) change in
fluorescence (ΔF/F) in AgRP neurons following saline or formalin paw injection (n=8). Dashed line
indicates time of paw injection. (G) Quantification of change in fluorescence (6 min time bins) in
mice following saline or formalin paw injection (n=8, two-way repeated measures ANOVA, p=ns).
Data are expressed as mean ± SEM, ns p>0.05, t-tests and post-hoc comparisons: **p<0.01,
***p<0.001; ANOVA interaction: ¥¥p<0.01; ANOVA main effect of group: ☼p<0.05.
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Figure 2.S1, Related to Figure 2.1 | Anti-Inflammatory and Opiate Drug Administration
Reduce Responses to Inflammatory Phase and Thermal Pain, Respectively.
(A) Experimental timeline for effects of an anti-inflammatory analgesic (ketoprofen) on the formalin
test. (B) Inflammatory phase formalin-induced paw licking (time) in i.p. saline- (n=5) and ketoprofen(n=6) treated mice (unpaired t-test, p<0.01). (C) Inflammatory phase formalin-induced lick bouts in
saline- and ketoprofen-treated mice (unpaired t-test, p<0.01). (D) Acute phase formalin-induced
paw licking (time) in saline- and ketoprofen-treated mice (unpaired t-test, p=ns). (E) Acute phase
formalin-induced lick bouts in saline- and ketoprofen-treated mice (unpaired t-test, p=ns). (F)
Experimental timeline for effects of morphine on the hotplate test. (G) Latency to paw withdrawal
from 52°C hotplate before and 30 min post i.p. saline injection (paired t-test, p=ns). (H) Latency to
paw withdrawal from hotplate before and 30 min post i.p. morphine injection (paired t-test, p<0.01).
(I) Experimental design: 24 h food deprived mice were injected with saline or formalin in their
hindpaw and change in paw circumference was measured 30 min post-injection. (J) Change in paw
circumference in food deprived saline- (n=6) and formalin- (n=9) injected mice (unpaired t-test,
p<0.01). Data are expressed as mean ± SEM, ns p>0.05, t-tests: **p<0.01.
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Figure 2.S2, Related to Figure 2.4 | AgRP Neuron Activity Specifically Inhibits Inflammatory
Phase Pain Response Without Off-Target Licking Effects.
(A) Experimental design: Laser light pulses delivered to AgRP neurons of AgRPGFP and AgRPChR2
mice began 10 min before formalin injection and continued while formalin-induced paw licking was
quantified. (B) Inflammatory phase formalin-induced lick bouts in AgRPGFP and AgRPChR2 mice
(unpaired t-test, p<0.01). (C) Laser stimulation-induced food intake (y-axis) correlates with
inflammatory phase paw licking (x-axis); AgRPGFP (grey circles, n=12), AgRPChR2 (blue circles,
n=12), red circles are group averages (Pearson regression, R=0.60, p<0.01). (D) Time spent paw
licking during acute phase of formalin test in AgRPGFP and AgRPChR2 mice (unpaired t-test, p=ns)
(E) Acute phase formalin-induced lick bouts in AgRPGFP and AgRPChR2 mice (unpaired t-test, p=ns).
(F) Experimental design: AgRPGFP and AgRPChR2 mice were injected with Complete Freund’s
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Adjuvant (CFA) after a baseline Von Frey test. Mice underwent additional Von Frey tests at 3h, 24
h, and 48 h post-CFA injection, with 1 h of laser stimulation before each test. (G) Percentage
withdrawal from Von Frey Filaments before and 3 h, 24 h, and 48 h post-CFA injection in AgRPGFP
mice (n=6, two-way repeated measures ANOVA, p<0.001). (H) Percentage withdrawal from Von
Frey Filaments before and 3 h, 24 h, and 48 h post-CFA injection in AgRPChR2 mice (n=9, two-way
repeated measures ANOVA, p=ns). (I) Latency to withdraw paw from hotplate during AgRP neuron
stimulation in AgRPChR2 mice (n=12, repeated-measures one-way ANOVA, p=ns). (J) Normalized
latency to withdraw paw from hotplate in AgRPGFP and AgRPChR2 mice after 45 min of laser
stimulation (unpaired t-test, p=ns). (K) Time spent licking paw in AgRPGFP (n=12) and AgRPChR2
(n=12) mice with laser stimulation following saline paw injection (two-way repeated measures
ANOVA, p=ns). (L) Inflammatory phase paw licking (time) in AgRPGFP and AgRPChR2 mice during
laser stimulation following saline paw injection (unpaired t-tests, p=ns). (M) Acute phase paw licking
(time) in AgRPGFP and AgRPChR2 mice during laser stimulation following saline paw injection
(unpaired t-tests, p=ns). Data are expressed as mean ± SEM, ns p>0.05, t-tests and post-hoc
comparisons: *p<0.05, **p<0.01, ***p<0.001; ANOVA interaction: ¥p<0.05, ¥¥¥p<0.001; ANOVA
main effect of drug: ☼☼☼p<0.001.
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Figure 2.S3, Related to Figure 2.4 | AgRPàPBN Neurons Selectively Mediate Inflammatory
Pain.
(A) Schematics of target brain regions and representative images of formalin-induced Fos
underlying AgRP axon projections in the BNST, PVT, PVH, LH, CeA, PAG, and PBN. Scale bar,
150 µm. (B) Representative images of fiber placements (indicated in white dotted lines. Scale bar,
1 mm. (C) Diagram of the major AgRP neuron projection subpopulations analyzed. (D) Food intake
(1 h) in ad libitum fed mice with (+, colored bars) and without (-, grey bars) laser stimulation of
AgRP axons (n=9-12/target region, paired t-test with Bonferroni correction, BNST and PVH
p<0.001; LH p<0.01, PVT p<0.05; CeA, PAG, PBN p=ns). (E) Inflammatory phase formalin-induced
lick bouts with (+, colored bars) and without (-, grey bars) AgRP neuron stimulation of discrete
AgRP projection subpopulations (n=9-12/target region, paired t-tests with Bonferroni correction, all
ps=ns except for PBN, p<0.001). (F) Acute phase formalin-induced paw licking (time) in
AgRPàPBNChR2 mice (n=5) following 40 min of laser stimulation compared to stimulation of
AgRPàPBNGFP mice (n=12) (unpaired t-test, p=ns). (G) Total distance traveled in AgRPàPBNChR2
mice (n=5) with and without 30 min laser stimulation (unpaired t-test, p=ns). (H) Time spent
immobile in AgRPàPBNChR2 mice (n=5) with and without 30 min laser stimulation (unpaired t-test,
p=ns). (I) Acute phase formalin-induced paw licking (time) during light pulse delivery in
AgRPàPBNGFP mice (n=12, paired t-test, p=ns). (J) Inflammatory phase formalin-induced paw
licking (time) during light pulse delivery in AgRPàPBNGFP mice (n=12, paired t-test, p=ns). (K)
Latency to paw withdrawal from 52°C hotplate during light pulse delivery in AgRPàPBNGFP mice
(n=12, one-way ANOVA, p=ns). Data are expressed as mean ± SEM, ns p>0.05, *p<0.05, **p<0.01,
***p<0.001.
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Figure 2.S4, Related to Figure 2.6 | Peptidergic NPY signaling in the lateral PBN mediates
inflammatory phase pain.
(A) Schematic and representative image demonstrating formalin-induced Fos and AgRP axons in
the lateral PBN (lPBN). (B) Food intake (1 h) following PBN microinjection of vehicle, NPY, an
AgRP analogue, or GABA agonists (n=8, one-way repeated measures ANOVA, p=ns). (C)
Schematic showing center of injection sites for mice injected with NPY in the lPBN (closed circles)
or the locus coeruleus (LC) area (open circles). (D) Time spent licking paw in LC vehicle- (n=5) or
49

NPY (n=5) -injected mice (two-way repeated measures ANOVA, p=ns). (E) Inflammatory phase
paw licking (time) in LC vehicle- (n=5) or NPY (n=5) -injected mice (unpaired t-tests, p=ns). (F)
Acute phase paw licking (time) in LC vehicle- (n=5) or NPY (n=5) -injected mice (unpaired t-tests,
p=ns). (G) Top, Experimental design: Laser stimulation was initiated 25 min post-formalin injection
and lasted for the duration of the test. Bottom, graph: formalin-induced paw licking (time) with the
onset of AgRPàPBN neuron activity in AgRPàPBNChR2 mice (n=12); traces of pain responses
with and without AgRPàPBNChR2 stimulation for the entire session are indicated in dotted lines for
reference. (H) Top, Experimental design: Laser stimulation was initiated 10 min before formalin
injection and terminated 25 min post-injection. Bottom, graph: formalin-induced paw licking (time)
with the offset of AgRPàPBN neuron activity in AgRPàPBNChR2 mice (n=7); traces of pain
responses with and without AgRPàPBNChR2 stimulation for the entire session are indicated in
dotted lines for reference. (I) Time spent responding to inflammatory pain following the onset or
offset of laser stimulation (25-45 min post-injection). Inflammatory phase pain responses after the
onset (magenta) and offset (purple) of AgRPàPBNChR2 stimulation are compared to the
inflammatory responses with and without AgRPàPBNChR2 stimulation (unpaired t-tests with
Bonferroni correction, stimulation vs. onset/offset vs. no stimulation, all ps<0.01). Data are
expressed as mean ± SEM, ns p>0.05, t-tests: **p<0.01, ***p<0.001
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Figure 2.S5, Related to Figure 2.6 | Glutamatergic Neurons in the lPBN Mediate
Inflammatory Pain.
(A) Genomic structure of genetically modified Gad2 allele. (B) Genomic structure of genetically
modified VGlut2 allele. (C) Strategy for expressing hM4D in Gad2 and VGlut2 PBN neurons: A
FlpO-dependent rAAV expressing Cre was combined with a Cre-dependent rAAV expressing
hM4D as in (Li et al., 2013), allowing for the expression of hM4D in Gad2+ and VGlut2+ lPBN
neurons. These neurons were inhibited by i.p. injection of clozapine-N-oxide (CNO) as previously
demonstrated (Mu et al., 2017). (D) Left, in situ hybridization for Gad2 and VGlut2 mRNA in the
PBN [images from Allen Brain Explorer, http://mouse.brain-map.org, (Lein et al., 2007)]. Red
boxes indicated region of images to the right. Scale bar, 1 mm. Right, representative images of
hM4D-mCherry expression (red) in the lPBN of experimental mice. Quantification of lPBN
sections revealed an average of 98.2 ± 6.4 and 194.8 ± 35.9 hM4D-expressing neurons (per
unilateral section) in Gad2-IRES-FlpO (n=6) and VGlut2-IRES-FlpO mice, respectively. Scale bar,
500 μm. scp, superior cerebellar peduncle. (E) Quantification of GAD65+ or VGlut2+ boutons
colabeled with mCherry in Gad2-IRES-FlpO (top) and VGlut2-IRES-FlpO (bottom) mice. (F) Time
spent licking paw in control (n=5) and VGlut2hM4D (n=6) neurons after injection of CNO (two-way
repeated measures ANOVA, main effect of group, p<0.01). (G) Inflammatory phase paw licking in
control (n=5), Gad2hM4D (n=6) Vglut2hM4D (n=6) mice following CNO injection. Data are expressed
as mean ± SEM, ns p>0.05, t-tests and post-hoc comparisons: *p<0.05, **p<0.01, ***p<0.001;
ANOVA main effect of group: ☼☼p<0.01.

52

Figure 2.S6, Related to Figure 2.7 | Acute Thermal but not Formalin-Induced Pain
Suppresses AgRP Neuron Activity.
(A) Calcium-dependent (mean, dark green; SEM, green shading) and calcium-independent
(mean, dark purple; SEM, purple shading) change in fluorescence (ΔF/F) in AgRP neurons of
food restricted mice (n=10) before and after chow refeeding. (B) Mean change in GCaMP6s
signal (ΔF/F) before and after chow presentation (two-way repeated measures ANOVA,
p<0.001). (C) GCaMP6s fluorescence changes (ΔF/F) of AgRP neurons in individual mice with
saline or formalin paw injection. (D) GCaMP6s fluorescence changes (ΔF/F) in AgRP neurons of
individual mice with 60 s exposure to 25°C or 52°C plate. (E) Maximum change in AgRP neuron
calcium dynamics with formalin or hotplate exposure relative to activity change observed
following chow presentation (n=10 25°C/52°C plate, n=8 saline/formalin injection; two-way
repeated-measures ANOVA, p<0.01). Data are expressed as mean ± SEM, ns p>0.05, t-tests
and post-hoc comparisons: ***p<0.001; ANOVA interaction: ¥¥p<0.01, ¥¥¥p<0.001; ANOVA
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main effect of pre vs. post chow presentation (Figure S6B) or ANOVA main effect of condition
(Figure S6E): ☼p<0.05, ☼☼☼p<0.001.
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STAR Methods
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be
fulfilled by the Lead Contact, J. Nicholas Betley. (jnbetley@sas.upenn.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice were group housed on a 12 h light/12 h dark cycle with ad libitum access to food (Purina
Rodent Chow, 5001) and water unless otherwise noted. Group housed adult male and female mice
(at least 8 weeks old) were used for experimentation. Agrp-IRES-Cre (Jackson Labs 012899,
Agrptm1(cre)Lowl/J) (Tong et al., 2008), Ai32 (Jackson Labs 012569, B6;129S-Gt(ROSA)26Sortm32(CAGCOP4*H134R/EYFP)Hze

/J) (Madisen et al., 2012), R26-LSL-Gi-DREADD (Jackson Labs 026219,

B6N.129-Gt(ROSA)26Sortm1(CAG-CHRM4*,-mCitrine)/Ute/J) (Zhu et al., 2016), VGlut2-IRES-FlpO and
Gad2-IRES-FlpO generated as described in Method Details, and C57BL/6J mice were used for
experimentation. Genotyping was performed using primers and conditions provided by Jackson
Labs or custom primers for Gad2-IRES-FlpO and VGlut2-IRES-FlpO mice as described in Method
Details. All mice were habituated to handling and experimental conditions prior to experiments. For
within-subject behavioral analyses, all mice received all experimental conditions. For betweensubject analyses, mice were randomly assigned to experimental condition. We performed
experiments in both male and female subjects, and did not observed any trends or significant sex
differences. Thus, to ensure our studies were appropriately powered and to minimize the number
of subjects who had to undergo pain assays, we combined males and females for analyses in all
experiments. All procedures were approved by the University of Pennsylvania Institutional Animal
Care and Use Committee.

METHOD DETAILS
Recombinant Adeno-Associated Virus (rAAV) Constructs and Production: The following Creor FlpO-dependent rAAV vectors were used: AAV1.CAGGS.Flex.ChR2-tdTomato.WPRE.SV40
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(titer: 1.38e13 GC/ml), AAVrh10.CAGGS.flex.ChR2.tdTomato.WPRE.SV40 (titer: 1.23e13 GC/ml),
AAV1rh.CAG.Flex.eGFP.WPRE.bGH

(titer:

1.708e13

GC/ml),

AAV1.Syn.Flex.GCaMP6s.WPRE.SV40 (titer: 4.216e13 GC/ml), AAV-fDIO-Cre-GFP (titer:
2.91e13 GC/ml), pAAV-hSyn-DIO-hM4D(Gi)-mCherry (titer: 4.3e12 GC/ml). All viruses were
produced by the University of Pennsylvania Vector Core, except for the latter which was purchased
from Addgene (ID 44362). CAG, promoter containing a cytomegalovirus enhancer; the promoter,
first exon and first intron of the chicken beta actin gene; and the splice acceptor of rabbit betaglobin gene. Syn, human Synapsin 1 promoter. FLEX, Cre-dependent flip-excision switch. WPRE,
woodchuck hepatitis virus response element. bGH, bovine growth hormone polyadenylation signal.
ChR2, channelrhodopsin-2. GCaMP, Genetically encoded calcium indicator resulting from a fusion
of GFP, M13 and Calmodulin. DIO, Double-floxed inverted oreientation. hM4, human M4
muscarinic receptor.
Generation of FlpO mice:
VGlut2-IRES-FlpO mouse generation: Targeting vector construction: The targeting vector was
constructed using a recombineering technique previously described (Liu et al., 2003). A 8,572 bp
genomic DNA fragment containing exon 9-12 of the VGlut2 gene was retrieved from BAC clone
RP23-228J18 to a vector containing the DT gene, a negative selection marker. A cassette of IRESFlpO-loxP2272-ACE-Cre POII NeoR-loxp2272 was inserted between stop codon TAA and 3’ UTR.
The length of the 5’ homologous arm is 5,519 bp and that for the 3’ arm is 3,049 bp. ES cell targeting
and screening: The targeting vector was electroporated into F1 hybrid of 129S6 x C57BL/6J ES
cells derived by the Janelia Transgenic Facility. The G418 resistant ES clones were screened by
nested PCR using primers outside the construct paired with primers inside the inserted cassette.
The primer sequences were as follows: 5’ arm forward primers: VGlut2 Scr F1 (5’CAGCTCCTTTGAGAATGGCA-3’) and VGlut2 Scr F2 (5’- CCTGACAGTTTCAAAACGTGG-3’).
Reverse

primers:

IRES

R1

(5’-AGGAACTGCTTCCTTCACGA-3’)

CCTAGGAATGCTCGTCAAGA-3’).

3’

arm

forward

primers:

and

IRES

ACE

R2
F3

(5’(5’-

ACAGCACCATTGTCCACTTG-3’) and ACE F4, (5’-GCTGGTAAGGGATATTTGCC-3’); Reverse
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primers: VGlut2 Scr R3 (5’-ACATTGGTGCCACTTAGCTG-3’) and VGlut2 Scr R4 (5’GCATGTGAGCTACCTTAAGC-3’). Generation of chimera and F1 genotyping: The PCR positive
ES clones were expanded for generation of chimeric mice. The ES cells were aggregated with 8cell embryos of CD-1 strain. The chimeras were mated with wildtype C57BL/6J females and the
neo cassette was automatically removed in F1 pups. The F1 pups were genotyped by PCR using
primers flanking the insertion site and a primer in IRES for the 5’ arm. The primer set VGlut2 gt F
P1 (5’-TGCTACCTCACAGGAGAATG-3’) and IRES P3 (5’-GCTTCGGCCAGTAACGTTAG-3’).
The PCR products are 186 bp for the mutant allele. The primer set for the 3’ arm is VGlut2 P2 (5’TGACAACTGCCACAGATTG-3’) and FlpO gt F P4 (5’-CTGGACTACCTGAGCAGCTA-3’). The
generated PCR products are 294 bp for the mutant allele. The primer set VGlut2 P1 (5’TGCTACCTCACAGGAGAATG-3’)

and

Vglut2

P2

(5’-TGACAACTGCCACAGATTG-3’)

is

designed to detect the wildtype allele for homozygote genotyping. The correct targeting was further
confirmed by obtaining homozygotes from chimera x F1 heterozygous females mating. The mouse
lines from two independent ES cell clones were homozygosity tested and bred for experiments.
Genotyping PCR: The template DNA was obtained by digesting an ear piece in 50 μl proteinase K
buffer (50 mM Tris pH 8.8, 1 mM EDTA pH 8.0, 0.5% Tween-20 and proteinase K 0.6 mg/ml). The
reaction was incubated at 55°C overnight and heat inactivated at 100°C for 10 minutes. 0.5 μl of
the template was used in 12 μl PCR reaction. The reaction was carried out with an initial denature
cycle of 94°C for 3 min, followed by 35 cycles of 94°C 30 s, 55°C 30 s and 72°C 30 s and ended
with one cycle of 72°C for 5 min.
Gad2-IRES-FlpO mouse generation: Targeting vector construction: The targeting vector was
constructed using a recombineering technique previously described (Liu et al., 2003). A 10,389 bp
genomic DNA fragment containing exon 16 of the Gad2 gene was retrieved from BAC clone RP2327D24 to a vector containing the DT gene, a negative selection marker. A cassette of IRES-FlpOloxP2272-ACE-Cre POII NeoR-loxp2272 was inserted between stop codon TAA and 3’ UTR. The
length of the 5’ homologous arm is 3,195 bp and that for the 3’ arm is 7,193 bp. ES cell targeting
and screening: The targeting vector was electroporated into F1 hybrid of 129S6 x C57BL/6J ES
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cells derived by the Janelia Transgenic Facility. The G418 resistant ES clones were screened by
nested PCR using primers outside the construct paired with primers inside the inserted cassette.
The primer sequences were as follows: 5’ arm forward primers: Gad2 Scr F1 (5’CAATTGCTGAGCTGAAGTGC-3’) and Gad2 Scr F2 (5’-CAAGCAGTCAGCAGATTCCA-3’).
Reverse

primers:

IRES

R1

(5’-AGGAACTGCTTCCTTCACGA-3’)

CCTAGGAATGCTCGTCAAGA-3’).

3’

arm

forward

primers:

and

IRES

ACE

R2
F3

(5’(5’-

ACAGCACCATTGTCCACTTG -3’) and ACE F4 (5’-GCTGGTAAGGGATATTTGCC-3’); Reverse
primers:

Gad2

Scr

R3

(5’-GGCTTGATTCCTCAGAGGAA-3’)

and

Gad2

Scr

R4

(5’-

GCACAACAGTTGGACCTTAG-3’). Generation of chimera and F1 genotyping: The PCR positive
ES clones were expanded for generation of chimeric mice. The ES cells were aggregated with 8cell embryos of CD-1 strain. The chimeras were mated with wildtype C57BL/6J females and the
neo cassette was automatically removed in F1 pups. The F1 pups were genotyped by PCR using
primers flanking the insertion site and a primer in IRES for the 5’ arm. The primer set Gad2 gt F
P1 (5’-TATGGGACCACAATGGTCAG-3’) and IRES P3 (5’-GCTTCGGCCAGTAACGTTAG-3’).
The PCR products are 212 bp for the mutant allele. The primer set for the 3’ arm is Gad2 P1 (5’TATGGGACCACAATGGTCAG-3’), Gad2 P2 (5’- TGCTGGGATTAAAGGCATGC-3’) and FlpO gt
F P4 (5’-CATCAACAGGCGGATCTGAT-3’). The generated PCR products are 261 bp for the
mutant allele and 325 bp for wildtype allele. The correct targeting was further confirmed by
obtaining homozygotes from chimera x F1 heterozygous females mating. The mouse lines from
three independent ES cell clones were homozygosity tested and were bred for experiments.
Genotyping PCR: Genotyping PCR was performed as for VGlut2-IRES-FlpO mice.
Viral Injections, Fiber Optic and Cannula Placement: Bilateral viral injections and unilateral
implantation of ferrule-capped optical fibers (200 µm core, NA 0.37 for optogenetic stimulation; 400
µm core, NA 0.48 for fiber photometry, Doric) were performed as previously described (Betley et
al., 2013). For somatic stimulation of AgRP neurons, Agrp-IRES-Cre mice were crossed with Ai32
mice to express ChR2 in AgRP neurons. Mice were anesthetized with isoflurane (1.5-3%), given
ketoprofen (5 mg/kg) and bupivacaine (2 mg/kg) analgesia and placed into a stereotaxic device
62

(Stoelting). An optical fiber was placed over the arcuate hypothalamic nucleus (ARC) at bregma 1.35 mm, midline ±0.25 mm, skull surface -5.8 mm. For axonal stimulation of AgRP neurons, a
rAAV encoding Cre-dependent ChR2 was bilaterally injected into the ARC of AgRP-IRES-Cre mice
using the aforementioned ARC injection coordinates (150 nl per site, bilaterally). Optical fibers were
unilaterally implanted according to the following coordinates. BNST: bregma +0.85 mm, midline
±0.82 mm, skull surface -3.8 mm; PVH: bregma -0.5 mm, midline ±0.2 mm, skull surface -5.4 mm;
PVT: bregma -1.0 mm, midline ±0.0 mm, skull surface -2.7 mm; LH: bregma -1.0 mm, midline ±0.9
mm, skull surface -5.4 mm; CeA: bregma -1.15 mm, midline ±2.4 mm, skull surface -4.25 mm; ARC:
bregma -1.35 mm, midline ±0.25 mm, skull surface -5.8 mm; PAG: bregma -4.4 mm, midline ±0.6
mm, skull surface -2.8 mm; lateral PBN: bregma -5.8 mm, midline ±1.2 mm, skull surface -3.7 mm.
Fibers were secured to the skull with bone screws and dental cement. For pharmacological
experiments, mice were implanted with unilateral 26 gauge guide cannulae (Plastics One,
Roanoke, VA) above the lateral PBN (according to the above coordinates) which were secured to
the skull with bone screws and dental cement (Alhadeff et al., 2015). For chemogenetic inhibition
of lateral PBN neurons, VGlut2-IRES-FlpO and Gad2-IRES-FlpO mice were bilaterally injected
(200 nl/hemisphere) in the lateral PBN with a FlpO-dependent rAAV encoding Cre, and a Credependent rAAV encoding inhibitory Designer Receptors Exclusively Activated by Designer Drugs
(DREADDs, hM4D). For fiber photometry, a rAAV encoding Cre-dependent GCaMP6s was
bilaterally injected into the ARC of AgRP-IRES-Cre mice using the following coordinates: bregma 1.35 mm; midline ±0.25 mm; skull surface -6.15 mm and -6.3 mm (250 nl per site, bilaterally), and
an optical fiber was implanted over the ARC using the following coordinates: bregma -1.35 mm;
midline ±0.25 mm; skull surface -6.0 mm. Mice were given at least 3 weeks for recovery and
transgene expression. Fiber and cannula placements were verified post-mortem.
General Experimental Design: For each experiment, our subject numbers were determined by
our pilot studies, laboratory publications, and power analyses [power=0.8, significance level=0.05,
effect sizes=10-30%]. For within-subject behavioral and fiber photometry analyses, all mice
received all experimental conditions. For between-subject analyses, mice were randomly assigned
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to experimental condition. For all behavioral and fiber photometry experiments, experiments were
performed in at least two cohorts to ensure replicability of results, by at least 2 researchers who
were blinded to experimental conditions. For histological experiments, protein intensities and
neuron counts were quantified by 4 research assistants who were blinded to experimental
condition. For all behavioral and fiber photometry experiments, virus expression, fiber placements,
and/or cannula placements were verified post-mortem, and any mice with viral expression or
implants outside of the area of interest were excluded from all analyses.

In Vivo Photostimulation: Photostimulation was performed as previously described (Betley et al.,
2013), with 10 ms pulses at 20 Hz for 1 s, repeated every 4 s. The output beam from a diode laser
(450 nm, Opto Engine) was controlled by a microcontroller (Arduino Uno) running a pulse
generation script. The laser was coupled to a multimode optical fiber (200 µm core, NA 0.37, Doric)
with a 1.25 mm OD zirconium ferrule (Kientech) and mating sleeve that allowed delivery of light to
the brain by coupling to the implanted ferrule-capped optical fiber in the mouse. Power was set to
ensure delivery of at least 2 mW/mm2 to AgRP soma and at least 5 mW/mm2 to the center of the
AgRP neuron projection fields.
Food Deprivation/Restriction: For 24 h food deprivation, mice were placed in a cage with alpha
dry bedding and ad libitum access to water, but no food, 24 h prior to experimentation. For chronic
food restriction, mice were weighed at the same time each day and given chow once daily (1.5–3.0
g) after experimentation to maintain 85-90% of their starting body weight.
Food Intake Experiments:
Effects of AgRP neuron stimulation on food intake: Mice were allowed to habituate for at least one
hour to a chamber with a lined floor and ad libitum access to chow and water. Following the
habituation period, food intake was measured for 1 h to establish a pre-stimulation baseline.
Photostimulation was performed during the next hour. After each hour, food intake was measured.
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For somatic AgRP neuron stimulation, only mice that consumed >0.6 g of chow were included in
experiments. Food intake evoked by stimulation of each AgRP neuron projection subpopulation
was measured and reported in Figure S3D.
Effects of AgRP neuron inhibition on food intake: Mice were habituated to an empty home cage
with a lined floor. Mice were food deprived for 24 h, intraperitoneally (i.p.) injected with saline or
clozapine-N-oxide (CNO, 2.5 mg/kg, Tocris), and placed into their cage with ad libitum access to
chow and water. Chow intake was measured 4 h post-injection, accounting for crumbs.
Effects of hotplate exposure on latency to feed: 24 h food deprived mice were individually placed
in a home cage with a lined floor and access to water. After a 10 min habituation period, mice were
exposed to a cast iron plate at either 25°C or 52°C for 1 min and immediately placed back into the
cage with food and water. Latency to consume food was measured.
Effects of formalin injection on food intake: 24 h food deprived mice were individually placed in a
home cage with a lined floor and access to water. After a 10 min habituation period, mice were
injected subcutaneously in the dorsal hindpaw with saline or 2% formalin (20 µl, Sigma HT50-1-2)
and returned to their cage with food. Food intake was recorded 1 h post-injection.

Inflammatory Pain Measurements (Formalin Test): Mice were placed in a clear enclosure for a
10 min habituation period. Mice were subcutaneously injected in the dorsal hindpaw with saline or
2% formalin (20 µl). Mice were monitored for time spent licking paw, and number of lick bouts, for
1 h post-injection by researchers blinded to experimental condition. All sessions were videorecorded. The time spent paw licking was grouped into 5 min bins (Hunskaar and Hole, 1987) and
recorded for 1 h. Additionally, acute (0-5 min) and inflammatory (15-45 min) phase pain responses
were quantified.
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Effects of ketoprofen on formalin test: The non-steroidal anti-inflammatory drug ketoprofen (30
mg/kg) or saline was administered subcutaneously 30 min before formalin injection.
Effects of food deprivation on formalin test: Food was removed 24 h prior to formalin injection. Ad
libitum fed mice served as controls.
Effects of formalin on paw inflammation: 24 h food deprived mice were lightly anesthetized and
paw circumference was measured immediately before saline or formalin paw injection. Paw
circumference was measured again 30 min post-injection.
Optogenetic AgRP neuron stimulation: To assess the effects of AgRP neuron stimulation on acute
and inflammatory phase pain responses to formalin, mice received optogenetic stimulation of AgRP
neurons or individual projection subpopulations beginning 10 min prior to formalin injection and
lasting throughout the formalin test. To assess the ability of AgRP neuron stimulation to affect an
ongoing inflammatory pain response, stimulation of AgRP neurons or AgRPàPBN neurons was
initiated 25 min post-formalin injection and lasted for the duration of the formalin test. To assess
whether the offset of AgRPàPBN neuron activity results in a reinstatement of inflammatory phase
pain response, laser stimulation was given 10 min prior to formalin injection and terminated 25 min
post-formalin injection. To test whether prolonged AgRPàPBN neuron stimulation affects the
ability to paw lick, mice were stimulated for 40 min and formalin-induced acute phase pain was
measured.
Chemogenetic AgRP neuron inhibition: To assess the necessity of AgRP neuron activity for the
inhibition of inflammatory pain by hunger, mice were 24 h food deprivied and i.p. injected with CNO
(2.5 mg/kg) 15 min before formalin injection.
Chemogenetic inhibition of lateral PBN VGlut2 and Gad2 neurons: To determine whether lateral
PBN glutamatergic (VGlut2-expressing) or GABAergic (Gad2-expressing) neurons mediate
inflammatory pain responses, VGlut2hM4D, Gad2hM4D, and control mice were i.p. injected with CNO
(2.5 mg/kg) 15 min before formalin injection.
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Thermal Pain Measurements (Hotplate Test): A cast iron plate with plexiglass walls was placed
on a hotplate and heated to 52°C. Mice were placed on the hotplate and latency to withdraw paw
was recorded by researchers blinded to experimental condition. All sessions were video-recorded.
Effects of morphine on hotplate test: Mice underwent a baseline hotplate test and were
subsequently i.p. injected with saline or morphine (10 mg/kg). Mice were tested again on the
hotplate 30 min post-injection.
Effects of food deprivation on hotplate test: Food was removed 24 h prior to hotplate test. Ad libitum
fed mice served as controls.
Optogenetic AgRP neuron stimulation during hotplate test: To assess the effects of AgRP neuron
stimulation on acute thermal pain response, mice were placed in a plexiglass chamber, attached
to patch fibers, and allowed to habituate for 30 min. Mice underwent a baseline hotplate test, and
5 min later laser stimulation was initiated. Mice were tested again on the hotplate following 15 and
45 min of stimulation of AgRP neurons or control light delivery to GFP-expressing mice. A separate
experiment was performed to assess the role of AgRPàPBN neurons on acute thermal pain by
delivering light to the PBN of mice expressing either ChR2 or GFP in AgRP neurons, using identical
experimental procedures.

Mechanical Pain Measurements (Von Frey Test): Mice were habituated for 30 min in small
plexiglass chambers atop mesh flooring. Twelve Von Frey filaments (ranging from 0.008 g to 6 g)
were used. Starting with the smallest Von Frey filament and continuing in ascending order, each
filament was applied to the plantar surface of the hind paw until the filament bent. Each filament
was tested 5 times. The number of withdrawal responses was recorded for each filament, and the
percentage withdrawal responses for each filament was calculated (# of withdrawal trials/total
trials). Withdrawal threshold was determined as the filament at which the mouse responded with a
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paw withdrawal to >50% of trials. To test the effects of hunger on mechanical pain, mice were 24
h food deprived and then subjected to the Von Frey test.

Inflammation-Induced Sensitization: Complete Freund’s Adjuvant (CFA, Sigma) was diluted 1:1
in saline and injected (20 µl) into the plantar surface of the paw after a baseline Von Frey or hotplate
test. Given that we and others observe a more robust CFA-induced sensitization to thermal pain at
55°C (Carey et al., 2017), we used this temperature for CFA-induced thermal sensitization. Von
Frey or hotplate tests were repeated 3 h, 24 h, and 48 h post-CFA injection.
Effects of hunger on inflammation-induced sensitization: Mice were 24 h food deprived and
subjected to Von Frey or hotplate tests as described above. Mice were provided enough food in
one daily aliquot to maintain 85-90% BW through the rest of testing (up to 48 h post-CFA injection).
Effects of AgRP neuron stimulation on inflammation-induced sensitization: Optogenetic AgRP
neuron stimulation was performed for 1 h before each of the post-CFA Von Frey tests (3 h, 24 h,
and 48 h post-CFA injection).

Conditioned Place Avoidance: Two-sided apparatus were used with distinct visual (black vs.
white walls), textural (flooring: plastic vs. soft textural side of Kimtech bench-top protector), and
olfactory (almond vs. peppermint extract) cues. A neutral middle zone to shuttle between sides was
maintained and the chamber was equipped with an overhead camera to track mouse position. Ad
libitum fed mice were habituated to the apparatus and a pre-conditioning preference was
determined via AnyMaze software. Mice were then separated into two groups: food restricted (8590% of initial body weight) or ad libitum fed. Conditioning, which consisted of a saline paw injection
(20 µl) on the less preferred side or a 2% formalin paw injection (20 µl) on the preferred side was
performed twice daily for four days. To isolate conditioning to the inflammatory phase of formalin
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pain, mice were placed in the apparatus 15 min post-injection. After conditioning, all mice were
given ad libitum access to food. The next day, mice were given access to both sides of the
apparatus and their position and activity were tracked. The percentage occupancy, shifts in
occupancy, and total distance traveled in the formalin-paired side during the post-conditioning test
were calculated. To control for any associative learning deficits during hunger, the same
conditioned place avoidance paradigm was used, except that mice were given i.p. saline on the
less preferred side and i.p. lithium chloride (125 mg/kg) on the preferred side during conditioning.
Locomotor Activity Assays:
Effects of food deprivation of formalin-induced immobility: Mice were habituated to 10” x 10” x 10”
plexiglass chambers. Food was removed from mice 24 h prior to 2% formalin injection, and mice
were placed in chambers and video-recorded during the inflammatory phase following formalin
injection (15-45 min post-injection). Videos were analyzed with AnyMaze software (Stoelting) for
time spent immobile, which was defined as not changing position in the X-Y grid for at least 8 s.
Effects of AgRPàPBN neuron stimulation on locomotor activity: Mice were habituated to 10” x 10”
x 10” plexiglass chambers. AgRPàPBN neurons were optogenetically stimulated for 30 min and
behavior was video-recorded. Videos were analyzed with AnyMaze software (Stoelting) for total
distance traveled and time spent immobile, which was defined as not changing position in the X-Y
grid for at least 8 s.

Immunohistochemistry and Imaging: Mice were transcardially perfused with 0.1 M phosphate
buffered saline (PBS) followed by 4% paraformaldehyde (PFA). Brains were removed and postfixed for 4 h in PFA and then washed overnight in PBS. Coronal brain sections were cut (30-200
µm sections) on a vibratome or cryostat and stored in PBS. Brain sections were incubated overnight
at 4°C with primary antibodies diluted in PBS, 1% BSA and 0.1% Triton X-100. Antibodies used:
goat anti-AgRP (1:2,500, Neuromics, GT15023), rabbit anti-cFos (1:5,000, Cell Signaling, 2250),
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guinea pig anti-RFP (1:10,000) (Betley et al., 2013), rabbit anti-GFP (1:5,000, Invitrogen, A-11122),
rabbit anti-NPY (1:1,500, Immunostar, 22940), rat anti-GAD65 (1:2,000) (Betley et al., 2009),
guinea pig anti-VGlut2 (1:2,000, SYSY, 135404). Sections were washed 3 times and incubated
with species appropriate and minimally cross-reactive fluorophore-conjugated secondary
antibodies (1:500, Jackson ImmunoResearch) for 2 h at room temperature. Sections were washed
twice with PBS and mounted and coverslipped with Fluorogel. Epifluorescence images were taken
on a Leica stereoscope to verify fiber placements, cannula placements, and obtain low
magnification images. Confocal micrographs were taken on a Leica STED laser scanning
microscope using a 20X, 0.75 NA objective for quantification of Fos immunoreactivity under AgRP
axons; a 40X, 1.3 NA objective for quantification of protein expression in AgRPàPBN terminals;
and a 63X or 100X, 1.4 NA objective for protein colocalization of mCherry, VGlut2, and GAD65 in
PBN axon terminals.
Quantification of Protein Expression:
Immediate early gene protein expression analysis: To quantify the number of neurons expressing
Fos protein under AgRP axons, mice received no treatment (n=3) or a 20 µl subcutaneous injection
of formalin (5%, n=3) or saline (n=3) in the dorsal hindpaw. Two hours later, mice were perfused
and brains were processed for immunohistochemistry. First, images of Fos and AgRP from a
formalin-treated mouse were obtained in each of the major AgRP projection target regions. Identical
image acquisition settings were maintained for all subsequent imaging of Fos and AgRP in
experimental and control mice. To quantify the number of Fos-expressing neurons in each AgRP
neuron target region, single optical sections (pinhole = 1 airy unit, 2-4 sections/mouse/AgRP target
region) were used and the AgRP neuron staining was used to define the region for quantification
(see Figure 4A).
Quantification of synaptic protein expression: Ad libitum fed (n=2) and 24 h food deprived (n=3)
mice were perfused and PBN brain sections were processed for NPY, the GABA synthetic enzyme
GAD65, and AgRP immunoreactivity. Confocal images were obtained first from a food deprived
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mouse so that the intensities of NPY, GAD65, and AgRP were in the linear range. Image acquisition
settings were maintained for all subsequent imaging and 2 PBN images per mouse were obtained.
For intensity quantifications, single confocal sections (pinhole = 1 airy unit) were used and the
intensities of NPY, GAD65, and AgRP were calculated using the histogram function on Adobe
Photoshop.
Colocalization of hM4D, Vglut2, and GAD65 in lPBN neurons: To determine the specificity of
expression of hM4D in the Gad2-IRES-FlpO and Vglut2-IRES-FlpO knock-in lines, staining was
performed against mCherry, Vglut2 and GAD65 in coronal sections from at least 2 mice/line used
for experimentation. For quantification, single confocal sections (pinhole = 1 airy unit) were used
and the number of Vglut2+ or GAD65+ structures that expressed hM4D-mCherry were counted.

Pharmacology: For all experiments, mice were habituated to handling and infusion procedures.
Drugs were diluted from frozen aliquots before each experiment and microinjected (100 nl) with a
Hamilton syringe attached to an internal cannula (Plastics One) and microliter syringe pump (PHD
Ultra, Harvard Apparatus) into the PBN of mice immediately before a formalin test (see above) or
food intake measurements.

Effects of lPBN NPY, GABA agonists, and AgRP analogue on formalin-induced inflammatory pain:
Neuropeptide Y [NPY, Tocris, 0.1 µg], GABAA and GABAB receptor agonists [muscimol, Tocris, 25
ng and baclofen, Tocris, 25 ng], an AgRP analogue [melanocortin 4 receptor antagonist; SHU9119,
25 pmol] or vehicle [artificial cerebrospinal fluid (aCSF)] was microinjected into the lateral PBN
immediately before paw injection of formalin.
Effects of lPBN NPY, GABA agonists, and AgRP analogue on food intake: The aforementioned
drugs were infused in the lPBN during the light cycle and food intake was recorded 1 h postinjection.
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Effects of locus coeruleus NPY on formalin-induced inflammatory pain: Since AgRP axons
terminate both in the lPBN and the locus coeruleus, NPY or vehicle was infused in the locus
coeruleus area (directly medial from lPBN) immediately before formalin paw injection.
Effects of lPBN NPY Y1 receptor antagonist on the inhibition of inflammatory pain by hunger:
Microinjections of the selective NPY Y1 receptor antagonist BIBO 3304 [Tocris, 3 µg], GABAA and
GABAB antagonists [saclofen, 100 ng, Sigma, and bicuculline, 10 ng, Sigma] or vehicle (50%
DMSO in aCSF) were infused into the lPBN of 24 h food deprived mice.
Effects of lPBN NPY Y1 receptor antagonist on the inhibition of inflammatory pain by AgRPàPBN
stimulation: To test whether the protective effects of AgRPàPBN neuron stimulation on
inflammatory pain are mediated by NPY, we performed an experiment similar to that in (Atasoy et
al., 2012). Mice expressing ChR2 in AgRP neurons were injected in the lPBN with vehicle or the
Y1 receptor antagonist BIBO 3304. An optic fiber was then inserted through the PBN cannula and
a formalin paw injection was administered. AgRPàPBN stimulation occurred throughout the
duration of the formalin test.

Fiber Photometry: Food-restricted (85-90% body weight) mice in their home cage were attached
to a patch fiber (400 µm core, NA 0.48, Doric) and connected to 405 nm and 490 nm LEDs (Thor
Labs, M405F1, M470F3) modulated by a real-time amplifier [Tucker-Davis Technology (TDT),
Alachua, FL, RZ5P] and focused onto a femtowatt photoreceiver (Newport, Model 2151) (Figure
6C) (Gunaydin et al., 2014). Changes in calcium-dependent GcaMP6s fluorescence (490 nm)
signal were compared with calcium-independent GCaMP6s fluorescence (405 nm), providing
internal control for movement and bleaching artifacts (Lerner et al., 2015; Su et al., 2017).
Fluorescence measurements (1 Hz) were extracted from Synapse software (TDT), processed in
MatLab (GraphPad), and expressed as DF/F, where the denominator represents average baseline
fluorescence.
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Effects of acute thermal pain on AgRP neuron activity: Food restricted (85-90% BW) mice were
connected to the fiber photometry setup for a 5 min baseline period in their home cage. Mice were
then placed on a 25°C or 52°C plate for 1 min, after which they returned to their cage. GCaMP6s
fluorescence was monitored for 10 min following hotplate exposure.
Effects of acute and inflammatory formalin-induced pain on AgRP neuron activity: Food restricted
(85-90% BW) mice were connected to the fiber photometry setup for a 5 min baseline period in
their home cage. Mice were injected in the dorsal hindpaw with 2% formalin or saline (20 µl) and
returned to their cage. GCaMP6s fluorescence was monitored for 1 h post-formalin injection.

QUANTIFICATION AND STATISTICAL ANALYSES
Data were expressed as means ± SEMs in figures and text. Paired or unpaired two-tailed t-tests
with or without Bonferroni corrections and Pearson regressions were performed as appropriate.
One-way, two-way, and repeated measures ANOVA were used to make comparisons across more
than two groups using SigmaPlot or STATISTICA. Test, statistics, significance levels, and sample
sizes for each experiment are listed in Supplementary Tables 1 and 2. ns p>0.05, t-tests and posthoc comparisons: *p<0.05, **p<0.01, ***p<0.001; interaction: ∞p<0.05, ∞∞p<0.01, ∞∞∞p<0.001;
main effect (group, condition or drug): ☼<0.05, ☼☼p<0.01, ☼☼☼p<0.001.
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CHAPTER 3:

HUNGER HAS A POTENT AND RELIABLE ANTI-INFLAMMATORY EFFECT
ON INJURY-INDUCED INFLAMMATION.

Thus far, we have shown that food deprivation, through AgRP neurons, can reduce
inflammatory pain behavior. We had two hypotheses about how hunger could be influencing pain:
1. Hunger could be reducing the perception of pain at the level of the central nervous system or 2.
Hunger could be causing changes at the injury site to prevent pain signals from reaching the central
nervous system. While the work in this dissertation does not directly answer the question of how
hunger influences pain, we became interested in understanding what was happening at the paw
after injection of a noxious chemical during hunger. Can hunger have a targeted effect on injuryinduced inflammatory responses?
Hunger can reduce pain behavior exclusively during the inflammatory phase of pain
(Alhadeff et al., 2018). This specificity led us to question hunger’s influence on the underlying
inflammatory response to these nocifensive agents. In our previous work, we primarily interrogated
hunger’s influence on the pain response to formalin, yet we did show that hunger could influence
the pain response to complete freund’s adjuvant (CFA) as well. We started our interrogation of
hunger and inflammation using both inflammatory models from our original pain study: formalin and
CFA paw injections. As our experiments continued, we focused on CFA because the infection
triggers a much larger and more sustained inflammatory response (Ren and Dubner, 1999). To
gain an understanding of the inflammatory response to CFA we measured edema levels,
temperature, and inflammatory cell counts at the injury site.
CFA is a mixture of mycobacteria and paraffin oil that can be injected in an animal to create
an inflammatory response that induces swelling/edema, heat, redness, and pain (Ren and Dubner,
1999). Historically CFA has been used to model chronic inflammatory and autoimmune diseases
such as arthritis, encephalomyelitis, thyroiditis, and myasthenia gravis (Billiau and Matthys, 2001).
Autoimmune diseases are defined as chronic disruption of the immune system resulting in immune
reactions to the body’s own organs, tissues, and cells (National Institute of Health, 2005). Ultimately
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this causes production of antibodies to natural proteins in the body. CFA can be used as an arthritic
model by injection into a joint. Initially, the joint becomes swollen and painful, while overtime the
bones become damaged (Jacobson et al., 1999; Ratkay et al., 1993). After full initiation of the
adjuvant-induced arthritis, mice produce high levels of antibodies against collagen leading to an
autoimmune response to the collagen rich joints (Ratkay et al., 1993). CFA is also used as a local
inflammatory agent to test inflammatory pain responses (Walker et al., 1999). CFA induces
hyperalagesia and allodynia within 2 hours of injection for at least one week (Ren and Dubner,
1999). Immediately after CFA exposure the innate immune system is triggered to release proinflammatory cytokines and chemokines, especially tumor necrosis factor alpha (TNFα), interferon
gamma, interleukin-12 and interleukin-6 (Billiau and Matthys, 2001).
It is known that food restriction can suppress systemic inflammation by reducing proinflammatory markers and inhibiting pro-inflammatory signaling pathways (Brandhorst et al., 2015;
Meydani et al., 2016; Traba et al., 2015; Vandanmagsar et al., 2011). Previous work investigating
the role of food restriction on inflammation have evaluated phenotypes of aging-induced
inflammation, genetic inflammatory disorders, and obesity-induced inflammation (Brandhorst et al.,
2015; Fontana et al., 2004; Heilbronn and Ravussin, 2003; Li et al., 2021b; Mercken et al., 2013;
Vandanmagsar et al., 2011; Youm et al., 2015). Food restriction’s ability to combat an acute
inflammatory event, like an injury, has been under studied.
Our model evaluates CFA 24 h after introduction to the mouse’s dorsal footpad – capturing
the initial immune response to the bacterial infection. At this time point, we are evaluating synovitis
created from the infiltration of immune cells to the injection site, not long-term arthritic changes
which occur between three and seven days after injection (Oliveira et al., 2007). We chose to look
at CFA on a short-term scale to understand how food deprivation and the central nervous system
influence targeted inflammatory events. The arthritic model causes global changes that leads to an
autoimmune reaction to collagen throughout the body. Our work adds pertinent information about
the intimate relationship the central nervous system has with immune responses to specific injuries.
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Hunger reduces injury-induced inflammation.
To assess injury-induced edema, we measured paw volume after the introduction of a
chemical stimuli using a plethysmometer which uses volume displacement as a proxy for size.
Briefly, the paw is submerged in a saline solution and volume displacement is detected (Figure
3.1a). All measurements were calculated as a percent increase from the original paw volume prior
to the injury. We observed a 40% increase in paw volume 1 hour after a formalin paw injection
(Figure 3.1b, 3.1c) and a 100% increase in paw volume 24 hours after a CFA paw injection (Figure
3.1d) in ad libitum fed mice. Interestingly, 24-hour food deprivation attenuated the injury-induced
inflammatory response resulting from both formalin and CFA paw injections by approximately 50%
(Figure 3.1c, 3.1d). Importantly, food deprivation had no effect on paw volume after saline paw
injections showing that the reduction in paw size is not a consequence of dehydration or weight
loss from food deprivation (Figure 3.1c, 3.1d). To corroborate our plethysmometer findings, we also
measured paw circumference before and after the chemical injuries. We observed a 20% increase
in paw circumference 1 hour after a formalin paw injection and a 40% increase in paw
circumference 24 hours after a CFA injection. Again, 24-hour food deprivation reduced paw
circumference by approximately 50% (Figure 3.2a-c). This effect on inflammation is sustained, as
chronic food restriction has the ability to reduce CFA paw inflammation for up to 1 week (168 hours,
Figure 3.2d).
Local inflammation is characterized by increases in swelling (edema), redness,
temperature, and cytokine/chemokine infiltration (Medzhitov, 2008; Nathan, 2002). Thus far, we
have discovered that food deprivation can reduce edema and wanted to evaluate hunger’s
influence on these other characteristics of inflammation. Using an infrared camera, we were able
to specifically measure paw temperature across conditions (Figure 3.3a). 24 hours after a CFA paw
injection, paw temperature increased by about 4ºC from baseline paw temperatures (Figure 3.3b).
Food deprivation reduced paw temperature by about 3ºC returning the temperature to near
baseline values (Figure 3.3b). Because food deprivation has a profound effect on inflammation, we
76

next looked at whether food deprivation has an effect on the cytokine response to injury. TNFα is
a proinflammatory cytokine released by macrophages in early in the response to an immune
challenge (Billiau and Matthys, 2001). To understand food deprivation’s influence on cytokine
levels, we measured TNFα levels at the injury site. We found a significant reduction in TNFα levels
in food deprived mice compared to ad libitum fed controls (Figure 3.3c).
To evaluate structural changes in the paw, we performed histology on paws injected with
CFA either in ad libitum or food deprived conditions. We observed that the reduction in CFAinduced paw volume caused by hunger is directly related to the levels of edema (Figure 3.3d) as
defined by the comparison of vacuole sizes and frequency between ad libitum fed and food
deprived groups. There were no differences in histopathological changes at the injury site (Oliveira
et al., 2007) as defined by qualitative suppurative inflammation scores and CD45+ cell staining in
the paw (Figure 3.3e, 3.3f). Because of this lack of cellular changes, we next explored the possibility
that hunger irreversibly reduces inflammation. We measured paws of animals before, during and
after 24h food deprivation and found that while hunger dramatically reduces paw volume after CFA
injection, refeeding the animals reversed the effect of food deprivation (Figure 3.3g). Together with
our paw histology findings showing no histopathological changes in food deprivation, this suggests
that hunger has an acute effect on inflammation and the signals produced must be maintained for
the ongoing suppression of inflammation.

Hunger is a potent anti-inflammatory mechanism regardless of sex, age or weight.
To assess whether biological variables influence the ability of hunger to suppress
inflammation, we evaluated the effect of food deprivation on CFA-induced inflammation in animals
of different sex, age, and body weight. Across experimental cohorts, we consistently found that
food deprivation reduced paw volume after an injection of CFA (Figure 3.4a). Given that there are
sex differences in immune responses (Doyle and Murphy, 2017; Klein and Flanagan, 2016; Kovats
et al., 2009), we examined how hunger influences inflammation in male and female mice. As
previously reported, we observed that female mice had a larger paw volume after a CFA injection
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(Cook and Nickerson, 2005; Doyle and Murphy, 2017), however, food deprivation reduces the
inflammation in both male and female mice (Figure 3.4b). The immune system can also be
influenced by age (Shaw et al., 2013; Taniguchi and Karin, 2018) or body weight (Vandanmagsar
et al., 2011; Wellen and Hotamisligil, 2005). We therefore quantified paw volume after CFA injection
in mice at varying ages and body weights. Although age influences the inflammatory response to
CFA, hunger reduced CFA-induced inflammation to the same extent across all age and body weight
groups (Figure 3.4c, 3.4d). Overall, we found that hunger can reliably and reproducibly reduce
CFA-induced edema by about 50% regardless of sex, age, and body weight.
Because hunger is a highly reliable, reproducible, and potent mechanism to attenuate
injury-induced inflammation, we next compared food deprivation to standard inflammation
treatments. Ad libitum fed and food deprived mice were given vehicle or a non-steroidal antiinflammatory drug (NSAID). As expected, both food deprivation and NSAID administration reduced
paw size (Figure 3.5a, 3.5c). However, compared to typical doses of NSAIDs, we found that food
deprivation has a larger anti-inflammatory effect. Indeed, food deprivation reduced CFA-induced
paw volume 20% more than administration of ketoprofen or ketorolac (Figure 3.5e, 3.5d)

Hunger has a complex relationship with inflammation that cannot be recapitulated
pharmacologically.
Thus far we have identified hunger as a potent anti-inflammatory mechanism for injuryinduced inflammation. However, we do not know the mechanism by which hunger is reducing
inflammation. We started to answer this question by systemically activating and inhibiting different
pharmacological systems and measuring paw volume. A reduction in paw size while mice are ad
libitum fed could identify a pathway that hunger is utilizing to reduce paw inflammation.
Alternatively, a failure to reduce paw size in food deprived mice could identify a pathway necessary
for hunger’s influence on inflammation. Together, these experiments could identify a system or
pathway that hunger is acting through to influence inflammation.
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Glucocorticoids
The hypothalamic-pituitary-adrenal (HPA) axis is a neuroendocrine pathway that can
initiate anti-inflammatory signaling in order to maintain balance during immune reactions (Pavlov
et al., 2003a). Cytokines are able to cross the blood brain barrier making them capable of interacting
with all stages of the HPA axis. The HPA axis primarily releases glucocorticoids to inhibit proinflammatory pathways and prevent long term gene transcription for an inflammatory environment
(Rivest, 2001). When activated, the PVH of the hypothalamus secretes corticotrophin-releasing
hormone (CRH) which produces adrenocorticotropin hormone (ACTH) in the anterior pituitary
gland. Finally, ACTH stimulates the release of glucocorticoids from the adrenal glands leading to
an anti-inflammatory regulation of the immune system (Webster et al., 2002) To evaluate the role
of glucocorticoids in the anti-inflammatory effect of hunger, we introduced the glucocorticoid agonist
corticosterone (ort) in ad libitum mice and the antagonist RU486 in food deprived mice. Activation
of the glucocorticoid system with cort during satiety had no effect on paw volume (Figure 3.6a).
Inhibition of the glucocorticoid system with RU486 during food deprivation also had no effect on
paw volume (Figure 3.6b). Systemic interrogation of the glucocorticoid system did not have a
significant effect on paw volume, so we used behavioral stress as an organic activator of the
glucocorticoid system. Rodent restraint stress increases corticosterone blood circulation within 10
minutes (Hare et al., 2014). Mice were maintained in restraint tubes for 1 hour between paw
measurements. We found that there was no difference in paw volume before or after restraint stress
(Figure 3.6c)
Substance P
Substance P (SP) is a tachykinin neuropeptide found in central, peripheral and immune
systems making it an excellent candidate for cross-communication between the brain and immune
system. SP has a high affinity for neurokinin 1 receptors (NK1Rs) which are present on many
immune cell types including dendritic cells, macrophages, neutrophils, and T-cells. Nerves release
SP on to lymphatic tissues to produce a proinflammatory environment and typically relay pain
information (Suvas, 2017). SP signaling directs guided proinflammatory responses specifically to
79

bacterial infected areas allowing effective and efficient bacterial clearance (Pascual, 2004). Since
SP is a proinflammatory molecule, we tested the role of SP on paw volume by blocking NK1Rs in
satiety and stimulating NK1Rs with SP in food deprivation. We found no significant difference in
paw volume between mice treated with saline and a NK1R antagonist under ad libitum fed
conditions (Figure 3.6d). Similarly, we found no difference in paw volume between mice treated
with saline and SP under food deprived conditions (Figure 3.6e).
Opioids
Opioid receptors increase in the central nervous system after CFA injections suggesting a
relationship between inflammation and opioid signaling (Besse et al., 1992; Millan et al., 1988;
Nahin and Byers, 1994). However, there is a controversy over whether opioids participate in fueling
a pro or anti-inflammatory response (Eisenstein, 2019). Despite this, we thought it was important
to understand if opioids influence paw volume. We tested activation of opioid receptors in satiety
and antagonism of opioid receptors in food deprivation. Ad libitum fed mice treated with
buprenorphine to activate the opioid system had no differences in paw volume compared to saline
controls (Figure 3.6f). Food deprived mice treated with naloxone to block opioid signaling had no
difference in paw volume compared to saline controls (Figure 3.6g).
Oxytocin
Oxytocin (OXT) has been used to treat a variety of conditions ranging from mood and
personality disorders to digestion and metabolic issues to autonomic and immune function
(Hurlemann and Grinevich, 2018). A key hormone for early development, OXT is a protective
molecule allowing for adaptation to stressors and prepping the body for future traumas (Carter et
al., 2020, Kingsbury and Bilbo, 2019). Because of this protective function, OXT is believed to have
anti-inflammatory effects. In fact, it has been shown that higher levels of oxytocin can increase
wound healing after surgery (Gouin et al., 2010, Carter et al., 2020). OXT can also reduce
inflammatory markers through degranulation of mast cells after a heart attack (Xiong et al., 2020).
However, OXT is also important for body fluid regulation and too high levels of oxytocin can lead
to pulmonary edema (Ferguson et al., 2008; Mansour et al., 2021). OXT and vasopressin work in
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tandem to maintain body fluids and immune responses, usually having opposite effects of each
other. We tested if OXT had an influence on paw volume of food deprived mice. We found that both
saline and oxytocin treated mice had similar reductions in paw size during food deprivation (Figure
3.6h).
Leptin
Leptin is a potent pro-inflammatory molecule that has become of particular interest in the
interaction between obesity and inflammatory diseases (Abella et al., 2017). Leptin is a hormone
secreted by adipose tissue that primarily serves to regulate energy expenditure and calorie
consumption (Rosenbaum and Leibel, 2014). However, adipose tissue positively correlates with
levels of circulating leptin and could be the contributing mechanism of chronic inflammation in
obese individuals (Lago et al., 2009). Leptin production is triggered by cytokine release when there
is an acute threat. Acute leptin levels lead to proinflammatory immune responses, while chronic
leptin levels cause leptin resistance and dampened overall immune function (Abella et al., 2017;
Wrann et al., 2012). Because of leptin’s influence on inflammation and association with feeding,
we evaluated if leptin has a role in the anti-inflammatory effect of hunger. Mice treated with leptin
had no difference in paw volume to saline controls when food deprived (Figure 3.6i).
Ghrelin
During food deprivation many different chemical compounds are released to trigger the
physiological effects of hunger. One key “hunger hormone” is ghrelin. Ghrelin is well known to
induce feeding behavior. In fact, ghrelin initiates feeding through activation of AgRP neurons in the
hypothalamus (Nakazato et al., 2001). However, ghrelin is involved in many more physiological
functions besides feeding. Ghrelin has been implicated in energy expenditure, sympathetic nerve
activity, and metabolism among other functions (Pradhan et al., 2013). We therefore tested if
ghrelin has an influence on inflammation. Systemic treatment of ad libitum fed mice with ghrelin
was not significantly different than saline treated mice and therefore had no effect on paw
inflammation (Figure 3.6j).
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Serotonin
Serotonin (5-HT) is a hormone that coordinates many physiological functions from mood
and behavior to inflammation and immunity throughout the body and central nervous system
(Berger et al., 2009). The majority of 5-HT is in the periphery produced by enterochromaffin cells
of the gut and carried throughout the body on platelets (Maurer-Spurej et al., 2004; Gershon and
Tack, 2007; Jonnakuty and Gragnoli, 2008). Many types of immune cells have 5-HT receptors and
can affect innate immune responses to injury and toxins by influencing immune cell signaling
(Ahern, 2011; Baganz and Blakely, 2012). Since 5-HT is believed to activate the immune response
(Konig et al. 1992; Mossner and Lesch, 1998; Gordon and Barnes, 2003), we hypothesized that
systemic 5-HT administration in food deprived mice would block the anti-inflammatory effect of
hunger. However, we found that mice treated with 5-HT had no difference in paw volume compared
to controls (Figure 3.6k).
Microbiome
The gut is filled with bacteria that can elicit anti-inflammatory and proinflammatory effects
based on the strain of bacteria, diet, and genetics of the host organism. An unhealthy microbiome
has been linked to a variety of autoimmune disorders such as rheumatoid arthritis, Crohn’s disease,
and asthma (Wang et al., 2020). A healthy microbiome has bacteria that release anti-inflammatory
metabolic compounds such as butyrate which inhibits the production of proinflammatory cytokines
in innate immune responses (Klampfer et al., 2003; Lührs et al., 2009). We evaluated the role of
the microbiome in CFA inflammation by using antibiotics to deplete all gut bacteria in our mice as
previously described (Virtue et al, 2019). We found that saline and antibiotic treated mice had the
same paw volume in ad libitum fed and food deprived conditions (Figure 3.6l).

Discussion
Hunger has a potent effect on inflammation. We robustly and reliable found food
deprivation to attenuate paw volume by about 50%. Food deprivation also reduced other aspects
of inflammation including temperature and pro-inflammatory cytokine levels. We attempted to
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identify a pharmacological pathway that food deprivation was working through to reduce
inflammation but were unsuccessful. Each tested system has been broadly implicated in
inflammation before, however, we failed to see any change in paw inflammation in our
manipulations. The negative data here highlights the complexity of the immune system. One
hypothesis for the failure to influence inflammation with our pharmacological challenges could be
the compensatory nature of pharmacological systems. In fact, there has been a push in the field to
develop multi-target pharmacological treatment for a variety of diseases and indications because
the body can adapt with one player missing (Anastasio, 2017). The immune system is such a critical
component of survival, that it is not surprising that there is redundancy among its pathways. There
may be a balance between these systems evaluated that we are unable to capture with
manipulation of any given one. An alternative hypothesis is that hunger is causing a change in the
neural control of inflammation. We know that feeding behavior is coordinated by the central nervous
system and hunger is mediated by AgRP neurons in the hypothalamus (Hahn et al., 1998; Horvath
et al., 1992, 1997; Cowley et al., 2003; Liu et al., 2012; Takahashi and Cone, 2005; Yang et al.,
2011; Su et al, 2017). Because of this, we next sought to evaluate the role of AgRP neurons in the
anti-inflammatory effect of hunger.
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Figure 3.1 | Hunger reduces paw inflammation induced by CFA and formalin.
(a) Experimental design: Mice were injected with saline, CFA, or formalin and paw volume was
measured using a plethysmometer at various time points post-injection. (b) Images of paws 24 h
after CFA injection followed by ad libitum access or 24 h food deprivation. Scale bar, 5 mm. (c)
Increase in paw volume of ad libitum (n=8) and 24 h food deprived (n=8) mice 1 h after a saline or
formalin injection (two-way ANOVA, main effect of ad libitum v food deprived p=0.029). (d) Increase
in paw volume of ad libitum (n=8) and 24 h food deprived (n=8) mice 24 h after a saline or CFA
injection (two-way ANOVA, main effect of ad libitum v food deprived p=0.003). Data are expressed
as mean ± SEM; post-hoc comparisons: *p<0.05, ***p<0.001; two-way ANOVA interaction:
∞p<0.05; ANOVA main effect: ☼p<0.05, ☼☼p<0.01.
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Figure 3.2 | Hunger reduces paw circumference induced by CFA and formalin.
(a) Experimental design: Mice were injected with saline, formalin or CFA and paw circumference
was measured. (b) Increase in paw circumference of ad libitum (n=14) and 24 h food deprived
(n=14) mice 1 h after formalin injection (unpaired t-test, p=0.014). (c) Increase in paw circumference
of ad libitum (n=15) and 24 h food deprived (n=16) mice 24 h after CFA injection (unpaired t-test,
p=0.005). (d) Increase in paw circumference in ad libitum fed (n=14) and food restricted (n=16)
mice maintained at ~90% body weight following paw injection of CFA over 1 week (two-way
repeated measures ANOVA, main effect of state p<0.001). Data are expressed as mean ± SEM; ttest and post hoc comparisons: *p<0.05, **p<0.01, ***p<0.001; two-way ANOVA interaction:
∞∞∞p<0.001; ANOVA main effect: ☼☼p<0.01.
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Figure 3.3 | Hunger reduces paw edema and inflammation associated increase in
temperature.
(a) Infrared images of paws 24 h after injection with CFA in ad libitum fed and 24 h food deprived
conditions. (b) Paw temperature of mice without a CFA injection (n=13), 24 h after a CFA injection
in ad libitum fed (n=12) and 24 h food deprived states (n=15) (one-way ANOVA, p<0.001). (c)
Concentration of TNFα detected in paws 24 h after CFA injection in ad libitum (n=6) or food
deprived (n=7) mice (unpaired t-test, p=0.004). (d) Qualitative edema score from paw histology
analysis of ad libitum fed (n=6) and 24 h food deprived (n=6) mice 24 h after a CFA injection
(unpaired t-test, p=0.002). (e) Qualitative suppurative inflammation score from paw histology
analysis of ad libitum fed (n=6) and 24 h food deprived (n=6) mice 24 h after a CFA injection
(unpaired t-test, p=0.641). (f) CD45+ area in ad libitum fed (n=6) and 24 h food deprived (n=5) mice
24 h after a CFA injection (unpaired t-test, p=0.430). (g) Increase in paw volume of mice (n=8) 24
h after a CFA injection in ad libitum fed, 24 h food deprived and refed states (one-way repeated
measures ANOVA, p<0.001). Data are expressed as mean ± SEM, t-test and post-hoc comparison:
**p<0.01, ***p<0.001.
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Figure 3.4 | Hunger reduces paw inflammation regardless of sex, age, or weight.
(a) Composite graphs showing the increase in paw volume of all mice tested in this figure across
age, sex, and weight (n=126) 24 h after a CFA paw injection in ad libitum fed state followed by a
subsequent 24 h food deprivation (paired t-test, p<0.001). (b) Increase in paw volume of male
(n=71) and female (n=55) mice 24 h after a CFA paw injection during ad libitum fed state
subsequently followed by 24 h food deprivation (two-way ANOVA, main effect of ad libitum v food
deprived p<0.001). (c) Increase in paw volume of 15-20 (n=16), 20-25 (n=50), 25-30 (n=54), and
>30 (n=6) g mice 24 h after a CFA paw injection during ad libitum fed state subsequently followed
by 24 h food deprivation (two-way ANOVA, main effect of ad libitum v food deprived p<0.001). (d)
Increase in paw volume of 10-20 (n=16), 20-30 (n=50), 30-40 (n=54), and >40 (n=7) week old mice
24 h after a CFA injection during ad libitum fed subsequently followed by 24 h food deprivation
(two-way ANOVA, main effect of ad libitum v food deprived p<0.001). Data are expressed as mean
± SEM; t-tests and post-hoc comparisons: *p<0.05, **p<0.01, ***p<0.001; two-way ANOVA
interaction: ∞∞p<0.01; ANOVA main effect: ☼☼☼p<0.001.
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Figure 3.5 | Hunger is comparable to non-steroidal anti-inflammatory drugs in reducing CFAinduced inflammation.
(a) Increase in paw volume of mice 24 h after a CFA injection measured 1 h following administration
of vehicle in ad libitum fed (n=7) and 24 h food deprived (n=8) states or 30 mg/kg ketoprofen in ad
libitum (n=8) or 24 h food deprived (n=7) states (two-way ANOVA, main effect of injection p<0.001).
(b) Increase in paw volume of mice (n=8) 24 h after a CFA injection in ad libitum fed mice treated
with 30 mg/kg ketoprofen or 24 h food deprived mice treated with vehicle (paired t-test, p=0.003).
(c) Increase in paw volume of mice 24 h after a CFA injection measured 1 h following administration
of vehicle in ad libitum fed (n=8) and 24 h food deprived state (n=8) or 30mg/kg ketorolac in ad
libitum fed (n=8) and food deprived (n=8) states (two-way ANOVA, main effect of injection p=0.023).
(d) Increase in paw volume of mice (n=8) 24 h after a CFA injection measured 1 h following
treatment with 30 mg/kg ketorolac in the ad libitum fed state and vehicle in the 24 h food deprived
state (paired t-test, p=0.011) Data are expressed as mean ± SEM; t-tests and post-hoc
comparisons: *p<0.05, **p<0.01, ***p<0.001; two-way ANOVA interaction: ∞∞∞p<0.001; ANOVA
main effect: ☼p<0.05.
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Figure 3.6 | Pharmacological interrogation of systems known to influence immune
responses failed to change the CFA-induced paw volume in ad libitum or food deprived
conditions.
(a) Increase in paw volume of mice 1 h after treatment with control (n=7) or 10mg/kg corticosterone
(Cort) (unpaired t-test, p=0.850). (b) Increase in paw volume of mice 1 h after treatment with control
(n=4) or 25mg/kg RU486 (n=7) during food deprivation (unpaired t-test, p=0.217). (c) Increase in
paw volume of mice (n=10) before and after 1 h of restraint stress (paired t-test, p=0.242). (d)
Increase in paw volume of mice 1 h after treatment with saline (n=8) or the 5mg/kg NK1R antagonist
L-733-060 (n=8) (unpaired t-test, p=0.590). (e) Increase in paw volume of mice 1 h after treatment
with saline (n=8) or 5µg/kg Substance P (SP) (n=8) (unpaired t-test, p=0.920). (f) Increase in paw
volume of mice 1 h after treatment with saline (n=9) or 0.1mg/kg buprenorphine (Bup) (n=8)
(unpaired t-test, p=0.628). (g) Increase in paw volume of mice 1 h after treatment with saline (n=8)
or 10mg/kg naloxone (Nal) (n=9) during food deprivation (unpaired t-test, p=0.596). (h) Increase in
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paw volume of mice 1 h after treatment with saline (n=7) or 1mg/kg oxytocin (n=8) during food
deprivation (unpaired t-test, p=0.983). (i) Increase in paw volume of mice 1 h after treatment with
saline (n=7) or 1mg/kg leptin (n=7) (unpaired t-test, p=0.636). (j) Increase in paw volume of mice 1
h after treatment with saline (n=9) or 1mg/kg ghrelin (n=8) (unpaired t-test, p=0.716). (k) Increase
in paw volume of mice 1 h after treatment with saline (n=5) or 1mg/kg serotonin (5-HT) (n=6) during
food deprivation (unpaired t-test, p=0.891). (l) Increase in paw volume of mice chronically treated
with saline (n=6) or antibiotics (n=7) during ad libitum and food deprived states (two-way ANOVA,
main effect of treatment p=0.821). Data are expressed as mean ± SEM; t-tests and post-hoc
comparisons: ***p<0.001
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CHAPTER 4:

AGOUTI-RELATED PROTEIN EXPRESSING NEURONS PROJECTING TO

THE PARAVENTRICULAR HYPOTHALAUMS AND PARABRACHIAL NUCLEUS CAN
REDUCE INJURY-INDUCED INFLAMMATION.
Is the anti-inflammatory response to hunger mediated by the brain? We next explored the
possibility that neural circuits activated by food deprivation attenuate inflammatory responses to
injury. Hunger is a full body experience causing disturbances in many systems that likely cannot
be fully captured through AgRP neuronal manipulations, however, AgRP neuronal activity can
recapitulate many phenotypes of a hungry animal. First, we can look at physiology. AgRP neuron
activity is directly related to food deprivation. AgRP neuron activation significantly increases as an
animal becomes food deprived and significantly decrease when sated (Cowley et al., 2003; Liu et
al., 2012; Takahashi and Cone, 2005; Yang et al., 2011). AgRP neurons are interoceptive neurons
that continually sense circulating nutrients and hormones to determine the right amount of activity
for the appropriate feeding behavior. In fact, AgRP neurons rapidly change their activity levels in
response to the calories consumed and subsequent satiation signals released for a given meal (Su
et al., 2017). Activation of AgRP neurons also influences metabolism through changes in adiposity
and insulin resistance (Pei et al., 2019; Steculorum et al., 2016). Next, we can look at behavior.
Feeding behavior requires food seeking, detection, and consumption. AgRP neurons encourage
food seeking by facilitating the pairing of contextual food cues with successful food consumption
(Wang et al., 2021). AgRP neurons also participate in food detection as they reduce activity upon
the presentation of sensory food cues (Betley et al., 2015; Su et al., 2017). Lastly, AgRP neurons
are both necessary and sufficient to food consumption. Activation of AgRP neurons induces
immediate food intake (Aponte et al., 2011; Krashes et al., 2011), while ablation causes anorexia
(Gropp et al., 2005; Luquet et al., 2005). Aside from these obvious features of food intake, AgRP
neurons also facilitate in dampening other biological drives and motivational states including sleep,
anxiety, fear, and pain to prioritize feeding behaviors (Burnett et al., 2016; Goldstein et al., 2018;
Alhadeff et al., 2018). Taken together, all these data highlight AgRP neurons as a manipulatable
pathway to produce many features of hunger. AgRP neurons are of particular relevance for our
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inflammation studies because of their ability to inhibit formalin- and CFA-induced inflammatory pain
(Alhadeff et al., 2018). Because AgRP neurons recapitulate many facets of hunger and have been
implicated in inflammatory pain responses, we investigated how activation of AgRP neurons
influences CFA-induced inflammation.

Activation of AgRP neurons reduces inflammation.
AgRP neurons makeup about 10,000 neurons in the ARC (Betley et al., 2013). To test their
role in inflammation, we activated these neurons for 1 h, 24 h after a CFA paw injection. We
expressed excitatory DREADDs in AgRP neurons and activated them with an intraperitoneal (i.p.)
injection of CNO (Figure 4.1a). As expected (Krashes et al., 2011), chemogenetic activation of
AgRP neurons caused ad libitum fed animals to robustly increase food intake compared to controls
(Figure 4.1b). Chemogenetic activation of AgRP neurons led to an attenuation in CFA-induced paw
volume (Figure 4.1c) while CNO in control mice had no effect on paw volume (Figure 41.d). For a
complementary approach to activate AgRP neurons, we engineered mice to express the lightsensitive ion channel, ChR2 exclusively in AgRP neurons and activated them with delivery of light
(Figure 41.e). As expected (Aponte et al., 2011), optogenetic activation of AgRP neurons increased
food intake (Figure 41.f). Optogenetic activation of AgRP neurons attenuated CFA-induced paw
size (Figure 4.1g, 4.1h). Importantly, activating AgRP neurons also reduced the CFA-induced
increase in temperature, suggesting that the neural circuits activated by hunger are sufficient to
recapitulate hunger’s suppression of both indications of inflammation (Figure 4.1i, 4.1j).
How does AgRP neuron signaling reduce peripheral paw inflammation? To explore the
possibility that this central circuit mediates a rapid change in peripheral cytokines that influence
inflammation, we next measured circulating levels of inflammatory cytokines following formalin paw
injection (Figure 4.1k). We found a significant reduction in levels of TNFα (Figure 4.1l) following
AgRP neuron stimulation. These data suggest that AgRP neuron activity may ultimately signal the
periphery to decrease levels of inflammatory cytokines during food deprivation that can lead to
reduction in inflammation.
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Interestingly, activation of AgRP neurons was unable to reduce CFA-induced paw volume
to the same extent as food deprivation. To understand AgRP neuron activity during food
deprivation, we used fiber photometry to monitor calcium signaling of AgRP neurons while
undergoing food deprivation. We engineered mice to express a genetically encoded calcium
indicator in AgRP neurons and monitored neural activity of AgRP neurons in response to a food
pellet at increasing hours of deprivation (Figure 4.2a, 4.2b). AgRP neurons reach peak activation
after 4 hours of food deprivation (Figure 4.2c, 4.2d). However, paw volume does not reach its peak
attenuation until after 18 hours of food deprivation (Figure 4.2e). In fact, after 4 hours of food
deprivation, paw volume appears to be attenuated to the same degree as AgRP chemogenetic and
optogenetic activation (Figure 4.1). This suggests that AgRP neurons are only one piece of the
complicated relationship between food deprivation and injury-induced edema. From here, we
sought to identify the pathway by which AgRP neurons are partially reducing CFA-induced paw
volume.

AgRPàPVH and AgRPàPBN subpopulations reduce inflammation.
Hypothalamic AgRP hunger neurons project to multiple targets throughout the brain from
the ARC (Betley et al., 2013; Broberger et al., 1998). Because AgRP neurons form anatomical
subpopulations that do not collateralize (Betley et al., 2013), we were able to individually stimulate
each axon projection to explore where hunger information is transmitted to suppress inflammation.
We performed a systematic analysis of the major AgRP neuron projection subpopulations by
activating individual projections in ad libitum fed mice and measuring CFA-induced changes in paw
volume (Figure 4.3a). We found that activation of AgRP projection subpopulations in the PVH and
PBN reduced paw volume after CFA (Figure 4.3b). In contrast, activation of projection
subpopulations to the BNST, PVT, LH, CeA, and PAG had no effect on paw volume (Figure 4.3b).
This reduction is dependent on the expression of ChR2, as light stimulation of control mice had no
effect (Figure 4.3c). Interestingly, we found a difference in these two axonal populations to influence
paw temperature. AgRPàPVH stimulation reduced CFA-induced paw temperature, however
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AgRPàPBN stimulation did not change paw temperature (Figure 4.3d-4.3g). Further, neither
population was able to reduce TNFα levels at the paw (Figure 4.h). We verified activation of each
brain region through feeding assay, pain assays, and histology (Alhadeff et al., 2018; Betley et al.,
2013) (Figure 4.4). The PVH and PBN are dense, complex structures with many cell types and
functions. We next wanted to identify the subpopulation within each structure that AgRP is inhibiting
to reduce paw inflammation.

No tested subpopulations within the pvh and pbn were able to reduce paw inflammation.
The PVH and PBN are dense brain regions with numerous cell types participating in many
behavioral and physiological functions (see Appendix 1 and 2). We sought to identify the
subpopulation of neurons within the PVH and PBN mediating the reduction in inflammation during
AgRP inhibition of each structure. We started investigating the PVH by testing two major neuron
populations previously implicated in regulating the immune system and inflammation: OXT and
CRH neurons. OXT is a critical hormone in maintaining resilience to stressors, including
inflammation, and typically inhibits proinflammatory cytokines (Carter et al., 2020) Manipulation of
PVHOXT neurons had no effect on inflammation as both chemogenetic activation (HM3D) and
inhibition (HM4D) did not change paw size in ad libitum (Figure 4.5a) or food deprived (Figure 4.5b)
mice. We then tested activation of the central corticosterone system since glucocorticoids are
believed to regulate the immune system (Rivest, 2001; Webster et al., 2002). Optogenetic (Figure
4.5c) and chemogenetic (Figure 4.5d) activation of PVHCRH neurons had no effect on inflammation
in ad libitum fed mice. During food deprivation, chemogenetic activation of PVHCRH also had no
effect on inflammation compared to controls (Figure 4.5e).
We have already implicated the PBN to regulate behavioral pain responses associated
with inflammatory agents, we therefore started our interrogation of the PBN by looking at the
populations that influenced pain behavior (Alhadeff et al., 2018). Chemogenetic inhibition of
vesicular glutamate transporter 2 expressing (VGLUT2) neurons in the PBN reduced pain behavior
during the formalin pain assay, however, PBNVGLUT2 inhibition was unable to reduce paw
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inflammation (Figure 4.6a). To specifically test if PBN neurons reducing inflammation are the same
as PBN neurons attenuating pain behavior, we took advantage of mutant TRAP mice (FosCreERT2)
(Corder et al., 2019). We expressed inhibitory DREADDs (HM4D) into the PBN of TRAP mice
followed by the induction of activity-dependent DNA recombination during a formalin pain assay
(Figure 4.6b). This allowed for HM4D expression exclusively in neurons within the PBN that were
activated during the 1 h formalin pain assay. Chemogenetic inhibition of PBN pain neurons failed
to cause a change in paw volume (Figure 4.6c).

Discussion
How does food deprivation, and AgRPàPVH and PBN signaling, ultimately result in reduced
inflammation? The central control of inflammation is in part mediated by the HPA axis (Waldburger
and Firestein, 2010). This system originates in the PVH and results in secretion of peripheral antiinflammatory glucocorticoids. While food deprivation is well-known to increase circulating
glucocorticoids, activating AgRP neurons does not significantly elevate plasma corticosterone
(Steculorum et al., 2016), even though a subset of AgRP neurons densely innervate the PVH.
Because it is unlikely that AgRP neurons are influencing these anti-inflammatory pathways, it is
plausible that AgRP neurons are instead reducing inflammation through the inhibition of
proinflammatory signals. In fact, both the PVH (Elmquist and Saper, 1996; Elmquist et al., 1996;
Ericsson et al., 1994; Fulwiler and Saper, 1984; Moga et al., 1990; Sagar et al., 1995) and the PBN
(Herbert et al., 1990; Mascarucci et al., 1998) have already been implicated in the central nervous
system proinflammatory response originating from the NTS. Catecholaminergic neurons from the
NTS directly target PVH neurons to activate the HPA axis, while glutamatergic signaling by NTS
neurons in the PBN initiates visceral reflexes and transmits immune-sensory information to
forebrain structures (Goehler et al., 2000; Herbert et al., 1990). Because AgRP neurons are
inhibitory, it is possible that they block proinflammatory outputs from these pathways
We found that our circuit manipulations failed to reduce edema to the same degree as food
deprivation. An intact immune system is critical for survival. Because of this, there are multiple
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redundant pathways to ensure the detection of threats (Goehler et al., 2000). Here we identified
two pro-inflammatory pathways, NTSàPVH and NTSàPBN, that are likely interrupted by AgRP
activity. However, food deprivation is a complex full body condition that influences multiple systems
outside the AgRP circuit. Alternate immune organs and pathways could be influenced by the severe
level of food deprivation leading to a breakdown of multiple pathways of the pro-inflammatory
response to CFA that are not captured in our AgRP neuronal activation model of hunger.
We found a parallel of AgRPàPBN to reduce injury-induced edema and inflammatory pain
behavior and affect. It will be imperative for future work to determine whether the same or different
PBN neurons mediate these two distinct but likely related functions. The PBN is believed to send
immunosensory input to the CeA (Ericsson et al., 1994; Elmquist et al., 1996; Tkacs and Li, 1999)
to integrate sensory information with an emotional context to produce the appropriate autonomic
response (Roozendaal et al., 1990; LeDoux, 1995). The CeA could be the downstream target of
these PBN neurons to enact both responses: decreased edema and fear.
Since we were unable to find specific cell types within the AgRP hunger pathway reducing
inflammation, we questioned how inflammatory signals could be interacting with the central nervous
system. The vagus nerve is a major pathway for bilateral communication between the periphery
and central nervous system (Berthoud and Neuhuber, 2000; Goehler et al., 2000; Yuan and
Silberstein, 2016). We next evaluated if the vagus nerve was critical for hunger to reduce CFAinduced paw inflammation.
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Figure 4.1 | AgRP neuron activity reduces peripheral paw inflammation.
(a) Schematic and representative image of Cre-dependent hM3D-mCherry expression in AgRPIRES-cre mice, scale bar, 200 µm. (b) 60 min food intake measurement following saline or 1 mg/kg
CNO administration in ad libitum fed AgRP hM3D-expressing (n=10) mice (paired t-test, p<0.001).
(c) Increase in paw volume 24 h after CFA injection in ad libitum fed AgRP hM3D-expressing (n=12)
mice before and 75 min after 1 mg/kg CNO administration (paired t-test, p<0.001). (d) Increase in
paw volume 24 h after CFA injection in ad libitum fed AgRP mCherry-expressing (n=7) mice before
and 75 min after 1 mg/kg administration of CNO (paired t-test, p=0.153). (e) Schematic and
representative image of Cre-dependent ChR2-eYFP expression in Ai32 x AgRP-IRES-Cre mice
with an optical fiber over the ARC to selectively activate AgRP neurons, scale bar, 200 µm. (f) 60
min food intake measurements without (-) and with (+) optogenetic stimulation in ad libitum fed
AgRP ChR2-expressing (n=12) mice (paired t-test, p<0.001). (g) Increase in paw circumference
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24 h after CFA injection in ad libitum fed control (n=7) and AgRP ChR2-expressing (n=9) mice
(unpaired t-test, p<0.01). (h) Increase in paw volume 24 h after CFA injection in ad libitum fed AgRP
ChR2-expressing (n=12) mice before (-) and after (+) 60 min of optogenetic stimulation (paired ttest, p<0.001). (i) Paw temperature 24 h after CFA injection of ad libitum fed AgRP ChR2expressing mice (n=8) before (-) and after (+) 1 h of optogenetic stimulation (paired t-test, p=0.010).
(j) Percent change in paw temperature before (-) and after (+) 1 h of optogenetic stimulation (paired
t-test, p=0.010). (k) Experimental timeline: Control or AgRP ChR2-expressing mice were injected
with formalin and given laser stimulation for 1 h before blood collection. (l) Relative levels of blood
TNFα following 1 h of laser stimulation to control (n=6) or AgRP ChR2-expressing (n=6) mice
(unpaired t-tests, p<0.05). Data are expressed as mean ± SEM, t-tests: *p<0.05, **p<0.01,
***p<0.001.

98

Figure 4.2 | AgRP activity peaks after 4 hours of food deprivation, however, 18 hours of food
deprivation maximally reduces CFA-induced edema.
(a) Representative image showing GCAMP6s expression in AgRP neurons of AgRP-IRES-Cre
mice. (b) Schematic showing the dual-wavelength fiber photometry setup used to monitor AgRP
neuron activity during food deprivation. (c) Calcium-dependent (mean, green; SEM, green shading)
and calcium-independent (mean, gray; SEM, gray shading) change in fluorescence (∆F/F) in AgRP
neurons in response to a food pellet at increasing hours of food deprivation (one-way repeated
measures ANOVA, p=0.0211). (d) Peak calcium-dependent ∆F/F in response to a food pellet at
increasing hours of food deprivation. (e) Increase in paw volume at various time points after food
removal in mice (n=12) injected with CFA (one-way repeated measures ANOVA, p<0.001). Data is
expressed as mean + SEM, t-tests: *p<0.05, ***p<0.001.
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Figure 4.3 | AgRPàPVH and AgRPàPBN neuron activity suppresses CFA-induced paw
inflammation.
(a) Diagram of the major AgRP projection subpopulations analyzed. Delivery of light to individual
axon target fields of ChR2 expressing AgRP neurons (PVH shown here) allows for selective
activation of discrete AgRP neuron projection subpopulations. (b) Increase in paw volume 24 h
after a CFA injection in mice before (-) and after (+) 1 h of optogenetic stimulation of AgRP neuron
projection subpopulations (n=8-9/group, two-way mixed effects ANOVA, Holm-Sidak post hoc,
PVH p<0.001, PBN p=0.045, all other structures p=ns). (c) Increase in paw volume 24 h after a
CFA injection of mice before (-) or after (+) 1 h of light exposure to AgRP neuron projection
subpopulations (PVH, PBN) with control expression of tdTomato (n=6/group, two-way mixed effects
ANOVA, p=0.863). (d) Paw temperature 24 h after CFA injection in mice (n=6) before (-) and after
(+) 1 h of optogenetic stimulation of AgRP neuron projections in the PVH (paired t-test, p=0.044).
(e) Percent change in paw temperature before (-) and after (+) 1 h of optogenetic stimulation of
AgRP neuron projections in the PVH (n=6) (paired t-test, p=0.049). (f) Paw temperature 24 h after
CFA injection in mice (n=5) before (-) and after (+) 1 h of optogenetic stimulation of AgRP neuron
projections in the PBN (paired t-test, p=0.563). (g) Percent change in paw temperature before (-)
and after (+) 1 h of optogenetic stimulation of AgRP neuron projections in the PBN (n=5) (paired t100

test, p=0.521). (h) Concentration of TNFα detected in paws 24 h after CFA injection in ad libitum
fed (n=6), food deprived (n=6), AgRPàPVH optogenetic stimulation (n=6) and AgRPàPBN
optogenetic stimulation (n=5) mice (one-way ANOVA, p=0.012). Data are expressed as mean ±
SEM, t-test and post-hoc comparisons: *p<0.05, ***p<0.001.
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Figure 4.4 | Axon targets were confirmed through feeding assays, pain assays, and
histology.
(a) ChR2-evoked feeding before (-) and after (+) 1 h stimulation of AgRPàBNST, PVT, PVH, and
LH axon targets (paired t-tests, p=0.002 for PVT, p<0.001 for all other structures). (b) Time spent
licking during formalin assay in ad libitum fed (n=5) and AgRPàPBN stimulated mice (n=7)
(unpaired t-test, p=0.012). (c) Fiber placement over the CeA, scale bar = 400 µm, and fos activation
in the ARC after 1 h of AgRPàCeA axonal stimulation, scale bar = 100 µm. (d) Fiber placement
over the PAG, scale bar = 400µm, and Fos activation in the ARC after 1 h of AgRPàPAG axonal
stimulation, scale bar = 100µm. Data are expressed as mean ± SEM, t-test and post-hoc
comparisons: *p<0.05.
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Figure 4.5 | Manipulations of PVHOXT and PVHCRH neurons had no effect on CFA-induced
paw volume.
(a) Increase in paw volume after CFA injection in OXT-IRES-cre mice expressing PVHmCherry (n=3),
PVHHM3D (n=5), or PVHHM4D (n=4) 75 minutes after 1mg/kg CNO administration (one-way ANOVA,
main effect of virus p=0.862). (b) Increase in paw volume after CFA injection and 24 h food
deprivation in OXT-IRES-cre mice expressing PVHmCherry (n=3), PVHHM3D (n=5), or PVHHM4D (n=4)
75 minutes after 1mg/kg CNO administration (one-way ANOVA, main effect of virus p=0.298). (c)
Increase in paw volume after CFA injection in Ai32 x CRH-IRES-cre mice (n=7) before (-) and after
(+) 60 min of optogenetic stimulation (paired t-test, p=0.920). (d) Increase in paw volume after CFA
injection in CRH-IRES-cre mice expressing PVHmCherry (n=5) or PVHHM3D (n=6) 75 minutes after
1mg/kg CNO administration (unpaired t-test, p=0.528). (e) Increase in paw volume after CFA
injection and 24 h food deprivation in CRH-IRES-cre mice expressing PVHmCherry (n=5) or PVHHM3D
(n=6) before (0) and after (75) 1mg/kg CNO administration (paired t-tests, p=0.901, p=0.695). Data
expressed as mean ± SEM.
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Figure 4.6 | Manipulations of PBN populations capable of reducing inflammatory pain had
no effect on CFA-induced paw volume.
(a) Increase in paw volume after CFA injection in VGlut2-IRES-cre mice expressing PBNmCherry
(n=7) or PBNHM4D (n=7) 75 minutes after 1mg/kg CNO administration (unpaired t-test, p=0.407). (b)
Schematic for strategy to express HM4D in “PBN pain neurons” using Fos Trap mice. (c) Increase
in paw volume after CFA injection in Fos Trap mice expressing PBNmCherry (n=2) or PBNHM4D (n=7)
75 minutes after 1mg/kg CNO administration (unpaired t-test, p=0.249). Data expressed as mean
± SEM.
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CHAPTER 5:

HUNGER USES THE EFFERENT PATHWAY OF THE VAGUS NERVE TO
REDUCE PERIPHERAL INFLAMMATION

The vagus nerve, also known as cranial nerve 10, is critical for communication between
the periphery and central nervous system. The vagus transmits sensory information from peripheral
organs to the brain and returns motor output to regulate heart rate, respiration, gut motility, and
endocrine signaling among other things (Berthoud and Neuhuber, 2000; Yuan and Silberstein,
2016). To carry out these dual functions, the vagus nerve is composed of two signaling pathways:
the afferent and efferent pathways. Vagal afferents detect interoceptive stimuli such as pain,
pressure, nutrient levels, and inflammation through chemosensors and mechanosensors (Berthoud
and Neuhuber, 2000). This information is transmitted to the brain, integrated among different
structures, and returned to the periphery through vagal efferents (Craig, 2003). The vagus nerve
allows for bidirectional communication and control of physiological functions to be tailored to the
organism’s mood, environment, and physiology at any given moment.
Both vagal pathways are composed of bipolar cells with cell bodies located in the nodose
ganglion. The afferent pathway collects sensory information in the periphery and transmits it to the
NTS and area postrema. Second order sensory neurons in the NTS carry information to other
regions of the brain including the PBN, the hypothalamus, and motor nuclei in the medulla
(Berthoud and Neuhuber, 2000). The central nervous system then returns information to the
periphery via vagal efferents in the dorsal motor nucleus (DMX) (Yuan and Silberstein, 2016). The
afferent pathway is primarily composed of glutamatergic neurons expressing the transient receptor
potential cation channel subfamily V member 1 (TRPV1), while most efferent neurons are
cholinergic (Berthoud and Neuhuber, 2000; Yuan and Silberstein, 2016). Together these two
branches of the vagus nerve communicate and integrate information to elicit physiological changes
to adapt to acute and chronic stimuli within the organism and in its surrounding environment.
Due to the vagus nerve’s branching, chemosensation, and bidirectional communication, it
is a key player in immunosensory detection and integration with the central nervous system. The
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vagus nerve has afferent endings surrounding all major organs allowing for immediate recognition
of inflammatory signals (Goehler et al., 2000; Pavlov and Tracey, 2012). The vagus nerve is also
surrounded by dendritic cells. Dendritic cells are immunochemosensors located throughout the
body. They detect pathogenic threats through TOLL-like receptors or by engulfing pathogenic
particles. Once activated, dendritic cells release proinflammatory molecules include cytokines and
chemokines that activate the vagus nerve (Sousa et al., 1999). The vagus nerve expresses many
different types of immunoreceptors that allows the nerve to be responsive to inflammatory
molecules. In fact, the cytokines can induce fos activation in vagal neurons (Goehler et al., 2000).
Since the vagus nerve is poised so well for immune-to-brain communication, it is likely that the
vagus is playing a role in anti-inflammatory effect of hunger.

Subdiaphragmatic vagotomy disrupts the anti-inflammatory effect of hunger.
The vagus nerve is known to influence the immune system by bridging the periphery with
the central nervous system through the inflammatory reflex (Bonaz et al., 2017; Goehler et al.,
2000; Pavlov and Tracey, 2012; Pavlov et al., 2003b). The inflammatory reflex initiates neural,
endocrine, and behavioral responses to immune threats as an immediate innate defense
mechanism to reestablish homeostasis (Bonaz et al., 2016, 2017). To understand if vagal signaling
is responsible for the attenuation of CFA-induced paw inflammation during food deprivation, we
performed a bilateral subdiaphragmatic vagotomy (VGX) as previously described (Alhadeff et al.,
2019) (Figure 5.1a). This procedure destroys both the afferent and efferent connections of the
vagus nerve preventing communication between the gut and the central nervous system.
Importantly, this type of vagotomy leaves connections to the cardiac and respiratory systems intact.
VGX and sham-operated mice both had a large inflammatory response to CFA resulting in similar
increases in paw volume. However, after food deprivation, sham-operated mice had significantly
smaller paws compared to VGX mice. Food deprivation failed to reduce the paws of VGX mice to
the same extent as sham-operated mice (Figure 5.1b). This suggests that hunger is incapable of
its full anti-inflammatory effect without vagal signaling.
106

Pharmacological blockade of all vagal output pathways disrupts the anti-inflammatory
effect of hunger.
We verified this result by pharmacologically blocking the inflammatory outputs of the vagus
nerve. The vagus nerve communicates between the central nervous system and inflammatory
pathways through adrenergic, corticosterone, and cholinergic signaling pathways (Bonaz et al.,
2017) (Figure 5.2a, adapted from Bonaz et al., 2017). We tested the influence of each of these
pathways on the relationship between hunger and inflammation. First, we looked at the HPA. Vagal
afferents can influence immune responses through interaction with the HPA. In fact, VGX rats fail
to show the proinflammatory response to a model of septic shock typically initiated by the HPA
(Goehler et al., 1997; Watkins et al., 1995). Further, vagal afferents can activate the NTS in
response to inflammatory cytokines leading to a release of anti-inflammatory glucocorticoids from
the HPA to balance the immune response (Bonaz et al., 2017). To test the role of the HPA, we
used corticotropin releasing factor (CRF) antagonists to prevent the output from the HPA and
therefore render vagal communication ineffective. Systemic treatment with a CRF1 antagonist,
antalarmin, and CRF2 antagonist, astressin 2B, had no effect on paw volume measurements
compared to controls (Figure 5.2b). The vago-parasympathetic reflex uses acetylcholine as a
modifier of the immune system. Specifically, the release of acetylcholine on to α7 nicotinic
acetylcholine receptors (nAChRs) on macrophages causes a reduction in the release of proinflammatory cytokines (Jonge and Ulloa, 2007; Wang et al., 2003). To test the role of the vagoparasympathetic reflex on the anti-inflammatory effect of hunger, we blocked all nAChRs using the
antagonist mecamylamine during hunger. Mice systemically treated with mecamylamine had no
difference in paw size compared to controls (Figure 5.2c). We also specifically tested the role of α7
nAChR with the antagonist methyllycaconitine (MLA). Mice systemically treated with MLA also had
no difference in paw size compared to controls during food deprivation (Figure 5.2d.) The vagus
can also connect the immune-to-brain axis through the vago-sympathetic reflex. Through the vagosympathetic reflex, the vagus nerve activates the spleen to reduce TNFα production through
adrenergic signaling to T-cells (Bonaz et al., 2017; Rosas-Ballina et al., 2011). To test the role of
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the vago-sympathetic reflex in food deprivation, we blocked beta adrenergic signaling using
propranolol and SR59230A. Antagonism of beta adrenergic signaling had no effect on paw volume
in food deprivation compared to controls (Figure 5.2e). We also tested the vago-sympathetic reflex
by removing the spleen and therefore removing the output of vagal nerve activation. Splenectomy
mice failed to show a difference in paw volume compared to sham mice during ad libitum or food
deprived conditions (Figure 5.2f).
Pharmacological blockade of each output path of the vagus nerve had no effect on paw
inflammation just like our pharmacological manipulations previously (see Figure 3.6). With
redundancy and complexity in mind, we next tried to block all three pharmacological outputs form
the vagus by administering a cocktail of adrenergic, corticosterone, and cholinergic antagonists.
Simultaneous blockade of these three signaling pathways during food deprivation failed to reduce
CFA-induced paw volume to the same extent as control treated mice (Figure 5.2g), recapitulating
the effect of surgical VGX. Together these data suggest that food deprivation is partially working
through the vagus nerve to reduce CFA-induced edema. Completely eliminating vagal signaling to
and from the central nervous system either through surgical removal or pharmacological
antagonism during food deprivation prevents the full attenuation of CFA-induced paw volume by
food deprivation.

Hunger influences CFA-induced inflammation through the efferent vagus nerve.
The VGX and pharmacology studies revealed a role for the vagus nerve in reducing
inflammation during hunger, however, it did not tell us which direction of communication is
responsible. Since the afferent and efferent pathways of the vagus nerve serve different functions,
we sought to determine a directionality to the vagus nerve’s influence on CFA-induced inflammation
during hunger. To do this we used an afferent pathway specific vagotomy technique. Capsaicin is
a neurotoxin that can ablate afferent fibers of the vagus nerve through binding of TRPV1 receptors
(Berthoud, Patterson, Willing, Mueller, & Neuhuber, 1997; Hölzer, 1991, Prechtl & Powley, 1990;
Sengupta & Gebhart, 1994). After administration of capsaicin, mice will no longer have afferent
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signaling from the periphery through the vagus to the brain but will still have brain to periphery
signaling through efferent fibers (Figure 5.3a). We verified that the capsaicin vagotomy (CAPS)
ablated the afferent fibers through a cholecystokinin (CCK) feeding assay, hot plate assay and
formalin pain assay. Administration of the satiation hormone CCK prevents food deprived animals
from immediately eating chow. While CCK caused sham mice to eat very little chow, CAPS mice
ate significantly more chow during the 30-minute assay (Figure 5.3b). CAPS mice also had a
significantly longer latency to react on the hot plate than sham mice (Figure 5.3c). Interestingly,
CAPS mice also had differences in paw licking during the inflammatory phase of the formalin pain
assay. CAPS mice spent significantly less time licking their paw in response to the inflammatory
pain compared to sham mice (Figure 5.3d). Through these three assays, we were confident that
our CAPS model was successful at ablating the majority of vagal afferent neurons. To evaluate the
role of the afferent vagus in inflammation, we measured CFA-induced inflammation to in ad libitum
fed and food deprived animals. Both capsaicin and control treated mice had an increase in paw
volume after a CFA injection while ad libitum fed showing that the immune response to injury was
still intact. Interestingly, both groups also had a similar decrease in paw volume after food
deprivation suggesting that the afferent vagus is not mediating the anti-inflammatory effect of
hunger (Figure 5.3e). This shows that gut to the brain communication via the afferent fibers is not
necessary. The different phenotypes between the VGX and CAPS models leads us to propose that
efferent vagal fibers are mediating the anti-inflammatory effect of hunger.
While we have not directly tested the role of efferent vagal fibers in our CFA model, we
wanted to see if there are differences in the activation of each pathway during hunger. To do this
we looked at fos staining in the brainstem at structures where each path integrates with the central
nervous system. The afferent pathway projects on to NTS neurons while the efferent pathway
projects from the DMX (Berthoud and Neuhuber, 2000). These two brain regions are in proximity
of each other but have different expression profiles. The main identifier for NTS neurons is CCK,
while DMX neurons express choline acetyltransferase (ChAT). It is well known that NTS neurons
are activated by feeding. D’Agostino et al. (2016) showed that NTSCCK neurons express the
109

immediate early gene fos after consuming nutrients but not when fasted (Figure 5.4a, 5.4b; adapted
from D’Agostino et al., 2016) Conversely, preliminary data shows that DMXChAT neurons become
active during food deprivation as evident by fos staining (Figure 5.4c). Together with our VGX and
pharmacology studies, this suggests that the efferent fibers are the critical pathway in the vagus
nerve to reduce CFA-induced inflammation during hunger.

Discussion
The vagus nerve has already been implicated in bridging the central nervous system with the
immune system. The vagus nerve is well poised to serve as an immunosensory organ because it
branches throughout the body and, thus, can have immediate detection of acute threats (Goehler
et al., 2000). In fact, the vagus nerve expresses immunoreceptors that respond to the presence of
cytokines and chemokines in the lymph and vascular systems (Goehler et al., 1997, 1999). Further,
cytokines activate vagal sensory neurons as indicated by staining for the immediate early gene fos
(Goehler et al., 2000). Our work shows that AgRP neurons can influence injury-induced edema
responses mediated by the vagus likely through inhibition of the PVH and PBN. This finding
corroborates two locations already known to be involved in central nervous system inflammatory
pathways. When an immune threat is detected by the vagus nerve, excitatory inputs are transmitted
to NTS. There is a parallel and redundant pro-inflammatory pathway from the NTS to both the PVH
(Ericsson et al 1994, Sagar et al. 1995, Elmquist et al 1996, Fulwiler and Saper 1984, Moga et al
1990, Elmquist and Saper 1996) and the PBN (Herbert et al 1990, Schaffar et al., 1997, Mascarucci
et al 1998). Both pathways are dependent on the vagus as subdiaphragmatic vagotomies prevents
neuronal activation (Wan et al., 1994; Gaykema et al., 1995; Kapcala et al., 1996). We suggest that
AgRP neurons can block these pathways at the PVH and PBN ultimately prevent pro-inflammatory
signaling and changing the output of the vagus through efferent fibers to suppress injury-induced
edema.
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Figure 5.1 | Mechanical destruction of both vagal pathways attenuates the suppression of
CFA-induced paw inflammation during food deprivation.
(a) Diagram of sub-diaphragmatic vagotomy procedure. (b) Increase in paw volume after CFA
injection of sham- (n=11) and VGX- (n=13) operated mice during ad libitum fed and food deprived
states (two-way ANOVA, main effect of operation p=0.049; main effect of state: p<0.001). Data
expressed as mean ± SEM; post-hoc comparisons: **p<0.01, ***p<0.001; two-way ANOVA
interaction: ∞p<0.05; ANOVA main effect: ☼p<0.05.
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Figure 5.2 | Pharmacological blockade of anti-inflammatory vagal outputs attenuates the
anti-inflammatory effect of hunger.
(a) Diagram of anti-inflammatory vagal pathways adapted from Bonaz et al. 2017. (b) Increase in
paw volume of mice injected with CFA, food deprived and treated with saline (n=8) or 30mg/kg
antalarmin and 15μg/kg astressin 2B (A/A) (n=8) to block CRF signaling (unpaired t-test, p=0.756.
(c) Increase in paw volume of mice injected with CFA, food deprived and treated with saline (n=8)
or 5mg/kg mecamylamine (Mec) (n=8) to block nAChRs (unpaired t-test, p=0.659). (d) Increase in
paw volume of mice injected with CFA, food deprived and treated with saline (n=8) or 5mg/kg
methyllycaconitine (MLA) (n=8) to block α7 nAChRs (unpaired t-test, p=0.677). (e) Increase in paw
volume of mice injected with CFA, food deprived and treated with saline (n=8) or 10mg/kg
propranolol and 5mg/kg SR59230A (P/S) (n=8) to block adrenergic signaling (unpaired t-test,
p=0.506). (f) Increase in paw volume of mice injected with CFA in sham- (n=4) and splenectomy(n=6) operated mice during ad libitum fed and food deprived states (two-way ANOVA, main effect
of operation p=0.909; main effect of state: p<0.001). (g) Increase in paw volume of mice injected
with CFA, food deprived and treated with saline (n=8) or a cocktail of A/A, Mec, and P/S (n=8) to
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block all vagal signaling (unpaired t-test, p=0.002). Data expressed as mean ± SEM; t-test and
post-hoc comparisons: *p<0.05, **p<0.01
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Figure 5.3 | The afferent vagal pathway is not required for the anti-inflammatory effect of
hunger.
(a) Diagram of vagal pathways ablated by systemic treatment with capsaicin. (b) CCK-induced
feeding in sham- (n=10) or capsaicin- (n=8) treated (CAPS) mice after 24 h food deprivation
(unpaired t-test, p=0.004). (c) Latency to paw withdraw of sham- (n=10) or capsaicin- (n=8) treated
mice on 52°C hot plate (unpaired t-test, p<0.001). (d) Time spent licking paw during phase II of
formalin pain assay in sham- (n=4) and CAPS- treated mice (n=7) (unpaired t-test, p=0.040). (e)
Increase in paw volume after CFA injection in sham- (n=8) or capsaicin- (n=10) treated mice in ad
libitum fed and food deprived states (two-way ANOVA, main effect of treatment p=0.435; main
effect of state: p<0.001). Data expressed as mean ± SEM; t-test and post-hoc comparisons:
*p<0.05, **p<0.01, ***p<0.001.
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Figure 5.4 | Hunger is likely working through the efferent pathway to reduce inflammation.
(a) Representative fos labeling in the NTS of CCK reporter mice during ad libitum fed, fasted or
fasted then re-fed mice (white arrows denote colocalized neurons, scale bar = 200 μm) (adapted
from D’Agostino et al., 2016). (b) Quantification of fos positive NTSCCK neurons (n=3-4) (one way
ANOVA, p<0.001) (adapted from D’Agostino et al., 2016) (c) Representative fos activation (green)
in ChAT positive (red) DMX neurons of mice ad libitum fed or 24 h food deprived (scale bar = 100
μm).
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CHAPTER 6:

METHODS FOR INFLAMMATION EXPERIMENTS
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STAR Methods
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice were group housed on a 12 h light/12 h dark cycle with ad libitum access to food (Purina
Rodent Chow, 5001) and water unless otherwise noted. Vivarium rooms are controlled between
21.5 and 22.3 degrees Celsius with maintained with negative pressure between -191.6 to 109.5
Pascal. Group housed adult male and female mice (at least 8 weeks old) were used for
experimentation. Agrp-IRES-Cre (Jackson Labs 012899, Agrptm1(cre)Lowl/J) (Tong et al., 2008), CrhIRES-cre (Jackson Labs 012704, B6(Cg)-Crhtm1(cre)Zjh/J), Oxt-IRES-cre (Jackson Labs 024234,
B6;129S-Oxttm1.1(cre)Dolsn/J), Vglut2-IRES-cre (Jackson Labs 016963, Slc17a6tm2(cre)Lowl/J),
Ai32 (Jackson Labs 012569, B6;129S-Gt(ROSA)26Sortm32(CAG-COP4*H134R/EYFP)Hze/J) (Madisen et al.,
2012), Ai9 (Jackson Labs 007909, B6.Cg-GT(ROSA)26Sortm9(CAG-tdTomato)Hze/J) (Madisen et
al., 2012), TRAP2 (Fostm2.1(icre/ERT2)Luo/J)(Allen et al., 2017), CD1 (Charles River 022) and
C57BL6 (Jackson Labs 000664) mice were used for experimentation. All mice were habituated to
handling and experimental conditions prior to experiments. We performed experiments in both male
and female subjects and did not observe any trends or significant sex differences. Thus, to ensure
our studies were appropriately powered and to minimize the number of subjects who had to
undergo painful procedures, we combined males and females for analyses in all experiments. All
procedures were approved by the University of Pennsylvania Institutional Animal Care and Use
Committee.

METHOD DETAILS
Recombinant Adeno-Associated Virus (rAAV) Constructs:
The following Cre-dependent rAAV vectors were used: AAV1-Syn-Flex-GCaMP6s-WPRE-SV40
(titer: 4.216e13 GC/mL), AAV5.Ef1a.doublefloxed-hChR2(H134R)-WfP-wPRE-HGHpA (titer:
1x1013 vg/mL, Addgene 20298), AAV5.hSyn.DIO.hM3D(Gq).mcherry (titer: 7×10¹² vg/mL, Addgene
44361), AAV8.hSyn.DIO.mcherry (titer: 1x1013 vg/mL, Addgene 50459). These viruses were
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purchased from Addgene. Flex, Cre-dependent ﬂip-excision switch. GCaMP, Genetically encoded
calcium indicator resulting from a fusion of GFP, M13 and Calmodulin. WPRE, woodchuck hepatitis
virus response element. ChR2, channelrhodopsin-2. hSyn, human Synapsin 1 promoter. DIO,
double-floxed inverse orientation. hM3, human M3 muscarinic receptor.
Viral Injections, Fiber Optic and Cannula Placement:
Bilateral viral injections and unilateral implantation of ferrule-capped optical fibers (200-µm core,
NA 0.37 for optogenetic stimulation) were performed as previously described (Alhadeff et al., 2018).
For somatic stimulation of AgRP neurons, Agrp-IRES-Cre mice were crossed with Ai32 mice to
express ChR2 in AgRP neurons. Mice were anesthetized with isoflurane (1.5-3%), given ketoprofen
(5 mg/kg) and bupivacaine (2 mg/kg) analgesia and placed into a stereotaxic device (Stoelting). An
optical fiber was placed over the arcuate hypothalamic nucleus (ARC) at bregma -1.35 mm, midline
±0.25 mm, skull surface -5.8 mm. For axonal stimulation of AgRP neurons, a rAAV encoding Credependent ChR2 was bilaterally injected into the ARC of AgRP-IRES-Cre mice using the
aforementioned ARC injection coordinates (150 nl per site, bilaterally). Optical fibers were
implanted unilaterally according to the following coordinates: BNST: bregma +0.85 mm, midline
±0.82 mm, skull surface -3.8 mm; PVH: bregma -0.5 mm, midline ±0.2 mm, skull surface -5.4 mm;
PVT: bregma -1.0 mm, midline ±0.0 mm, skull surface -2.7 mm; LH: bregma -1.0 mm, midline ±0.9
mm, skull surface -5.4 mm; CeA: bregma -1.15 mm, midline ±2.4 mm, skull surface -4.25 mm;
ARC: bregma -1.35 mm, midline ±0.25 mm, skull surface -5.8 mm; PAG: bregma -4.4 mm,
midline ±0.6 mm, skull surface -2.8 mm; lateral PBN: bregma -5.8 mm, midline ±1.2 mm, skull
surface -3.7 mm. Fibers were secured to the skull with bone screws and dental cement. Mice were
given at least 3 weeks for recovery and transgene expression. For fiber photometry (FP)
experiments, unilateral injections of a virus designed to express GCaMP6s for AgRP neurons were
performed in the arcuate hypothalamicnucleus (ARC, 300mL total) according to the coordinates
above. A ferrule-capped optical fiber (400-mm core, NA 0.48, Doric, MF2.5, 400/430-0.48) was
implanted 0.2 mm above the injection site and secured to the skull with Metabond cement (Parkell,
S380) and dental cement (Lang DentalManufacturing, Ortho-jet BCA Liquid, B1306 and Jet Tooth
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Shade Powder, 143069). For chemogenetic inhibition of AgRP neurons, PVHOXT, PVHCRH,
PBNVGLUT2, and PBN FosTrap pain neurons, the appropriate transgenic cre mouse was bilaterally
injected (300nl/hemisphere) with Cre-dependent rAAV encoding inhibitory Designer Receptors
Exclusively Activated by Designer Drugs (DREADDs, HM4D) or Cre-dependent rAAV encoding
excitatory Designer Receptors Exclusively Activated by Designer Drugs (DREADDs, HM3D). Fiber
placements and viral expression were verified post-mortem.
Complete Subdiaphragmatic Vagotomy:
Mice were maintained on a liquid diet (Ensure Plus Vanilla, Abbott, 53642) for at least 3 days prior
to surgery to promote survival and recovery. Mice were anesthetized with isoﬂurane (1.5%–3%)
and treated with subcutaneous meloxicam (5 mg/kg), bupivacaine (2 mg/kg) and buprenorphine
SR (1 mg/kg) analgesia. An abdominal midline incision was made through skin and muscle. The
stomach was laporotomized to expose the esophagus, and the dorsal and ventral vagal trunks
were then exposed by gently teasing them apart from the esophagus. The vagal trunks were
resected and cauterized. Control mice received a sham surgery that consisted of all surgical
procedures except for the resection and cauterization of the vagus nerve. Functional veriﬁcation of
vagotomy was conﬁrmed by examining CCK induced anorexia (see below). Histological veriﬁcation
of vagotomy was conﬁrmed using an i.p. injection of 0.1% Fluoro-Gold and examining Fluoro-Gold
presence in the dorsal motor nucleus of the vagus (DMX) 5 days post-injection.
Capsaicin-Induced Vagotomy:
4-week-old mice were treated with varying 3 doses of capsaicin for 2 days to ablate the afferent
vagal pathway. Mice were pretreated with an i.p. injection of 0.3mg/kg atropine 30 minutes before
each capsaicin dose. Mice were maintained at 1.5-3% isoflurane 10 minutes prior to capsaicin
treatment and for 30 minutes post injection. On day 1, mice received 8mg/kg capsaicin in the
morning and 15mg/kg in the evening. On day 2, mice received a second 15mg/kg dose of capsaicin.
Mice were given 4 weeks to recover from the procedure before being used for experiments. Vagal
afferent ablation was verified by examining CCK induced anorexia, and pain measurements.
119

Splenectomy:
Mice were anesthetized with isoﬂurane (1.5%–3%) and treated with subcutaneous meloxicam (5
mg/kg), bupivacaine (2 mg/kg) and buprenorphine SR (1 mg/kg) analgesia. An abdominal midline
incision was made through skin and muscle. The stomach was laporotomized to expose the spleen.
The spleen was resected and cauterized. Control mice received a sham surgery that consisted of
all surgical procedures except for the resection and cauterization of the spleen.
FosTrap “pain neuron” capture:
Trap2 mice with bilaterally injections of HM4D were i.p. injected with 50mg/kg of 4hydroxytamoxifen (dissolved in ethanol and diluted in corn oil, and subsequent removal of ethanol
by evaporation). Mice then underwent a formalin pain assay (described below).
General Experimental Design:
For each experiment, our subject numbers were determined by our pilot studies, laboratory
publications, and power analyses [power=0.8, significance level=0.05, effect sizes=10-30%]. For
within-subject behavioral analyses, all mice received all experimental conditions. For betweensubject analyses, mice were randomly assigned to experimental condition. For all behavioral
experiments, virus expression, fiber placements, and/or cannula placements were verified postmortem, and any mice with viral expression or implants outside of the area of interest were excluded
from all analyses.
Induction of Peripheral Inflammation by Noxious Chemical Stimuli:
To induce inflammation mice were injected subcutaneously in the dorsal hind paw with 20 µl of 2%
formalin or saline (control). To induce longer-term inflammation, mice were injected subcutaneously
in the plantar hind paw with 30 μL of 1:1 ratio of Complete Freund’s Adjuvant (CFA) and saline.
Doses and volumes of chemicals were based on previous work from our lab and others’ (Alhadeff
et al., 2018; Carey et al., 2017; Hamm and Lyeth, 1984; Hunskaar and Hole, 1987; Marchand et
al., 2005).
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In Vivo Photostimulation:
Photostimulation of AgRP neurons was performed as previously described, with 10 ms pulses at
20 Hz for 1 s, repeated every 4 s (Aponte et al., 2011). The output beam from a diode laser (450
nm, Opto Engine) was controlled by a microcontroller (Arduino Uno) running a pulse generation
script. The laser was coupled to a multimode optical fiber (200 µm core, NA 0.37, Doric) with a 1.25
mm OD zirconium ferrule (Kientech) and mating sleeve that allowed delivery of light to the brain by
coupling to the implanted ferrule-capped optical fiber in the mouse. Power was set to ensure
delivery of at least 2 mW/mm2 to AgRP soma and at least 5 mW/mm2 to the center of the AgRP
neuron projection fields using the following software: https://web.stanford.edu/group/dlab/cgibin/graph/chart.php.
Photostimulation-induced food intake measurements:
To functionally verify our AgRP neuron stimulation, we measured 1 h AgRP neuron stimulationevoked food intake as previously described(Aponte et al., 2011). Briefly, at least one week following
ARC fiber optic implant and 3 weeks following AgRP axonal subpopulation fiber optic implant, AgrpIRES-Cre x Ai32 mice were allowed to habituate for at least one hour to a chamber with ad libitum
access to chow and water. Following the habituation period, food intake was measured for 1 h to
establish a pre-stimulation baseline. Photostimulation was performed during the next hour as
described above. After each hour, food intake was measured. Mice that consumed <0.55 g of chow
during 1 h of AgRP neuron stimulation were excluded from experiments.
Chemogenetic-induced food intake measurements:
To functionally verify our AgRP neuron activation via chemogenetic activation, we measured 1 h
AgRP neuron CNO-evoked food intake in a similar manner as for stimulation-evoked food
intake(Krashes et al., 2011). Briefly, at least three weeks following ARC HM3D injections, AgrpIRES-Cre mice were i.p. injected with CNO (1 mg/kg) or saline and allowed to habituate for fifteen
minutes to a chamber with access to water. Chow was then added to the chamber and food intake
was measured after 1 h. Feeding assay were performed in a counterbalanced manner so that each
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mouse received both a CNO and saline injection on different days. Mice that consumed <0.55 g of
chow during 1 h of AgRP neuron chemogenetic activation were excluded from experiments.
Food Deprivation/Restriction:
For 24 h food deprivation, mice were placed in a cage with alpha dry bedding and ad libitum access
to water, but no food, 24 h prior to experimentation. For chronic food restriction, mice were weighed
at the same time each day and given chow once daily (1.5–3.0 g) after experimentation to maintain
85%–90% of their starting body weight.
Effect of AgRP Neuron Stimulation on Food Intake.
Mice were allowed to habituate for at least one hour to a chamber with a lined floor and ad libitum
access to chow and water. Following the habituation period, food intake was measured for 1 h to
establish a prestimulation baseline. Photostimulation was performed during the next hour. After
each hour, food intake was measured. For somatic AgRP neuron stimulation, only mice that
consumed > 0.6 g of chow were included in experiments, see Figure 4.1f. Food intake evoked by
stimulation of each AgRP neuron projection subpopulation was measured and reported in Figure
4.4a.
Effect of AgRP Neuron Activation on Food Intake.
Mice were allowed to habituate for 15 min after an i.p. injection of saline or CNO (1mg/kg) to a
chamber with a lined floor and ad libitum access to water. Following the habituation period, food
intake was measured for 1. CNO and saline trials were counterbalanced across mouse so that
each mouse received both conditions over the course of a week. Only mice that consumed > 0.6 g
of chow were included in experiments, see Figure 4.1b.
Effect of CCK on Food Intake.
Sham or capsaicin-treated mice were overnight food deprived and given i.p. injections of CCK (10
mg/kg in saline). Food intake was measured after 30 min.
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QUANTIFICATION OF INFLAMMATION
Paw Volume Measurements:
Mice were anaesthetized with 1.5-3% isoflurane for a baseline paw volume measurement as well
as for inflammation-induced paw volume measurements. The plethysmometer (Ugo Basile, Italy,
37140) water cell was filled with a saline solution to create a visible meniscus. Before each trial,
the plethsymometer was calibrated with a 0.5 mL calibrating weight. The anesthetized mouse was
then positioned so that the paw was submerged in the solution up to the ankle joint and the volume
was recorded. Both paws were measured and recorded for all animals. Paw measurements were
taken by experimenters blinded to the experimental conditions. Mice were kept in their home cages
in the intervening time between paw measurements. Mice who had a raw CFA-induced paw volume
less than 0.25 were eliminated from experiments to ensure all mice had sufficient inflammation to
make comparisons. To analyze the data, paw volume measurements taken after the CFA injection
were compared to their original paw volume pre-injection using the following equation:
to obtain a percent increase from baseline paw volume.

Paw Circumference Measurements:
Mice were anaesthetized with 1.5-3% isoflurane for a baseline paw circumference measurement
as well as for inflammation-induced paw circumference measurements. A thin string was tied and
marked around the middle of the paw, ensuring all digits were included in the measurement.
Marked strings were measured by experimenters blinded to experimental condition. Mice were kept
in their home cages in the intervening time between injection and paw measurement.
Paw Temperature Measurements:
Mice were lightly anesthetized with 1.5-3% isoflurane. Mice were positioned so that their paw was
flat on a cardboard surface. Using an FLIR T450sc Professional Thermal Camera, paws were
imaged with the temperature sensor positioned in the center of the paw and the corresponding
temperature was recorded.
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Paw TNFα measurements:
Mice were heavily sedated using isoflurane prior to sample collection. Hindpaws were cut at the
patella, flash frozen on dry ice in 2 mL tubes, and stored at -80°C. Immediately before the ELISA,
hindpaw samples were crushed and placed in 2mL tubes with 3 mm zirconium beads and 1 mL of
lysis buffer (Invitrogen, FNN0071), and PMSF protease inhibitor (0.5 mM). Samples were shaken
in a microtube homogenizer at 3 times at 400 rpm for 30 seconds each time. 100 uL of the resulting
supernatant were collected for the ELISA and not diluted further. TNF-α concentration was
measured using a mouse Quantikine ELISA Kit (R&D Systems, Minneapolis, MN). The sensitivity
of this assay is 7 pg/mL.
Histopathology Analysis:
Animals were anesthetized with 3% isoflurane and the legs were removed at the hip joint. Paws
were rinsed in cold PBS then post-fixed in 10% formalin for 72 h on a shaker at room temperature.
Paws were then stored in 50% EtOH. After fixation, the entire legs were decalcified in 15% formic
acid for 12h and two sections at the level of the tarsus, going through the footpad, were obtained
and processed for paraffin embedding, sectioning and staining with hematoxylin and eosin. The
slides were evaluated semi-quantitatively by board certified veterinary pathologists, blinded to the
experimental group distribution.
For immunohistochemistry, 5 µm thick paraffin sections were mounted on ProbeOn™ slides
(Thermo Fisher Scientific). The immunostaining procedure was performed using a Leica BOND
RXm automated platform combined with the Bond Polymer Refine Detection kit (Leica #DS9800).
Briefly, after dewaxing and rehydration, sections were pretreated with the epitope retrieval BOND
ER2 high pH buffer (Leica #AR9640) for 20 minutes at 98°C. Endogenous peroxidase was
inactivated with 3% H2O2 for 10 minutes at room temperature (RT). Nonspecific tissue-antibody
interactions were blocked with Leica PowerVision IHC/ISH Super Blocking solution (PV6122) for
30 minutes at RT. The same blocking solution also served as diluent for the primary antibody. Rat
monoclonal primary antibody against CD45-LCA (BD Biosciences; #553076) was used at a
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concentration of 1:300 and incubated on the sections for 45 minutes at RT. A biotin-free polymeric
IHC detection system consisting of HRP conjugated goat anti-rat IgG (Vector Laboratories MP7444) was then applied for 25 minutes at RT. Immunoreactivity was revealed with the
diaminobenzidine (DAB) chromogen reaction. Slides were finally counterstained in hematoxylin,
dehydrated in an ethanol series, cleared in xylene, and permanently mounted with a resinous
mounting medium (Thermo Scientific ClearVueTM coverslipper). Pooled sections of murine
lymphoid tissues, including the cervical and mesenteric lymph nodes and the spleen, served as
positive controls. Negative controls were obtained either by omission of the CD45-LCA antibody or
replacement with an irrelevant isotype-matched rat monoclonal antibody.
The IHC slides were scanned at 20X magnification using a Leica Aperio AT2 slide scanner (Leica
Biosystems, Inc., Buffalo Grove, IL) and image acquisition and analysis was performed with
ImageScope (Leica Biosystems, Inc., Buffalo Grove, IL). A single positive pixel count algorithm was
generated to quantify the area of CD45-LCA positivity, while the total area of tissue on the slide
was measured using a Genie algorithm.
Effect of Food Deprivation on Formalin-Induced Peripheral Inflammation
Food was removed 24 h prior to formalin injection. Ad libitum fed mice served as controls. Paw
volume and paw circumference were measured 60-min post-injection.

Effect of Food Restriction on Formalin-Induced Peripheral Inflammation
Mice were maintained at 85-90% BW for 1 week prior to receiving a CFA paw injection. Paws were
measured 3 h, 24 h, 48 h, 72 h, and 168 h after the injection while still maintained on the restrictive
diet.
Effect of Food Deprivation on CFA-Induced Peripheral Inflammation
Ad libitum fed mice were injected with CFA and placed back into their home cage with water but
no food for 24 h. Ad libitum fed mice served as controls. Mouse BW, sex, and age were noted for
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all animals. Paw volume, circumference, and temperature were measured 24 h post-CFA injection.
Hindpaws were harvested after all measurements for use in histopathology anaylsis or TNFα
measurements.
Effect of Refeeding on CFA-Induced Peripheral Inflammation
Paw volume was measured before CFA injection and 24 h post injection. Mice were then food
deprived for 24 h and paw volume measured again. Ad libitum access to food was returned and
paw volume was remeasured.
Effect of NSAIDs on CFA-Induced Peripheral Inflammation
Ad libitum fed and food deprived mice received a subcutaneous injection of 10% ethanol in saline,
ketoprofen (30 mg/kg) (Costa et al., 2020; Girard et al., 2008), or ketorolac (30 mg/kg)(Russo et
al., 2017; Shin et al., 2006) 24 h after CFA injection. Doses were picked for their potent analgesic
and anti-inflammatory effects. Paw volume was measured 1 h post i.p. injection.
Effect of AgRP Neuron Activation on CFA-Induced Peripheral Inflammation
Mice received i.p. injection of CNO (1 mg/kg) to activate AgRP neurons 24 h after CFA injection.
Paw volume was measured 75 min after CNO administration.

Effect of Corticosterone Signaling on CFA-Induced Peripheral Inflammation.
Mice received i.p. injections of 10mg/kg corticosterone (Carter et al., 2013) or vehicle 24 h after
CFA injection. Paw volume was measured 1 h after corticosterone administration.
Mice were food deprived for 24 h and received I.p. injections of 25m/kg RU486 (Masson et al.,
2010) after CFA injection. Paw volume was measured 1 h after RU486 administration.
24 h after CFA paw injections, Mice were placed in restraint tubes for 1 h. Paw volume was
measured before and after the restraint stress.
Effect of Neurokinin Signaling on CFA-Induced Peripheral Inflammation.
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Mice received i.p. injections of 5mg/kg L-733-060 (Bang et al., 2003) or saline 24 h after CFA
injection. Paw volume was measured 1 h after L-733-060 administration.
Mice were food deprived for 24 h and received i.p. injections of 5ug/kg substance P (Growcott and
Shaw, 1979) or saline after CFA injection. Paw volume was measured 1 h after substance P
administration.
Effect of Opioid Signaling on CFA-Induced Peripheral Inflammation.
Mice received subcutaneous injections of 0.1mg/kg buprenorphine (Cho et al., 2019) or saline 24
h after CFA injection. Paw volume was measured 1 h after buprenorphine administration.
Mice were food deprived for 24 h and received i.p. injections of 10mg/kg naloxone (Nakagawa et
al., 1995) or saline after CFA injection. Paw volume was measured 1 h after naloxone
administration.
Effect of Oxytocin Signaling on CFA-Induced Peripheral Inflammation.
Mice were food deprived for 24 h and received i.p. injections of 1mg/kg oxytocin (İşeri et al., 2005)
or saline after CFA injection. Paw volume was measured 1 h after oxytocin administration.

Effect of Leptin Signaling on CFA-Induced Peripheral Inflammation.
Mice were food deprived for 24 h and received injections of 1mg/kg leptin (Zhou et al., 2021) or
saline after CFA injection. Paw volume was measured 1 h after leptin administration.
Effect of Ghrelin Signaling on CFA-Induced Peripheral Inflammation.
Mice received i.p. injections of 1mg/kg ghrelin (Egecioglu et al., 2010) or saline 24 h after CFA
injection. Paw volume was measured 1 h after ghrelin administration.
Effect of Serotonin Signaling on CFA-Induced Peripheral Inflammation.
Mice were food deprived for 24 h and received I.p. injections of 1mg/kg serotonin (Souza et al.,
2013) or saline after CFA injection. Paw volume was measured 1 h after serotonin administration.
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Effect of the Microbiome on CFA-Induced Peripheral Inflammation.
To deplete the gastrointestinal microbiota, mice were treated with a combination of ampicillin,
vancomycin, metronidazole, and kanamycin at a concentration of 1 gram each per liter of drinking
water (Virtue et al., 2019). After 10 days of antibiotic treatment, mice were injected with CFA.
Following paw measurements 24 h after injection, mice were food deprived and paws were
remeasured.
Effect of AgRP Neuron Stimulation on CFA-Induced Peripheral Inflammation
Mice received a CFA paw injection. Mice received optogenetic stimulation of AgRP neurons for 1
h. Paw volume and temperature were measured prior to CFA injection, 24 h post-CFA injection,
and 1 h after stimulation.
Effect of AgRP Subpopulations on CFA-Induced Peripheral Inflammation
Mice received a CFA paw injection. Mice received optogenetic stimulation of AgRP target
subpopulations for 1 h. Paw volume and temperature were measured prior to CFA injection, 24 h
post-CFA injection, and 1 h after stimulation.

Effect of PVH Subpopulations on CFA-Induced Peripheral Inflammation
Mice with mCherry, HM3D, or HM4D expression in PVHOXT neurons received CNO (1mg/kg) 24 h
after a CFA paw injection. Paw volume was measured 75 min after CNO administration. Mice were
then food deprived for 24 h and retreated with CNO. Paw volume was measured 75 min after CNO
administration.
24 h after CFA injection, mice received optogenetic stimulation of PVHCRH neurons for 1 h. Paw
volume was measured 1 h after stimulation.
Mice with mCherry, HM3D, and HM4D expression in PVHCRH neurons received CNO (1mg/kg) 24
h after a CFA paw injection. Paw volume was measured 75 min after CNO administration. Mice
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were then food deprived for 24 h and retreated with CNO. Paw volume was measured 75 min after
CNO administration.
Effect of PBN Subpopulations on CFA-Induced Peripheral Inflammation.
Mice with mCherry or HM4D expression in PBNVGLUT2 neurons received CNO (1mg/kg) 24 h after
a CFA paw injection. Paw volume was measured 75 min after CNO administration.
Mice with mCherry or HM4D expression in PBN Fos Trap pain neurons received CNO (1mg/kg) 24
h after a CFA paw injection. Paw volume was measured 75 min after CNO administration.
Effect of the Vagus Nerve on CFA-Induced Peripheral Inflammation.
Sham- and VGX-operated mice were injected with CFA. 24 h later paws were measured, and mice
were subsequently food deprived. Paws were measured again 24 h after food deprivation.
Sham- and CAPS-treated mice were injected with CFA. 24 h later paws were measured, and mice
were subsequently food deprived. Paws were measured again 24 h after food deprivation.
Effect of CRF signaling on CFA-Induced Peripheral Inflammation.
Mice were food deprived for 24 h and received I.p. injections of 30mg/kg antalarmin and 15ug/kg
Astressin 2B or vehicle after CFA injection. Paw volume was measured 1 h after administration of
CRF antagonists.
Effect of Cholinergic Signaling on CFA-Induced Peripheral Inflammation.
Mice were food deprived for 24 h and received I.p. injections of 5mg/kg mecamyllamine or saline
after CFA injection. Paw volume was measured 1 h after mecamyllamine administration.
Mice were food deprived for 24 h and received I.p. injections of 5mg/kg methyllycaconitine or saline
after CFA injection. Paw volume was measured 1 h after methyllcaconitine administration.
Effect of Adrenergic Signaling on CFA-Induced Peripheral Inflammation.
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Mice were food deprived for 24 h and received I.p. injections of 10mg/kg propranolol and 5mg/kg
SR59230A or vehicle after CFA injection. Paw volume was measured 1 h after administration of
adrenergic antagonists.
Effect of the Spleen on CFA-Induced Peripheral Inflammation.
Sham- and splenectomy-operated mice were injected with CFA. 24 h later paws were measured,
and mice were subsequently food deprived. Paws were measured again 24 h after food deprivation.
Effect of the Vagal-Immune Pathway on CFA-Induced Peripheral Inflammation.
Mice were food deprived for 24 h and received I.p. injections of a mixture of 30mg/kg antalarmin,
15ug/kg Astressin 2B, 5mg/kg mecamylamine, 10mg/kg propranolol and 5mg/kg SR59230A or
vehicle after CFA injection. Paw volume was measured 1 h after administration of adrenergic
antagonists.
Dual-wavelength Fiber Photometry
Dual-wavelength FP was performed as we and others have previously described (Lerner et al.,
2015; Su et al., 2017; Zalocusky et al., 2016). Two excitation wavelengths were used: 490 and 405
nm. 490 nm excites calcium-dependent ﬂuorescence from GCaMP6 protein, providing a measure
of AgRP neuron activity. 405 nm excites calcium-independent ﬂuorescence from GCaMP6 protein
and serves as a control for movement and bleaching artifacts. Excitation light intensities were
modulated at different frequencies (211 and 566 Hz for 490 and 405 nm, respectively) to avoid
contamination from overhead lights (120 Hz and harmonics) and cross-talk between excitation
lights. Excitation lights were generated through ﬁber-coupled LEDs (Thorlabs, M470F3 for 490 nm
and M405F1 for 405 nm) and modulated by a real-time ampliﬁer (Tucker-Davis Technology, RZ5P).
Excitation lights were passed through bandpass ﬁlters (Thorlabs, MF469-35 for 490 nm and FB40510 for 405 nm) before being collimated and combined by a 425-nm long-pass dichroic mirror
(Thorlabs, DMLP425). The combined excitation light was sent into a patch cord made of a 400-mm
core, NA 0.48, low-ﬂuorescence optical ﬁber (Doric, MFP_400/430/1100-0.48_1.5_FCM-MF). The
patch cord was connected to an implanted ﬁber contained in a 2.5-mm diameter ferrule via an
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interconnector (Thorlabs, ADAF2). GCaMP6 emission ﬂuorescence signals were collected through
the same patch cord, collimated, passed through a GFP emission ﬁlter (Thorlabs, MF525-39), and
focused onto a femtowatt photoreceiver (Newport, Model 2151, gain set to AC LOW) using a lens
(Edmund Optics, 62-561). The emission lights were converted to electrical signals, sampled at 1017
Hz, and demodulated by the RZ5P real-time processor. The FP experiments were controlled by
Synapse software (Tucker-Davis Technology). Synchronized infra-red cameras (Ailipu Technology,
ELP-USB100W05MT-DL36) controlled by Synapse were used to video-record mice during FP
experiments. Prior to experimentation, mice were habituated to experimental procedures. All FP
experiments occurred in each individual’s home cage with the lid removed. Baseline GCaMP6
ﬂuorescence signals were set to similar levels by adjusting the output power of 490and 405-nm
LEDs. To achieve maximum sensitivity of signals, the 490-nm signal was set to occupy 50% of the
detection range of the photoreceiver (20-100 mW at the tip of the ﬁber accounting for variations in
GCaMP6 expressions and optical ﬁber positions over AgRP neurons). The 405-nm signal was set
to occupy 5% of the detection range (2-10 mW output power at the tip of the ﬁber) to avoid
saturating the detector. Baseline GCaMP6 ﬂuorescence was recorded prior to a stimulus (5 min),
and post-stimulus ﬂuorescence was compared to baseline ﬂuorescence as described below.
Fiber Photometry Data Analysis
Demodulated data were exported from Synapse to MATLAB (MathWorks) using a script provided
by Tucker-Davis Technology. The 490- and 405-nm signals were independently processed and
normalized to baseline signals to determine DF/F, where DF/F = (F-Fbaseline)/Fbaseline and
Fbaseline is the median of pre-stimulus signal. No isosbestic normalization was introduced. Data
were down-sampled to 1 Hz in MATLAB. The subsequent processing of FP data was performed in
MATLAB and Excel. Mean DF/F was calculated by integrating DF/F over a period of time and then
dividing by the integration time. Minimum and maximum DF/F were calculated by taking the
averaged 10 s mean DF/F for each mouse at the average minimum or maximum of each
recording.
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Fiber Photometry Recordings During Food Intake
At least 1 week following surgery, mice were food-restricted and screened for their neural response
to chow refeeding. Baseline calcium activity was recorded for 5 min, and for 10 min following
presentation of chow. Mice that had < 20% DF/F (AgRP neurons) or < 10% DF/F (POMC, DAT
neurons or DA signal) were excluded from experiments. Further, to eliminate movement and
bleaching artifacts and ensure that changes in DF/F were not due to a loose ﬁber connection, FP
recordings with more than 15% change in the 405-nm signal were excluded from analyses.
Effect of Food Deprivation on Neural Activity
Ad libitum fed mice were removed from their home cage without access to chow towards the end
of their light cycle. FP recordings were performed at various time points at the end of the light cycle
through the dark cycle to evaluate changes to AgRP neural activity as the animal became hungry.

Inflammatory Pain Measurements (Formalin Test):
Mice were placed in a clear enclosure for a 10 min habituation period. Mice were subcutaneously
injected in the dorsal hindpaw with 2% formalin (20 µl). Mice were monitored for time spent licking
paw, and number of lick bouts, for 1 h post-injection by researchers blinded to experimental
condition. All sessions were video-recorded. The time spent paw licking was recorded for 1 h and
analyzed during the inflammatory phase (15-45) pain responses.
Effect of AgRPàPBN stimulation on Inflammatory Pain.
Mice received optogenetic stimulation of AgRPàPBN neurons mice received beginning 10 min
prior to formalin injection and lasting throughout the formalin test. Paw licking was recorded for 1 h
post formalin injection. The inflammatory phase of the formalin assay (15-45 m) was presented.
Effect of Capsaicin-Induced Vagotomy on Inflammatory Pain.
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Sham- and capsaicin-treated mice were injected with formalin in the dorsal hindpaw. Paw licking
was recorded for 1 h post formalin injection. The inflammatory phase of the formalin assay (15-45
m) was presented.
Thermal Pain Measurements (Hotplate Test):
A cast iron plate with plexiglass walls was placed on a hotplate and heated to 52ºC. Mice were
placed on the hotplate and latency to withdraw the paw was recorded by researchers blinded to
experimental condition.
Effect of Capsaicin-Induced Vagotomy on Thermal Pain.
Sham- and capsaicin-treated mice were tested on the hotplate. Latency to withdraw paw were
recorded.
Immunohistochemistry and Imaging:
Mice were transcardially perfused with 0.1 M phosphate buffered saline (PBS) followed by 4%
paraformaldehyde (PFA). Brains were removed and post-fixed for 4 h in PFA and then washed
overnight in PBS. Coronal brain sections were cut (150 µm sections) on a vibratome or cryostat
and stored in PBS. Brain sections were incubated overnight at 4°C with primary antibodies diluted
in PBS, 1% BSA and 0.1% Triton X-100. Antibodies used: rabbit anti-cFos (1:5,000, Cell Signaling,
2250), sheep anti-GFP (1:2000, AbD Serotec 4745-1051), goat anti-ChAT (1:2000, Millipore,
AB144P). Sections were washed 3 times and incubated with species appropriate and minimally
cross-reactive fluorophore-conjugated secondary antibodies (1:500, Jackson ImmunoResearch)
for 2 h at room temperature. Sections were washed twice with PBS and mounted and coverslipped
with Fluorogel. Epifluorescence images were taken on a Leica stereoscope to verify fiber
placements, cannula placements, and to obtain low magnification images. Confocal micrographs
were taken on a Leica SPE laser scanning microscope using a 20X, 0.75 NA objective for
visualization of Fos immunoreactivity.
STATISTICAL ANALYSES
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Data were expressed as means ± SEMs in figures and text. Paired or unpaired two-tailed t-tests
and Pearson regressions were performed as appropriate. One-way, two-way, and repeated
measures ANOVA were used to make comparisons across more than two groups using Prism.
Test, statistics, significance levels, and sample sizes for each experiment are listed in
Supplementary Table 1. ns p>0.05, t-tests and post-hoc comparisons: *p<0.05, **p<0.01,
***p<0.001; interaction: ∞p<0.05, ∞∞p<0.01, ∞∞∞p<0.001; main effect (group, state or drug):
☼<0.05, ☼☼p<0.01, ☼☼☼p<0.001.
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CHAPTER 7:

GENERAL DISCUSSION

We have uncovered the ability of a central circuit activated by food deprivation to reduce
inflammatory pain and inflammation (Table 7.1). We demonstrate that hunger specifically reduces
inflammatory pain behavior, leaving intact the response to more acute threats like mechanical and
thermal pain. Hunger also reduces peripheral paw inflammation by reducing swelling, temperature,
and TNFα levels at the injury site. Hunger activated AgRP neurons ramify throughout the brain to
influence behavior and physiology to prioritize food consumption. After interrogation of each AgRP
subpopulation we found that one axonal target reduced pain behavior, AgRPàPBN, while two
regions reduced inflammation, AgRPàPVH & PBN. NPY sensitive glutamatergic neurons in the
PBN are critical for the reduction in inflammatory pain behavior. Our investigation of neuron
populations responsible for reducing inflammation within the PVH and PBN were unsuccessful,
however, we found that the efferent pathway of the vagus nerve is likely bridging the CNS with the
periphery to reduce inflammation. Taken together, these findings reveal a central neural target that
can inhibit pain behavior and peripheral inflammation, providing new insight into how food
deprivation can influence non-feeding related behaviors and physiology.

Why does food deprivation influence pain and peripheral inflammation?
While inflammation is an adaptive response to injury, long-term inflammation and associated
pain can become maladaptive and prevent basic actions necessary for survival. When faced with
a homeostatic challenge such as food deprivation, neural circuits prioritize the most salient need.
We found a prime example of this as hunger, through AgRPàPBN neuron signaling, inhibits
responses to inflammatory pain (Alhadeff et al., 2018). It has become apparent that AgRP neurons
have a more complex relationship with hunger than just food intake. In fact, AgRP neurons and
their axonal target subpopulations have been broadly implicated in a hierarchical prioritization of
behavior, as their activity influences other survival needs. AgRP neuron activation yields a dire
hunger state that can shift biological need. With artificial AgRP activation, sleep, fear/anxiety, and
aggression are all altered (Burnett et al., 2016; Dietrich et al., 2015; Goldstein et al., 2018; Jikomes
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et al., 2016; Padilla et al., 2016) (Figure 7.1). AgRP neurons encourage a wake state, inhibiting the
drive to sleep presumably to ensure the capability of taking advantage of any feeding opportunity
(Goldstein et al., 2018). Anxiety and fear behavior are attenuated while risk taking behavior is
promoted during AgRP activation to avoid the fear of predation or injury from preventing the animal
to forage for food (Burnett et al., 2016; Jikomes et al., 2016; Padilla et al., 2016). Thus, an emerging
concept in the neurobiology of homeostasis suggests that need-sensing neurons, such as AgRP
neurons, use multiple mechanisms to inhibit competing behavioral drives.
While AgRP neuron stimulation is well known to influence behavior, the current work describes
physiological changes that are driven by activity in AgRP neurons. Specifically, we show that AgRP
neuron stimulation attenuates inflammation following paw injections of noxious chemicals in part
by reducing pro-inflammatory cytokines. Previous studies have shown that AgRP neuron activity
can also influence metabolism (Krashes et al., 2011), glucose homeostasis (Könner et al., 2007;
Steculorum et al., 2016) and autonomic nerve activity (Bell et al., 2017). These widespread effects
of activity in approximately 10,000 AgRP neurons highlight the pivotal role of AgRP neurons in
influencing both physiology and behavior (Betley et al., 2013).
How do so few neurons influence so much biology? The anatomical configuration of AgRP
circuits lends to a logic that promotes parallel, segregated, and distinct functional consequences.
For example, AgRP neuron projections to the BNST, PVT, PVH, and LH drive food intake (Betley
et al., 2013), and similar projections (to the anterior BNST and LH) mediate effects on glucose
homeostasis (Steculorum et al., 2016). In contrast, AgRP projections that do not directly drive food
intake filter noxious environmental and physiological stimuli to indirectly enable food intake
(Alhadeff et al., 2018; Essner et al., 2017; Padilla et al., 2016; Wu et al., 2012a). In addition to our
previous work demonstrating a role for AgRPàPBN signaling in behavioral responses to pain
(Alhadeff et al., 2018), here we identify a neural circuit architecture that attenuates peripheral
inflammation. It will be imperative for future work to determine the exact mechanism of how this
central signal is rapidly relayed to the periphery to reduce inflammation.
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While it is known that the central nervous system has bidirectional communication with the
immune system, these findings provide new neuron populations, AgRPàPVH and AgRPàPBN,
that are capable of reducing localized injury-induced edema. By developing an understanding of
how central and peripheral signals interact to inhibit inflammation, these experiments provide novel
targets for the development of analgesic and anti-inflammatory therapies.

The insular cortex is poised to be the hub that integrates inflammation and hunger cues to
prioritize feeding behaviors in formalin and CFA-models of inflammation.
Through this dissertation, we have investigated the role of AgRP projections in reducing
pain and inflammation at various subpopulations which include brainstem, midbrain, and forebrain
structures. However, we did not look beyond these regions to other areas that are known to
integrate interoceptive information. AgRP neurons are interoceptive cells that sense nutrients and
hormones in the body to determine the appropriate metabolic response. It is well established that
interoception requires integration by the cortex to enact the appropriate response to the peripheral
cues (Craig, 2003). The insular cortex is of particular importance as imaging studies have shown
context dependent activation for gustation behaviors in both rodents and primates (Frank et al.,
2013; Small et al., 2003; Veldhuizen et al., 2011). The insular cortex is able to use gustatory cues
to predict when satiation will be accomplished and anticipate the appropriate responses (Livneh et
al., 2020). To achieve gustatory awareness, the insular cortex combines information from all organ
systems and cues to create the proper physiological and behavioral output. For example, cardiac
fluctuations, stomach distention, and nutrients detection trigger changes to the activity in the insular
cortex (Frank et al., 2012; Herbert et al., 2012; Wang et al., 2008). It is thought that disordered
eating causes changes to insular function ultimately disrupting interoceptive capabilities. In fact,
anorexia nervosa patients have significantly higher insular cortex activation in response to food
cues, yet lower activation after consuming appetitive foods than healthy control subjects (Nunn et
al., 2011). This difference in activation suggests a disruption of the integration between internal
feeding signals and reward cues leading to disordered eating. Ultimately, anorexia nervosa patients
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are incapable of correctly detecting gustatory cues and therefore produce the appropriate response
to consumption. The insular cortex has also been implicated in inflammatory signaling. Imaging
studies have shown that systemic immune challenges activate the insular cortex, while lesion
studies have shown that it is required for pairing immune signals with conditioning cues (Harrison
et al., 2009; Ramıŕ ez-Amaya et al., 1996, 1998). Importantly, the insular cortex can also have a
direct effect on immune output in response to immune challenges. Inhibition of immune-reactive
neurons in the insular cortex significantly reduced the immune response to colitis (Koren et al.,
2021). Complementary to our work, Koren et al. (2021) have provided another example of how the
central nervous system can actively change immune responses to a targeted organ. This leads us
to question whether the insular cortex is a steppingstone for our presented AgRP mediated antiinflammatory mechanism.
AgRP neurons do, in fact, interact with circuits that project to the insular cortex. Livneh et
al. (2017) used multiple tracing approaches to identify a circuit that starts with AgRP neurons and
ends at the insular cortex. Using a combination of retrograde and anterograde tracing, they found
a four-structure pathway way: AgRPàPVTàbasal lateral amygdala (BLA) à insular cortex (Livneh
et al., 2017). While the primary pathway from AgRPàinsular cortex found in this work does not
include the AgRP axon targets we found implicated in inflammation, these researchers did find
staining in the PBN and PVH suggesting a connection to this pathway. PVH neurons were found
projecting to the BLA while PBN neurons were found through retrograde tracing from the insular
cortex (Livneh et al., 2017). This suggests that there may be some influence of these two structures
along the pathway to interoceptive processing. PVH and PBN neurons become active during
immune challenges (Buller et al., 2004; Elander et al., 2009; Ericsson et al., 1994; Goehler et al.,
2001; Hare et al., 1995; Marvel et al., 2004). Together with our data, we suspect that AgRP neurons
are able to influence peripheral inflammation through the insular cortex which then then causes a
reduction of pro-inflammatory signaling through the efferent pathway of the vagus nerve (Figure
7.2).
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Interoception and competing biological drives provide a unique entry point to develop
therapeutics for chronic inflammatory diseases.
The running theme throughout this dissertation has been focused on understanding how
biological drives can outcompete other behaviors and physiologic needs, likely through
interoception. This method of prioritizing one behavior over another is a unique method of potential
therapeutic value. Many chronic inflammatory diseases, especially autoimmune diseases, arise
from a disorder of one system that disrupts homeostasis across many systems. For instance,
obesity is classically considered as a disorder of over-consumption. However, the physiological
reality of this disease is much more complex. Obese individuals fail to have interoceptive responses
to cues other than gustatory related functions (Herbert and Pollatos, 2014). Obesity is also
compounded with high levels of inflammation, cardiac disease, respiratory disfunction, and
psychiatric disorders (Khaodhiar et al., 1999; Pi-Sunyer, 1999). Clearly a broad spectrum of
diseases, like obesity, may benefit from treatment approaches that establishes interoception, and
ultimately homeostasis, across multiple systems.
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Table 7.1 | Summary of key experimental findings to identify the pathway that hunger
functions through to reduce inflammatory pain and inflammation.
Formalin Pain
Assay

Paw volume

Temperature

TNFα

ÔÔÔ

ÔÔÔ

ÔÔÔ

ÔÔÔ

ÔÔ

ÔÔ

ÔÔ

ÔÔ

ArcAgRP à PVH

Ï

ÔÔÔ

ÔÔ

Ï

ArcAgRP à PBN

ÔÔÔ

Ô

Ï

Ï

?

Ô

?

?

ÔÔÔ

Ï

Ï

?

Hunger
ArcAgRP activation

Subdiaphragmatic
Vagotomy
Capsaicin
Vagotomy

Ï=no effect, Ô= minor effect, ÔÔ= medium effect,
ÔÔÔ= strong effect, ?=not tested
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Figure 7.1 | AgRP neurons have various effects on behavior and physiology to prioritize
food intake.
Diagram of how AgRP neurons projecting throughout the brain to influence many aspects of
behavior, metabolism, and physiology.

141

Figure 7.2 | Proposed circuit for AgRP influence on inflammation through the insular cortex
and out of the DMX (adapted from Livneh et al., 2017).
Livneh et al. (2017) found that AgRP neurons connect with the insular cortex (InsCTX) through the
PVT and BLA to allow for interoception of gustation. Our work suggests additional influence from
the PVH to change the inflammatory signaling to the insular cortex and ultimately lead to an antiinflammatory output from the DMX.
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APPENDIX A: BRIEF REVIEW OF THE ANATOMY AND FUNCTIONS OF THE PVH
The hypothalamus is a dense structure containing over eleven different subnuclei located
on the ventral surface of the brain bisected by the third ventricle. These nuclei are defined by their
location within the hypothalamus: medial to lateral as defined by the third ventricle and rostral to
caudal as defined by anterior, tuberal, and mammillary respectively (Figure A.1.1a, adapted from
Nesan and Kurrasch, 2016). The hypothalamus has two major output systems: the autonomic and
neuroendocrine systems. Through both systems, the hypothalamus integrates stimuli from the
periphery to release the appropriate behavioral and physiological response to maintain
homeostasis among all systems. The location of the subnuclei dictates the function of each
structure. Periventricular structures, bordering the third ventricle, respond to hormones, factors,
and neurotransmitters circulating in cerebrospinal fluid or the blood stream and interact with the
neuroendocrine system. Structures in the medial zone are large nuclei with receiving sensory inputs
and communicating amongst hypothalamic nuclei to coordinate adaptive behavior. The lateral
hypothalamus has dense connections between hypothalamic nuclei and out to cortical structures
allowing for global central nervous system integration of signals (Berthoud, 2002). Berthoud (2002)
created a simplified map of the hypothalamus with primary functions associated with each
substructure, however, it should be noted that the behaviors and outputs of each are not as specific
as this figure suggests (Figure A1.1b). The hypothalamus has reciprocal connections between the
limbic system structures, the brainstem, the thalamus, the basal ganglia, the retina, and the cortex.
Efferent projections are also found from the hypothalamus to the pituitary gland and motor centers
(Lechan and Toni, 2016). Given the complexity of the hypothalamus as a whole, this miniature
review will be focused on the paraventricular hypothalamus since it has been implicated in this
dissertation to mediate the anti-inflammatory effect of hunger.

Anatomy of the PVH
The PVH has two different cellular structures: the magnocelluar and parvocellular level. The
magnocellular level contains large cell bodies in the medial wings of the structure, while the
143

parvocellular level contains small to medium size neurons lining the third ventricle. The PVH has
efferent connections throughout the central nervous system including other hypothalamic
structures, the pituitary gland, and the spinal cord. The PVH communicates directly with the median
eminence through thyrotropin-releasing hormone (TRH), CRH, enkephalin, somatostatin, and
vasoactive intestinal peptide neurons parvocellular neurons (Kawano et al., 1991, Lechan and Toni,
2016). TRH and CRH initiate the hypothalamic-pituitary-thyroid axis and HPA axis (Qin et al., 2018).
Parvocellular neurons also project to the DMX and spinal cord to initiate autonomic responses
(Swanson and Kuypers, 1980). Magnocellular neurons project to the pituitary gland and secrete
arginine vasopressin and oxytocin to regulate feeding, fluid balance, and sex-specific behaviors
(Qin et al., 2018; Swanson and Kuypers, 1980). The afferent projections to the PVN are also
directed to specific sublevels. The ventrolateral medulla projects to the parvocellular level and
vasopressin magnocellular neurons. The NTS and locus coeruleus project only to parvocellular
neurons. AgRP neurons from the arcuate nucleus project to OXT magnocellular neurons and can
lead to obesity phenotypes when disrupted (Qin et al., 2018).

Stress & inflammation
PVN CRH neurons interact in the HPA stress axis. CRH neurons integrate neural input from limbic
structures and hormonal signals such as glucocorticoids and cytokines. CRH is then released to
the pituitary gland to eventually stimulate the release of more glucocorticoids from the adrenal
cortex. Glucocorticoids elicit the effects of stress on the body influencing things like metabolism
and heart rate, but also initiates immune cell migration to start local immune reactions The PVH is
key in the maintenance of feedback loops for the HPA axis as it can detect levels of circulating
glucocorticoids and adjust its output accordingly (Webster et al., 2002). PVH neurons also adjust
their reactivity to HPA axis outputs based on the time course of stress. For instance, the number of
angiotensin receptors increases on PVH neurons after extreme stress situations priming the system
for activation in future stressful environments (Armando et al., 2007; Ferguson et al., 2008;
Saavedra and Benicky, 2009).
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Metabolism
The ARC has reciprocal connections to the PVH. The PVH is primarily a feeding cessation structure
receiving input from POMC neurons onto MC4R. These MC4R neurons then project to the DMX
and brainstem to carry out the appropriate autonomic signals to prevent food intake (Garfield et al.,
2015). Additionally, PVHOXT neurons can sense leptin and boost satiation signaling in the NTS to
promote anabolic metabolism (Perello and Raingo, 2013; Sutton et al., 2014). PVHMC4R can also
be inhibit by AgRP to promote feeding behavior exemplifying the balance between opposing forces
throughout the autonomic nervous system (Qin et al., 2018). The PVH contains four receptor types
that promote satiation: Oxt, glucagon like peptide 1 receptors (Glp1r), Crh, and Mc4r (Figure A1.2).
Chronic activation of PVHGlp1r and PVHMc4r caused a significant increase in food intake leading to
obesity phenotypes, while PVHOxt and PVHCrh had no effect on food consumption or body weight
(Li et al., 2019a).

145

Figure A1.1 | The PVH is composed of multiple subnuclei with varying functions related to
autonomic and neuroendocrine systems.
(a) Coronal (left) and sagittal (right) of the mouse hypothalamus with labels for different subnuclei
defined by their anatomical location (adapted from Nesan and Kurrasch, 2016). (b) Depiction of
anatomical organization of the hypothalamus with general function labelled for each structure.
ventromedial hypothalamic nucleus (VMH), dorsomedial hypothalamic nucleus (DMH), lateral
hypothalamus (LH/LHA), suprachiasmatic nucleus (SCN), supraoptic nucleus (SON), anterior
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hypothalamic nucleus (AH), posterior hypothalamic nucleus (PH), the mammillary body (MB/MM),
supramammilary nucleus (SupM), lateral preoptic area (LPOA).
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Figure A1.2 | Examples of satiety inducing molecular markers in the PVH.
(a) Oxytocin has very dense expression throughout the PVH. (b) Glucagon-like peptide 1 receptor
is concentrated to the magnocellular layers of the PVH. (c) Corticotropin releasing hormone is
expressed densely in the mangocellular layers of the PVH. (d) Melanocortin 4 receptor is present
in the magnocellular level of the PVH. Images adapted from Allen Brain Explorer,
https://mouse.brain-map.org.
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APPENDIX B: BRIEF REVIEW OF THE ANATOMY AND FUNCTION OF THE SUB REGIONS
OF THE PBN
The PBN is large heterogeneous structure in the pontine nucleus. It surrounds the superior
cerebellar peduncles as they run between the brainstem and cerebellum. As a part of the
brainstem, the PBN is responsible for many autonomic functions(Hurley et al., 1991; Saper and
Stornetta, 2015) and acts as a relay station for visceral and sensory signals for higher order
processing(Saper and Loewy, 2016). The PBN is a complex structure that can be broken down into
three main regions: the medial PBN, lateral PBN, and Kölliker Fuse nucleus. Some of the well
characterized functions of the PBN include gustation(Biondolillo et al., 2009; Norgren, 1983;
Norgren and Pfaffmann, 1975), thermoregulation(Geerling et al., 2016; Nakamura, 2011),
breathing(Song et al., 2012; Yokota et al., 2007), appetite(Campos et al., 2016; Wu et al., 2012a),
pain(Coizet et al., 2010; Han et al., 2015), osmotic regulation(Geerling and Loewy, 2007; Ryan et
al., 2017), immune challenges(Buller et al., 2004), sleep(Gnadt and Pegram, 1986), and arousal
(Kaur et al., 2013; Muindi et al., 2016). Each function can be associated with a specific region of
the PBN (Figure B.1).

Anatomy of the PBN
The Medial PBN
The medial PBN (mPBN) is located ventral to the peduncles and has been well implicated in
gustatory sensation. The medial PBN responds to stimuli at the anterior and posterior portions of
the tongue. Taste information is transmitted to the nucleus tractus solitarii (NTS) through the facial
and glossopharyngeal nerves. The NTS then projects to the mPBN. The mPBN transmits gustatory
information to many brain regions including the thalamus, lateral hypothalamus, substantia
innominata, central nucleus of the amygdala, bed nucleus of stria terminalis, and the gustatory
cortex. The thalamus acts as the major hub for sensory information and is responsible for
transmitting the majority of taste information to the gustatory cortex. All other projection targets of
the mPBN have reciprocal connections back to the mPBN. These feedback loops allow for signal
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modulation(Norgren, 1983). The mPBN is also responsible for sleep and arousal behavior. Lesions
of the mPBN reduce wakefulness by 40%(Fuller et al., 2011). Activation of the entire PBN leads to
increased wakefulness and decreased sleep behavior. Activation of the projections from the PBN
to the preoptic area and basal forebrain or the lateral hypothalamus are sufficient in producing this
change in sleep. Inactivation of the mPBN increases rapid eye movement sleep(Kaur et al., 2013).
The Kölliker Fuse nucleus.
The Kölliker-Fuse nucleus (KF) is ventral and lateral to the peduncles and mPBN. It is responsible
for respiration and breathing rhythm. The NTS receives cardio-respiratory information from
baroreceptors in cardiac tissue and transmits this information to the KF(Michelini and Bonagamba,
1988). The KF then projects to the Phrenic nucleus in the ventral horn of the spinal cord and the
rostral ventral respiratory group in the medulla. Together, these projections control the muscle
groups required to maintain a steady breathing rhythm and heart rate. The KF also projects to the
amygdala and lateral hypothalamus. The KF is made up of VGlut2 positive glutamatergic neurons
that release glutamate onto all these structures(Yokota et al., 2007).
The Lateral PBN.
The lateral PBN (lPBN) is composed of many subregions: external lateral, lateral crescent, dorsal
lateral, central lateral, internal lateral, and ventral lateral. Each subregion can be defined by its
function. Related to cardiac and breathing rhythm, the external and dorsal lPBN responds to sodium
fluctuations. The NTS receives cardiac and vasodilation information from baroreceptors(Michelini
and Bonagamba, 1988) which is directly related to sodium levels in the system. When the body is
deprived of sodium, neurons in the external lPBN are activated. When salt is detected, the dorsal
and external lPBN neurons are activated by both the NTS and the area postrema(Geerling and
Loewy, 2007). The ventral parts of the lPBN, the lateral crescent and external lPBN, are responsible
for sleep and arousal. As stated previously, activation of the entire PBN can decrease sleep
behavior. However, the mPBN is associated with normal wake behavior and the lPBN with arousal.
Lesioning of the ventral lPBN greatly increased the latency to wake from repetitive CO2
arousals(Kaur et al., 2013). Alternatively, activating the ventral lPBN caused rats to awaken from
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anesthesia(Muindi et al., 2016). The lPBN also receives thermal information from the skin to
regulate body temperature. Thermoregulation is monitored by two parts of the lPBN: warm
responding neurons are in the lateral crescent and cool responsive neurons in the dorsal external
lPBN.

These

neuron

populations

promote

heat

dissipation

and

thermogenesis,

respectively(Geerling et al., 2016). Meal termination and appetite responsive neurons are found in
the external lPBN. Calcitonin gene related protein (CGRP) expressing neurons in the external lPBN
receives excitatory projections from the NTS and inhibitory projections from the arcuate nucleus of
the hypothalamus. These inputs balance CGRP neuron firing during different nutritional needs
states to modulate feeding behavior(Campos et al., 2016; Wu et al., 2012a). Generally, the dorsal
lPBN responds to threat stimuli including noxious, visceral, and immune challenge stimuli(Campos
et al., 2018; Palmiter, 2018). Pain stimuli are transmitted to the external lPBN through the
spinoparabrachial pathway. Lamina I neurons of the spinal cord transmit nociceptive information to
the lateral crescent and external lPBN. This information is then sent to the central amygdala and
ventromedial hypothalamus(Bester et al., 1997; Buritova et al., 1998). Immune challenges also
activate the lPBN. An immune challenge is triggered by systemic proinflammatory cytokines. Under
this condition, the NTS and ventrolateral medulla activate the external lPBN. These neurons then
project to the central amygdala and bed nucleus stria terminalis (Buller et al., 2004).

Molecular markers
It is believed that most afferent projections from the PBN are glutamatergic(Saper and Stornetta,
2015). In fact, in situ hybridization (ISH) data shows vesicular glutamate transport 2 densely
distributed throughout the PBN (Figure B.2A). Within this excitatory structure, there are also
GABAergic neurons as seen with glutamate decarboxylase 2 ISH data (Figure B.2B). There are
many markers that define the regions of the PBN as well. For example, calcitonin gene related
protein (CGRP) is highly expressed in the external lPBN (Figure A.2C). CGRP positive PBN
neurons play a role in threat detection and appetite. There are hundreds more markers within the
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PBN emphasizing the heterogeneity of this structure. A few have been particularly important in
creating mouse lines to target the lPBN(Palmiter, 2018) (Table B.1).
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Figure B2.1 | Anatomy and functions of the parabrachial nucleus.
A. The parabrachial nucleus (PBN) can be divided into three main subregions: the medial PBN
(red), the Kölliker Fuse nucleus (blue), and the lateral PBN (green). The lateral PBN can be further
broken down into smaller subregions. B. The different subregions of the PBN are responsible for
different functions. The medial PBN is responsible for sleep(Fuller et al., 2011; Kaur et al., 2013)
and gustatory(Norgren and Pfaffmann, 1975) information. The Kölliker Fuse controls breathing
rhythm(Yokota et al., 2007). The lateral PBN has a wide range of functions including: sleep &
arousal(Kaur et al., 2013; Muindi et al., 2016), thermoregulation(Geerling et al., 2016), pain and
threat responses(Bester et al., 1997; Buritova et al., 1998; Campos et al., 2018), appetite
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control(Campos et al., 2016; Wu et al., 2012a), and osmoregulation(Geerling and Loewy, 2007).
Figure adapted from Buller et al., Journal of Neuroimmunology, 2004.
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Figure B2.2 | Examples of molecular markers in the PBN.
A. Vesicular glutamate transport 2 is highly expressed throughout the PBN. B. Glutamate
decarboxylase 2 is expressed in the medial and lateral PBN. C. Calcitonin gene related protein is
densely expressed in the external lateral PBN. D. Dopamine Beta Hydroxylase is densely
expressed in the medial PBN. Images adapted from Allen Brain Explorer, http://mouse.brainmap.org.
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Table B2.1 | Subset of parabrachial nucleus genetic markers.
Molecular Marker
Foxp2
Lmx1b
Cholecystokinin
Corticotropin releasing hormone
Neurotensin
Prodynorphin
PACAP
Glycine receptor 3
Tachykinin 1
GABA A
Proenkephalin
Bombesin like receptor 3
Corticotropin releasing protein receptor 1
Leptin receptor
Mu opioid receptor
Neuropeptide Y 1 receptor
Oxytocin receptor
G protein coupled 88
Tachykinin receptor 1
Cerebellin 4
a5 nAChR
Lymphocyte antigen 6 locus h
a7 nAChR

Parabrachial Nucleus subregion(s)
Central lateral
External lateral
Medial & dorsal lateral
Dorsal lateral
External lateral
Central lateral
Lateral
Lateral
Internal & external lateral
Lateral & medial
Lateral & medial
Internal
Internal
Internal
Central
Central & external lateral
Ventral lateral
Dorsal lateral
Internal ventral lateral
Central lateral
External lateral
Lateral
Central
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